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CD23 (FcERII), the low affinity receptor for immunoglobulin E is a 45 kD type-11 
integral membrane protein which comprises a lectin-like domain, a coiled-coil stalk region. 
a single transmembrane portion and a short cytoplasmic sequence. 
CD23 bears sequence homology with C-type animal lectins which mediate 
endocytosis of their ligands. On the surface of B lymphocytes, it is non-covalently 
associated with HLA DR; the latter binds processed antigen in specialised cytoplasmic 
compartments and transports it to the cell membrane for presentation. Previous studies 
have implicated CD23 in the binding of IgE-antigen complexes and antigen presentation to 
homologous T cells. These findings imply that CD23 follows an intracellular path to 
mediate antigen processing and presentation. 
This study uses flow cytometry, confocal. and immunoelectron microscopy to 
investigate endocytosis of CD23, IgE and the cellular components involved in this process, 
in an in vitro system. In RPMI 8866 cells, antibodies BU38 and MHM6 to the lectin 
domain promote CD23 capping and endocytosis into a cytoplasmic endosomal 
compartment. Simultaneous labelling of the lectin and stalk regions of CD23 show that 
they are endocytosed together and targeted into the same cytoplasmic vesicles. An 
antibody to HLA DR induces simultaneous endocytosis of HLA DR and CD23 and alters 
the intracellular pathway of CD23. The non-covalent association of a soluble 37 kD CD23 
fragment with CD23-IgE complexes on the B cell surface is responsible for inducing 
endocytosis of CD23 and membrane-associated IgE. Upon endocytosis, IgE separates 
from CD23 and is processed into an acidic intracellular compartment. There may thus exist 
the possibility of more than one intracellular pathways for the processing of CD23, one of 
which is triggered by the presence of the 37 kD soluble CD23 fragments. 
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Chapter 1: Introduction 
1.1 INTRODUCTION 
Considerable scientific and medical interest has recently been focused on the low 
affinity receptor for immu-noglobulin E (FcF-RTI). Its interaction with the IgE antibody has 
been associated with the regulation of the IgE-antibody response, delayed allergic Z: ) 
reactions, the protective functions of cellular cytotoxicity and phagocytic clearance of 
antigen, as well as with B cell, T cell and myeloyd cell growth factor activity and the 
regulation of IgE synthesis (Delespesse et al., 1989; Conrad, 1990; Spiegelberg, 199 1). Its 
name, FcF-RII, denotes the fact that it was the second receptor to be identified which binds 
to the Fc region of IgE (Capron et al., 1986; Yukawa et al., 1987). The first receptor for 
IgE to be discovered (FcF-RI) is located on the skin mast cell and blood basophil surface 
and has been shown to mediate hypersensitivity reactions to allergens (Ishizaka, Tomioka 
& Ishizaka, 1970). It is also found on Langerhans cells and activated monocytes (Bieber et 
al., 1992; Wang et al., 1992). It has recently been discovered on eosinophils where it 
mediates IgE-dependent killing of schistosomes in vitro (Abdelillah et al., 1994). FcFRII 
was first discovered in the laboratory of Hans Spiegelberg (Spiegelberg, 1984; 
Spiegelberg, 1991). More recently, the name CD23 has been used to indicate that it is 
identical to the protein on the surface of B-lyrnphocytes which is recognized by a panel of 
monoclonal antibodies (Bonnefoy et al., 1987). This more recent name will be used in this 
work for the low affinity receptor for IgE. 
CD23 is located on the surface of B-lymphocytes where it mediates IgE-dependent 
antigen presentation to T cells and plays a role in cell to cell adhesion. It is also expressed 
by a number of other cell types including T-lymphocytes, follicular dendritic cells (FDC), 
natural killer cells (NK), Langerhans cells, epithelial cells of bone marrow and thymus, 
macrophages, eosinophils and platelets (Conrad, 1990; Delespesse et al. , 199 1; Delespesse 
et al., 1992). It was first identified in the human system as a 45 kD glycoprotein 
possessing one N-glycosylation site and other O-linked carbohydrates (Letellier, Nakajima 
& Delespesse, 1988). In the mouse, studies have defined the murine CD23 polypeptide as 
a 49 kD glycoprotein containing two sites of N-glycosylation (Keegan & Conrad, 1987). 
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CD23 is a type-11 integral membrane protein, i. e. it has its C-terminal region 
orientated extracellularly, and a short N-terminal region intracellularly. It is predicted to 
possess a single transmembrane sequence. It is classified as a C-type animal lectin since its 
extracellular region bears sequence homology with other members of the C-type animal 
lectin superfamily (Drickamer, 1981). Like other C-type animal lectins, CD23 binding to 
its ligand (IgE) is calcium-dependent (Richards & Katz, 1990). However, unlike most 
members of this superfamily which do bind carbohydrates, its binding to IgE does not 
require the recognition of the carbohydrate moieties on the IgE antibody (Drickamer, 
1988; Vercelli et al., 1989a). Moreover, CD23 is distinct from other immunoglobulin 
receptors in that it does not belong to the immunoglobulin superfamily to which all other 
known Fe receptors belong (Ravetch & Kinet, 199 1). 
Binding to CD21, a glycosylated membrane protein otherwise named CR2 
(Complement receptor 2), is the most recently attributed function of CD23. CD21 binds at 
the lectin domain region and prevents IgE attachment (Mossalayi et al., 1992). The 
association of CD23 with CD21 mediates up-regulation of IgE synthesis and the rescue of 
germinal centre B cells from apoptosis (Aubry et al., 1992; Bonnefoy et al., 1993). 
It has been suggested that CD23 exhibits autoproteolytic activity at the cell surface 
releasing soluble fragments (sCD23) (Letellier, Sarfati & Delespesse, 1989). Soluble 
CD23 fragments induce growth and differentiation of the precursors of plasma cells, T 
cells and basophils thus initiating immune responses (Sarfati et al., 1992). They are also 
involved in regulating IgE synthesis (Delespesse et al., 1992; Sarfati et al., 1992; Saxon et 
al., 199 1; Yu et al., 1994). 
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1.2 THE STRUCTURE OF CD23 
The structure of CD23 (Figure 1.1) can be divided into four distinct domains: the 
lectin domain and C-terminal tail, the coiled-coil stalk, the transmernbrane region and the 
N-terminal cytoplasmic sequence. The lectin domain is the 25 kD C-terminal extracellular 
region which contains the IgE and CD21 binding site as well as growth factor activity. The 
16 kD portion of the lectin domain which excludes the C-terminal tail bears homology 
with other C-type animal lectins. The coiled-coil stalk is the portion of the molecule 
between the lectin homology region and the transmembrane region of the protein believed 
to be responsible for oligomerisation. The single transmembrane segment anchors the 
protein and connects it to the cytoplasmic N-terminal domain. 
1.2.1 The Lectin Domain and C-terminal Tail 
Sequence homology studies of CD23 have been focused on the 25 kD extracellular 
head region which bears homology to other C-type animal lectins such as the human and 
rat forms of the asialoglycoprotein receptor (Holland, Leung & Drickamer 1984), the 
chicken hepatic lectin (Drickamer, 1981), the rat mannose binding protein A (Drickamer, 
Dordal & Reynolds, 1986), the rat Kupffer cell receptor (Hoyle & Hill, 1988), the murine 
and human Lyb-2 B cell antigen (Nakayama, von Hoegen & Parnes, 1989; Von Hoegen, 
Nakayama & Parries, 1990) and the murine Al (YEI/48) T cell antigen (Yokoyama et al., 
1989; Chan & Takei, 1989). In CD23, the lectin homology region begins at residue 
Gly157 and extends to Arg284 and Figure 1.2 illustrates the apparent homology between 
the human and murine forms of CD23 and some members of the C-type lectin superfamily. 
Four cysteine residues, Cys 191, Cys 282, Cys 259 and Cys 273, are conserved in all 
sequences and two, Cys163 and Cys174, are partially conserved. The level of homology in 
this region ranges from 22% between human CD23 and human Lyb-2 B cell antigen, to 
37% identity between human CD23 and the rat asialoglycoprotein receptor. The 
conservation of a number of hydrophobic amino acids along with the conservation of 
cysteines is an indication of a common evolutionary origin and related tertiary structure. 
Figure 1.2 further illustrates that the human form of CD23 possesses an extra 37 
residue C-terminal sequence with respect to the other lectins. It also contains an inverted 
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RGD sequence suggesting a possible cell adhesion function in a fibronectin-fike manner 
(Grangette et al., 1989). 
Another unique structural feature of the lectin-type region is the possession of two 
extra cysteine residues 160 and 288 which do not occur in other lectins. Evidence suggests 
that these cysteine residues are indeed paired as a disulfide bridge (Bettler et al., 1989). 
At the C-terminal end of the lectin homology domain lies a cleavage site which 
generates a 16 kD fragment that includes all of the lectin domain and lacks the C-terrninal 
tail (Letellier et al., 1990; Letellier et al., 1989). 
1.2.2 The Coiled-coil Stalk 
Another feature of the extracellular structure of CD23 is the region between the 
lectin homology domain and the transmembrane portion of the protein. This part of the 
sequence of human CD23 contains three homologous repeats each 21 residues in length 
(Suter, Bastos & Hofstetter, 1987). Like the human form, the rat species contains three 
repeats whereas the murine form has an additional repeat of the same length (GenEMBL 
database, 1993). Within this region there exists a repetitive series of four leucines at 
positions 95,102,109 and 116 separated by seven residues. This pattern, termed the 
leucine zipper motif, has been previously observed in DNA-binding proteins but it has also 
been identified in proteins with no DNA binding activity (Landshultz, Johnson & 
McKnight, 1988). It is more likely, however, that this pattern adopts an a-helical coiled- 
coil structure providing a mechanism for protein subunit dimerization (O'Shea, Rutkowski 
& Kim, 1989) or trimerisation. The formation of coiled-coil dimers or trimers, due to 
leucine zippers has been confirmed by X-ray structural studies of proteins containing this 
motif (Harbury et al., 1993). 
The possible existence of an a-helical. coiled-coil structure in CD23 was first 
identified by dot-plot analysis, comparing its sequence with that of tropomyosin, a protein 
which is known to adopt an a-helical coiled-cOil structure (Beavil et al., 1992; Gould et 
al, 1991). The results indicate that human, murine and rat forms of CD23 bear similarity to 
the repeating coiled-coil sequence of tropomyosin. In all of these proteins, these regions 
cover the whole sequence between the lectin domain and the transmembrane portion. In 
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The sequence and structural features of human CD23. The four regions of the molecule 
and its main structural features including N-glycosylation sites, the sites of proteolytic 
cleavage together with the molecular weights of the soluble fragments are shown (Gould 
et al., 199 1). 
daab 
HCD23 157 GFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDME GQLVSIHSPEE 
MCD23 180 GTACNICPKNWLHFQQKCYYFGKGSKQWIQARFACSDLQ GRLVSIHSQKE 
CHR 75 LFPCGAQSRQWEYFEGRCYYFSLSRMSWHKAKAECEEMH SHLIIIDSYAK 
RASGPR 147 GSERICCPINWVEYEGSCYWFSSSVKPWTEADKYCQLEN AHLVVVTSWEE 
KCR 416 WKYFNGKFYYFSRDKKSWHEAENFCVSQG AHLASVTSQEE 
RMBPA 115 LHAFSMG KKSGKKFFVTNHERMPFSKVKALCSELR GTVAIPRNAEE 
TET 44 QALQTVCLKG TKVHMKCFLAFTQTKTFHEASEDCISRG GTLGTPQTGSE 
Al 143 WFCYGMKCYYFVMDRKTWSGCKQTCQSSS LSLLKIDDEDE 
ECH I GCCPTFWTSFGSNCYRFFAVSLTWAEGEQFCQSFSVPSRGDIDS IGHLVSIHSETE 
HLYB-2 227 GSADTCCPSGWIMHQKSCFYISLTSKNWQESQKQCETLS SKLATFSEIYP 
MLYB-2 226 CSSDTCCPCGWIPYQERCFYISHTLRSLEESQKYCTSLS SKLAAFDEPSK 
HCD23 207 QD FLTKHASHTGS WIGLRNLDLKGEFIWVDGSHV DYSN WAPGEPTSR 
MCD23 230 QD FLMQHINKKDS WIGLQDLNMEGEFVWSDGSPV GYSN WNPGEPNNG 
CHR 125 QN FVMFRTRNERF WIGLTDENQEGEWQWVDGTDTRSSFTF WKEGEPNNR 
RASGPR 197 QR FVQQHMGPLNT WIGLTDQ NGPWKWVDGTDYETGFKN WRPGQPDDWYG 
KCR 456 QA FLVQITNAVDH WIGLTDQGTEGNWRWVDGTPFDYVQSRR FWRKGQPDNW R 
RMBPA 161 NK AIQEVAKTSA FLGITDEVTEGQFMYVTGGRL TYSN WKKDEPNDH 
TET 93 NDALYEYLRQSVGNEAE IWLGLNDMAAEGT WVDMTGARIAYKN WETEITAQP 
Al 183 LK FLQLVVPSDSC WVGLSYDNKKKDWAWIDNRPSKLALNT RKYNIRDG 
ECH 57 QNFVYHYFETSTKDDTTPEMWLGFNDRTTEGNFQWTDGSPN DFTA WVGSNPDNY 
HLYB-2 277 QSHSYYFLN SLLPNGGSGNSYWTGLSSN KD WKLTDDTQR T 
MLYB-2 276 Y YYEVSLPS GLEELLDRSKSYWIQMSKK WRHDYDSQ 
ccbd 
HCD23 254 SQGEDCVMMRG SGRW NDAFCDRKLGAWVCDRLATCTPPASEGSAESMGPDSRP 
MCD23 277 GQGEDCVMMRG SGQW NDAFCRSYLDAWVCEQLATC EISAPLASV 
CHR 174 GFNEDCAHVWT SGQW NDVYCTY ECYYVCEK 
RASGPR 246 HGLGGGEDCAHFTT DGHW NDDVCRR PYRWVCET 
KCR 508 HGNGEREDCVHLQR MW NDMACGT AYNWVCKK 
RMBPA 207 GSGEDCVTIVD NGLW NDISCQA SHTAVCE 
TET 145 DGGKTENCAVLSGAANGKW FDKRCRD QLPYICQ 
Al 231 GCMLLSK TRL DNGNCDQ VFICICGK 
ECH ill GSGEDCTQMVMGAGLNW IDLPCSSTRHYLICK 
HLYB-2 317 RTYAQSSKCNKVHK TWSWWTLESESCRS SLPYICEM 
























Sequence alignment of the lectin homology regions of the proteins: human and murine 
CD23 (HCD23, MCD23), chicken hepatic lectin (CHR), rat asialoglycoprotein receptor 
(RASGPR), rat Kupffer receptor (KCR), rat mannose binding protein A (RMBPA), 
tetranectin (TET), Al (Yel/48) T cell antigen (Al), echinoidin (ECH), and the human and 
murine Lyb-2 B cell antigen (HLYB-2, MLYB-2). Residues that are highly conserved are 
shown in bold. The pairing of cysteine residues in disulfide bonds is indicated by the letters 
a-d above the cysteine residue position (Gould et al., 1991). 
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Amino acid sequences of the N-terminal cytoplasmic ends of CD23a and CD23b isoforms. 
Sequences downstream of Glu at position 10 for isoform. and at position 9 for isoform b 
are identical. Isoform. a posesses a 5-amino acid sequence (Y-x-x-I-x) containing a 
tyrosine (Y) at position 6 and an isoleucine (1) at position 9. This sequence is believed to 
be important in mediating endocytosis via coated pits. Amino acids asparagine and proline 
at positions 2 and 3 of the isoform. b are believed to promote phagocytosis (Yokota et al., 
1992). 
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while in murine CD23 this homology extends to residue 170. The sequence homologý' of 
the rat ranges from residue 50 to 150. It is interesting to note that a similar feature was 
found in some other cell surface receptor molecules, all of which are members of the C- 
type lectin superfamily (Beavil et al., 1992). The human and rat forms of the 
asialoglycoprotein receptor, the human and murine forms of the B-cell differentiation 
antigen Lyb-2 and the rat Kupffer cell receptor along with the human and murine forms of 
CD23 share this structural motif. All four proteins, together with other C-type animal 
lectins, share a number of other similar features including sequence homology of their C- 
terminal lectin domains, the presence of a single transmembrane segment and a 
cytoplasmic N-terminus. 
A consequence of this coiled-coil structural motif may be that all four proteins 
exist as dimers, or trimers as is known to be the case for the asialoglycoprotein receptor. 
Although the state of oligornerization cannot be deduced from the sequence analysis, 
cross-linking and other studies suggest that both human and murine CD23 are trimeric in 
the cell membrane (Beavil R. et al., 1995; Dierks et al., 1993). Cross-linking studies have 
also shown that rat asialoglycoprotein receptor and chicken hepatic receptor can form 
hexamers in solution (Halberg et al., 1987; Loeb & Drickamer, 1987). The sequence 
similarity of all these proteins with that of tropornyosin may suggest the existence of an (X- 
helical coiled-coil structure within their extracellular region. The existence of such an (x- 
helical structure within CD23 is currently under investigation by circular dichroism (CD) 
studies. 
It has been postulated that the coiled-coil region in CD23 may form a stalk which 
acts as a rigid spacer between the lectin domain and the surface of the membrane. The 
coiled-coil stalk of CD23 is predicted to be 15 nm for the human and rat and 18 nm long 
for the murine form (Beavil et al., t 992; Gould et al., 199 1). Within this putative (X-helical 
coiled-coil stalk lie three of the five sites of proteolytic cleavage (Figure 1.1). The original 
proteolytic fragment is 37 kD, generated by proteolysis near the base of the stalk. 
This 
further gives rise to fragments of 33,29 and 25 kD, all of which contain the 
lectin domain 
(Figure 1.1,29 kD fragment not shown). The 25 kD cleavage point is located at the C- 
terminal end of the stalk and gives rise to a fragment that consists of the 
lectin domain and 
the DGR tail. From the location of the cleavage sites it might be predicted that the 
37 kD, 
33 kD and possibly the 29 kD fragments are capable of forming 
dimers or trimers, while 
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the 25 kD and the 16 kD fragments may not, since they lack the stalk region sequence 
(Gould et al., 1991). This may be important to the various functions of the soluble 
fragments, as will be discussed below. 
1.2.3 The Transmembrane and the Cytoplasmic Regions 
The single transmembrane segment of CD23, comprising mainly hydrophobic 
amino acids, is another feature that the protein has in common with other C-type hepatic 
lectins. It is connected to the short cytoplasmic N-terminal region. The human protein 
exists in two isoforms differing in their N-terminal six or seven amino acid residues. These 
are designated CD23a and CD23b and are derived from the same gene (Yokota et al., 
1988)(Figure 1.1). The existence of two forms is a result of two transcription initiation 
sites and first exons in the DNA sequence (Yokota et al., 1988). The presence of two 
different forms is unique to human CD23 and may relate to the different functions of 
CD23 on different cells. In the mouse only expression of the equivalent of human isoforin 
a has been reported (Rao, Van Dusen & Conrad, 1989). However, mRNA expressing the 
murine counterpart of human CD23 subtype b has recently been identified (Kondo et al., 
1994). Human isoform. CD23a is expressed on normal B-lymphocytes, while isoform 
CD23b is found on other cell types. A key structural difference between the two forms is 
that isoform a posesses a tyrosine residue at position 6 whereas isoform b has a serine 
residue at the same position (Figure 1.3). The presence of a five-amino acid sequence in 
the cytoplasmic region of cell surface integral proteins which include an aromatic amino 
acid followed by four others classified according to charge and polarity (Y-x-x-I-x, for 
CD23a, Tyr-Ser-Glu-Ile-Glu, see Figure 1.3) has previously been reported in connection 
with endocytosis via coated pits (Vega & Strominger, 1989; Yokota et al., 1992). Isoform 
b posesses amino acids asparagine and proline at positions 2 and 3 respectively, shown to 
promote phagocytosis (Yokota et al., 1992). 
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1.3 THE FUNCTIONS OF CD23 
1.3.1 IgE Bindmg 
The binding of CD23 to IgE is believed to be responsible for the protective 
functions of phagocytic clearance of antigen and release of inflammatory cytokines 
(Capron et al., 1986). Some studies have implicated CD23 in stimulating the maturation of 
small resting B-cells into antibody- synthesizing B-lymphocytes (Swendeman & Thorley- 
Lawson, 1987; Gordon et al., 1984). Binding of IgE-antigen complexes to CD23 on the 
surface of B lymphocytes triggers IgE-dependent antigen presentation to T cells (Pirron et 
al., 1990; Kehry & Yamashita, 1989; Heyman, Tianmin & Gustavsson, 1993; Gustavsson 
et al., 1994). Furthermore, with the help of interleukin-4 it is involved in heavy-chain 
switching to IgE production. B-lymphoblasts initially produce IgM antibody, and effector 
functions are diversified by class switching to IgG, IgA or IgE (Paul & Ohara, 1987; 
Banchereau, 1990). Recent evidence further suggests that murine CD23 is further 
involved in negative feedback regulation of IgE (Yu et al., 1994). 
The IgE molecule consists of two antigen-binding regions (Fab) and the constant 
region (Fc) in which the receptor binding sites are located (Figure 1.4) (Padlan & Davies 
1986; Helm et al., 1991). The binding site for CD23 is located in the CE3 region and is 
distinct from that for FcF_RI which is also located in the same domain (Nissim et al., 1993; 
Sutton & Gould, 1993). The location of CD23 binding is near the glycosylated Asn 371 
(Vercelli et al., 1989a) (Figure 1.4). Furtherstudies using synthetic peptide sequences from 
the CF-2, CF-3 and CF-4 domains of IgE determined that residues 364-383 and 401-415 both 
within the Ce3 domain could be involved in the binding of IgE to CD23 membrane and 
soluble forms (Ghaderi, & Stanworth, 1993). The two symmetry-related binding sites for 
CD23 in the IgE molecule are as far as possible from the central axis of IgE and from each 
other. As CD23 binds only to the disulfide-linked E-chain fragment dimers (Vercelli et al., 
1989a), this implies that CD23 should be at least in a dimeric form in order to bind to both 
sites on IgE simultaneously. The CD23 molecule binds to the protein part of IgE rather 
than to one of its two class-specific carbohydrate chains (Baenziger, Kornfeld & Kochwa, 
1974; Drickamer, 1988; Vercelli et al., 1989a). It actually appears to have a higher affinity 
for completely aglycosylated IgE or recombinant IgE Fc than for native (glycosylated) IgE 
(Vercelli et al., 1989a; Young et al., 1995). Recent evidence further suggests that mutant 
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IgE-Fc lacking two surface glycosylation sites at Asn265 and Asn371 has ten times higher 
affinity for CD23 than the intact native form. However, the IgE-Fc region exhibits lower 
affinity than both the double mutant and native IgE (Young et al., 1995). Nevertheless, 
CD23 has been found to bind weakly to a number of carbohydrates, but the binding of 
these carbohydrates does not inhibit the binding of IgE, or cause dissociation of the 
CD23-IgE complex (Richards & Katz, 1990) with the exception of fucose- I -phosphate 
which has been shown to prevent binding of IgE to immobilised soluble CD23 
(Delespesse et al., 1992). In contrast to the binding to IgE, recognition of CD21 by CD23 
involves the recognition of carbohydrates by the CD23 lectin domain as will be discussed 
later (Pochon et al., 1993). 
The Immunoglobulin E binding site on CD23 is predicted to be remote from the 
stalk region and the Asp-Gly-Arg containing "tail" (Figure 1.1) (Sutton & Gould 1993), 
based upon the results of mutagenesis experiments on human CD23 cDNA (Bettler et al., 
1989). According to this study, the region extending from cysteine 163 to cysteine 288 
contains the IgE binding site. Deletions in the cDNA within this sequence results in loss of 
binding to IgE, whereas any deletions outside this region do not eliminate IgE binding. 
The lectin domain is clearly involved in IgE binding since the 16 kD and 25 kD 
human CD23 fragments, which lack any stalk region sequences, retain the ability to bind 
IgE (Sarfati et al., 1987; Uchibayashi et al., 1989). However, sequences outside the lectin 
region must also affect IgE binding because the 25 kD fragment has a lower affinity for 
IgE than does the intact CD23 molecule itself, an effect which may be due to increased 
avidity of the intact oligomeric protein (Gould et al., 1991). Surprisingly, the murine 
CD23 soluble fragments are unable to bind IgE per 5e (Lee, Rao & Conrad, 1987). These 
observations may implicate the contribution of the entire structure of the protein to the 
formation of a binding site for IgE. 
Further evidence implicating the lectin domain as the IgE binding site comes from 
the calcium-dependent manner of the binding of CD23-IgE complexes, a characteristic 
shared with other members of the C-type animal lectin family which require calcium to 
bind their ligands (Drickamer, 198 1; Richards & Katz, 1990). 
The coiled-coil stalk region does however contribute to the binding of IgE. It is 
possible that oligornerization of the CD23 molecule via an a-helical coiled-coil association 
brings the lectin head domains in such a spatial arrangement as to enhance the binding of 
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the Fc domain of IgE. Alternatively, it may just be that an oligomeric structure for CD23 
enhances the effective binding (i. e. increased avidity rather than affinity). It has been 
shown that human CD23 may form trimers on the cell surface (Beavil R., et al., 1995): a 
trimeric arrangement of murine CD23 molecules has also been postulated and, as already 
stated, for murine CD23 only the intact molecule is capable of binding IgE. 
Dimerisation or trimerisation of CD23 on the cell surface may be of great 
significance for the understanding of its binding to IgE. As IgE has been shown to possess 
two binding sites for CD23 (Vercelli et al., 1989a) both CO domains of IgE may cross- 
link two lectin domains in a dimeric or trimeric CD23 molecule (Figure 1.5a). Such 
interaction may facilitate crosslinking and internalisation of IgE-antigen complexes by B 
lymphocytes. Alternatively, soluble CD23 fragments 37 or 29 kD which can retain their 
trimeric form may crosslink membrane-bound IgE and CD21 on the surface of committed 
B lymphocytes and activate IgE synthesis (Figure 1.5b) (Sutton & Gould, 1993). 
Binding of IgE and IgE-antigen complexes to CD23 stabilizes the membrane 45 
kD form and prevents its proteolysis (Lee, Rao & Conrad, 1987). It has further been 
shown in a cell culture model that binding of IgE-antigen or monoclonal antibodies to 
CD23 on B cells results in inhibition of ongoing IgE synthesis (Sherr et al., 1989). 
Furthermore, in an in vivo murine model, CD23-deficient mice exhibit normal germinal 
centre development and increased IgE antibody levels suggesting that CD23 acts as a 
negative feedback regulator of IgE (Yu et al., 1994). The above findings along with the 
observation that soluble CD23 released from the intact form induces IgE synthesis, imply 
that association of IgE and IgE complexes with membrane CD23 on the B cell surface 
exerts a down-regulatory effect on IgE expression (Chretien et al., 1990; Sarfati et al., 
1984b; Luo et al., 199 1; Gould et al., 199 1). 
Furthermore, the binding of IgE-antigen complexes on membrane-bound CD23 
may bridge two or more dimers or trimers on the same cell. This cross-linking scheme may 
suggest a mechanism for induction of internalisation and subsequent antigen presentation. 
Indeed, other members of the C-type lectin family such as the asialoglycoprotein receptor 
and the Kupffer cell receptor, are bridged by their ligands leading to a phenomenon termed 
capping (Ashwell & Hardford, 1982; Haltiwanger & Hill, 1986; Speiss, 1990). Capping 
induces endocytosis of the receptor-ligand complex via coated pits (Ashwell & Hardford, 




The structure of human IgE consists of two antigen-bIndIng fragments (Fab) and the 
constant region Fc which contains the receptor binding sites. The molecule has 2 identical 
light (L) chains (K or k) and 2 identical F- heavy (H) chains. CL is linked with CF- I with a 
disulfide bridge and 2 disulfide bridges link the 2 Cc2 domains. To the right, the predicted 
folded structure of the Fc region which contains the Cc4 and W domains (Padlan & 
Davies 1986; Helm et al., 1991). The binding site for CD23 is located in the CF-3 domain 











Possible interactions of the trimeric CD23 with IgE and CR2 (Sutton & Gould 1993). 
a. Membrane IgE CF-3 domains combine with two CD23 polypeptide chains at their 
lectin domains. 
b. Trimeric soluble CD23 (37 kD) bridges membrane-bound IgE with CR2. Two 
lectin domains combine with the Cc3 regions of IgE while a third may bind to CR2 or 
another membrane-bound IgE. 
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antigen presentation is involved for CD23-IgE complexes (Kehry & Yamashita, 1989, 
Pirron et al., 1990). 
1.3.2 Growth Factor Activity_and IgE Regulation 
CD23 is expressed in very low levels in resting B lymphocytes from perlpheral 
blood or tonsils. Its expression has been shown to be up-regulated on the B cell surface by 
a number of stimuli such as interleukin 4 (IL-4), phorbol esters and interleukin 2 (Defrance 
et al., 1987; Gordon et al., 1986b; Hivroz et al., 1989). Furthermore, upon transformation 
of B cells by Epstein-Barr virus, CD23 expression is augmented and remains at high levels 
(Thorley-Lawson & Mann, 1985; Gordon et al., 1986a, 1986b). In order for B cell 
transformation to occur, expression of CD23 is a prerequisite. Indeed, all EBV- 
transformed cell lines express CD23 (Thorley-Lawson & Mann, 1985). These results 
implicate CD23 over-expression in B cell malignancies where it is expressed in abnormally 
high levels. The link between CD23 and B cell transformation is further supported by the 
recent finding that CD21 is a counter-receptor for CD23. EBV is a ligand for CD21 and 
upon its binding it can induce cell growth (Nemerow et al., 1987; Tanner et al., 1987). 
Once EBV binds to CD21 and enters the B cells, it triggers expression of proteins 
promoting cell survival. It also induces continuous expression of CD23 and CD21 which 
are produced indefinitely in EBV transformed B cell lines in contrast to the maturing B 
cells in vivo on which they are no longer expressed (Wang et al., 199 1). 
The soluble cleavage fragments of CD23 which contain the lectin domain and 
portions of the coiled-coil stalk region were believed to contain autocrine growth- 
promoting activity (Cairns & Gordon, 1990; Swendeman & Thorley-Lawson 1986; 
Gordon et al., 1988). A recent report shows that the 25 kD recombinant species 
synergises with EL-la to promote survival and differentiation of germinal centre B cells 
(Liu et al., 199 1). The membrane form of CD23 could be the precursor responsible for B 
cell autostimulation through proteolysis and release of trimeric soluble fragments capable 
of promoting growth factor activity. Indeed, natural or recombinant membrane CD23 has 
been reported to possess a stimulatory function in B cell growth (Cairns & Gordon, 1990). 
Furthermore, crosslinking of membrane CD23 with surface Ig has been shown to induce 
mouse B cell activation (Campbell et al., 199 1; Waldschmidt & Tygrett, 199 1). 
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CD23 has further been implicated in the regulation of IgE synthesis. The 
lymphokine IL-4 is necessary for the switching of 19M-committed B cells to IgE- 
producing lymphocytes. IL-4 works in conjunction with CD23 allowing B cells to surVive 
and differentiate into plasma cells which secrete large amounts of IgE (Paul & Ohara, 
1987; Bancereau, 1990). Furthermore, as mentioned before, it also promotes up- 
regulation of CD23 expression. Interleukin-5 works in synergy with EL-4 to enhance IgE Z' 
production triggered by EL-4 in peripheral blood lymphocytes and tonsil cells (Pene et al., 
1988b). Inhibitors of IL-4-induced CD23 expression (IFN-(x, IFN-y, prostaglandin E2 and 
TGFP) also inhibit IgE synthesis (Pene et al., 1988a; Pene et al., 1989; Denoroy, Yodoi & 
Banchereau 1990; Wu et al., 1991). Furthermore, antibodies to CD40 can reverse the 
effects of IFN and TGFP both in IgE synthesis and CD23 down-regulation (Gordon et al., 
1991; Zhang, Clark & Saxon, 1991). Commercial B-cell growth factor (BCGF), a 
component promoting proteolysis of CD23 on B cells, synergises with IL-4 in up- 
regulating IgE synthesis (DeKruyff et al., 1989). 
Perhaps the most important finding implicating CD23 in IgE synthesis is that some 
monoclonal antibodies to CD23 prevent EL-4-induced IgE synthesis in an in vitro culture 
system. The results were specific for antibodies directed to the lectin domain. These 
antibodies prevent IgE binding to CD23 (Bonnefoy, Shields & Mermod, 1990). Another 
report claims that IgE synthesis induced by IIL-4 requires interaction between the T cell 
receptor/CD3 complex on T cells and MHC Class-11 antigens on B cells (Vercelli et al., 
1989b). Monoclonal antibodies against CD3 or MHC Class-11 as well as antibodies against 
cell-adhesion molecules CD2, CD4 and LFA-I all inhibit induction of IgE production 
(Vercelli et al., 1989b). 
Other studies implicate the soluble CD23 fragments in regulating IgE production. 
Originally, soluble CD23 fragments were found to enhance IgE synthesis in vitro (Sarfati 
et al., 1984a, 1984b; Sarfati & Delespesse, 1988a, 1988b). It has further been shown that 
soluble CD23 fragments of 29,33 and 37 kD promote IgE production. The 25 kD 
fragment appears to be inactive whereas the 16 kD species suppresses both ongoing and 
EL-4-induced IgE synthesis (Delespesse et al., 1992; Mossalayi et al., 1992; Sarfati et al., 
1992). 
Membrane CD23 is also a co-factor for EL-4-induced IgE production, as in an in 
vitro experiment it was shown that monoclonal antibodies to the lectin domain inhibit IL- 
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4-induced IgE expression by binding to membrane CD23 and preventing T cell -B cel] 
interaction (Bonnefoy, Shields & Mermod, 1990). Elevated IL-4 leads to CD23 up- 
regulation in B cells (Defrance et al., 1987). CD23 production enhances T cell -B cell 
interaction which would promote antigen presentation and differentiation of small resting 
B cells into IgE-secreting plasma cells (Gordon et al., 1991; Sutton & Gould, 1993). It 
has also been shown that engaging membrane CD23 with IgE immune complexes on the 
surface of IgE-secreting B cells, suppresses IgE production (Sherr et al., 1989). 
Finally, IgE itself and IgE-antigen complexes down-regulate IgE synthesis since 
IgE binding prevents release of soluble CD23 fragments (Lee, Rao & Conrad, 1987; Luo 
et al., 199 1). As the IgE binding site is too far from the stalk region for IgE to exert any 
steric effect on the site of proteolysis, IgE binding may work by stabilizing the coiled coil 
stalk and protecting it against fragmentation (Gould et al., 199 1). 
The negative feedback control that IgE and IgE-antigen complexes exert on IgE 
expression appears to occur both through blocking the CD21 binding site on CD23 as well 
as stabilizing CD23 and preventing the release of soluble fragments which bind to CD2 1. 
A proposed mechanism for the enhancement of IgE synthesis by soluble CD23 fragments 
is through CD21 (Figure 1.5b). A soluble CD23 fragment of 37 kD which retains part of 
the stalk region and is thus trimeric might crosslink membrane IgE and CD21 on the 
surface of a commited B lymphocyte. CD21 forms a signal transduction complex with 
CD19 on the cell surface which triggers activation of IgM synthesis (Matsumoto et al., 
1991). It has been proposed that the CD21/CD19 signal transduction complex may also 
activate the synthesis of IgE (Sutton & Gould, 1993). Finally, IgE-antigen complexes can 
down-regulate IgE production by crosslinking CD23 on the surface of B lymphocytes 
(Scherr et al., 1989). Crosslinkingof CD23-IgE-antigen is the first step in the process of 
antigen presentation to T cells and involves internalisation of the complex and degradation 
of IgE, an event which may further contribute to down-regulation of IgE expression 
(Chen, 199 1). 
1.3.3 IgE-Induced Antigen Presentation 
CD23 has been implicated in the presentation of MHC-antigen complexes, as 
mentioned above. It has been established that antigen-specific immunoglobulin on the 
surface of B lymphocytes is directly involved in antigen presentation to T cells 
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(Lanzavecchia, 1985). Surface immunoglobulin is bound to soluble antigen and the 19- 
antigen complex internalized. The antigen is processed and recycled to the B cell surface 
where it is presented to T cells by the class-H major histocompatibility complex proteins 
(MHC Class-11). 
The first evidence that CD23 may serve a similar role to that of surface Ig in 
antigen presentation, came from the finding that it is spatially associated on the surface of 
B lymphocytes with the MHC-Class 11 antigen HLA DR (Bonnefoy et al., 1988). 
The role of CD23 in antigen processing could parallel the endocytotic functions of 
other lectins of the C-type superfamily and especially that of the asialoglycoprotein 
receptor. Indeed, the proposed trimeric structure of CD23 and its homology to the 
oligomeric asialoglycoprotein receptor implies its capacity to internalise and process its 
ligand. The membrane structure of the mammalian hepatic lectin asialoglycoprotein 
receptor has been proposed to be trimeric (Halberg et al., 1987). The receptor is 
crosslinked by its ligand on the plasma membrane of parenchymal hepatocytes. The 
complex is intemalised via clathrin-coated pits and receptor and ligand are dissociated in 
endosomes (Geuze et al., 1983 a, b; see Spiess for review, 1990). Due to the structural 
similarities of the two molecules, it has been proposed that CD23 as well is capable of 
receptor-mediated endocytosis. 
Indirect evidence on the involvement of CD23 in antigen presentation was 
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provided by a study which showed that rat monocytes intemalise IgE-coated erythrocytes 
only after CD23 expression is induced on their cell membrane (Boltz-Nitulescu et al., 
1988). Furthermore, Flores-Romo et al. (1990) showed that anti-CD23 monoclonal 
antibodies, IgE and fragments derived from IgE all inhibit alloantigen presentation to T 
cells. 
I The function of CD23 in processing antigen to be presented to T cells was 
confirmed by coupling surface CD23 with IgE-antigen complexes and allowing 
for 
internalisation and presentation of antigen to T cells to take place (Pirron et al., 1990). To 
determine effective antigen presentation, intracellular Ca2+ mobilization was measured as 
an indicator of T cell activation. Indeed, binding of IgE-bound antigen to 
CD23 leads to 
significant increase in antigen presentation to antigen- specific autologous 
T cells. On the 
contrary, incubation of B lymphocytes with antigen not bound to 
IgE results in a very 
small increase in T cell activation, further suggesting the involvement of 
CD23 in the 
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process. At an IgE concentration of two molecules per molecule of antigen, the antigen- 
presenting capacity of B cells is drastically augmented. The increase is reversed by an 
antibody to CD23 lectin domain which blocks binding of IgE-antigen complexes. These 
findings directly implicate the low affinity receptor binding to the complexes as the key 
event in the uptake and processing of antigen. Another interesting observation is that in 
these experiments B cells were allowed to internalise CD23-IgE-antigen complexes and to 
process and present antigen to T cells for 6 hours at 370C. These findings are in line with 
a recent study on antibody-induced endocytosis of CD23 which shows that it is a rather 
slow process, requiring 6 hours incubation at 370C (Grenier-Brossette et al., 1992). 
The ability of antigen-specific IgE antibodies to enhance specific antibody response 
were also shown in an in vivo model. Pretreatment of mice with a specific monoclonal 
antibody to CD23 inhibited the IgE-mediated response (Heyman, Tianmin & Gustavsson, 
1993). Furthermore, it was recently reported that IgE upregulates the IgM, IgGI, IgG2a 
and the IgE response in vivo. This IgE-mediated enhancement required the presence of T 
cells in the system and it was proposed that the 19E-CD23 complex enhances the ability of 
B cells to present antigen to T cells. The presence of CD23 appears necessary for the IgE- 
induced antibody response but not for the non-IgE-induced response (Gustavsson et al., 
1994). 
Furthermore, it has been proposed that the signal sequences on the cytoplasmic N- 
terminal domain may play a key role in triggering endocytosis of the CD23-IgE complex 
via coated pits (Kehry & Yamashita, 1989). A recent study offers evidence that the a 
isoform of CD23 which is expressed exclusively on B lymphocytes is responsible for 
mediating its endocytosis and claims that antigen presentation is a function exclusive to 
CD23 isoform. a on B lymphocytes (Yokota et al., 1992). Indeed, CD23 is believed to be 
involved in a number of functions dependent on the cell type on which it is expressed. In B 
cells it is involved in IgE-mediated antigen presentation, cell adhesion and growth 
factor 
activity (Gordon et al., 1986a, 1986b; Gordon et al., 1987; Wang et al., 1987; 
Pirron et 
al., 1990; Kehri & Yamashita, 1989). In macrophages, eosinophils and platelets 
it can 
mediate delayed-type allergy and cytotoxicity effects (Capron et al., 
1986). It is thus 
possible that CD23a is involved in B-cell functions whereas the 
b isoforrn is responsible 
for IgE-mediated immunity and cellular cytotoxicity. Yokota et al. (1992) showed that the 
a isoform of CD23 transfected into AV2 mouse 
fibroblast cells, mediates endocytosis. On 
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the other hand, the b isoform induces IgE-dependent phagocytosis, thus demonstratiner the 
functional difference between the two forms. Use of site-directed mutagenesis points to 
the importance of an aromatic amino acid residue (Tyrosine 6 in the cytoplasmic region) 
for the endocytosis of CD23a and its targeting to coated pits (Figure 1.3) (Yokota et al.. 
1992). The importance of such an aromatic residue in mediating endocytosis and targeting 
the receptor to coated pits has been pointed out in studies of other cell surface receptors 
like the transferrin receptor, the low density lipoprotein and the mannose-6-phosphate 
receptor (Davis et al., 1987; Lobel et al., 1989; Jing et al., 1990). It has further been 
reported that some cell surface proteins known to be endocytosed via coated pits share a 
5-amino acid sequence in their cytoplasmic domains (Vega & Strominger, 1989). Yokota 
et al. (1992) also report that CD23 isoform b is internalised through IgE-mediated 
phagocytosis. They suggest that the asparagine and proline residues at positions 2 and 3 in 
the cytoplasmic tail of the b form are important in promoting phagocytosis (Figure 1.3). 
Their results support the function of CD23b in IgE-dependent cytotoxic activity of 
macrophages and eosinophils against parasites. They also point towards antigen 
presentation as a function exclusively attributed to CD23 isoform. a. 
1.3.4 Autoproteolysis 
The membrane form of CD23 is cleaved on the surface of B lymphocytes in a 
course of a few hours. The trigger for proteolysis is currently unknown. The initial 
cleavage results in a 37 kD fragment which contains the lectin domain and part of the 
coiled-coil stalk region (Figure 1.1). Further proteolysis yields fragments of 33,29,25 and 
16 kD (Letellier, Sarfati & Delespesse, 1989). All fragments contain the entire lectin 
domain. However, the a-helical coiled-coil structure is progressively lost with further 
proteolysis and is absent in the 25 and 16 kD fragments (Gould et al., 199 1). 
The initial and further cleavages of the intact CD23 may be the action of more than 
one protease. Isolation of intact CD23 from whole cells, in the presence of various 
protease inhibitors, still results in a mixture of fragments, with the 25 kD as the 
predominant species. However, addition of TLCK, an inhibitor specific for trypsin-like 
serine proteases, prevents the formation of the 25 kD fragment (Cairns & Gordon, 1990). 
Iodoacetamide, which inhibits thioesterases, causes the accumulation of the 37 kD 
fragment (Letellier, Sarfati & Delespesse, 1989). TLCK acts by binding to active histidine 
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residues in trypsin-like proteases. CD23 possesses two histidine residues one of which is at 
the surface of the coiled-coil stalk, close to the 37 kD cleavage site (Cairns & Gordon, 
1990). Another study suggests that purified 37 and recombinant 29 kD CD23 fragments 
cleave the 45 kD intact form as well as the 37 kD fragment down to the 25 IcD forrn 
(Letellier et al., 1990). The 25 kD fragment possesses no proteolytic activity. 
Furthermore, the 37 and 29 kD fragments are cleaved to the 25 kD form by CHO cells 
transfected with intact membrane CD23. In a control experiment, the presence of CHO 
cells with no 45 kD CD23 expressed on their surface, had no effect (Letellier et al., 1990). 
CD23 does not appear to bear homology with any class of proteases, however, it is 
possible that the oligomeric form of the molecule may result in a conformational 
arrangement in which active amino acid residues may be able to function as serine 
proteases. It is rather more likely that an, as yet unidentified, protease may require the 
soluble CD23 fragments as co-factors in order to trigger release of smaller species 
(Delespesse et al., 1992). 
Active proteolysis of CD23 results in an accumulation of soluble molecules in 
culture supernatants (Letellier et al., 1990). Unlike the other fragments however, the 16 
kD species is not accumulated in the supernatant and is thus not the result of extracellular 
cleavage. It is concentrated in the cytoplasm and is thought to be a product of 
internalisation and cytoplasmic degradation of CD23 (Grenier-Brossette et al., 1992). All 
proteolytic fragments retain their ability to bind IgE, but smaller fragments seem to have 
lower affinity than the intact protein (Gould et al., 199 1). 
As previously discussed, soluble fragments of CD23 possess various functions. 
Some have been thought to exert autocrine growth factor activities (Liu et al., 199 1; 
Cairns & Gordon, 1990). Soluble fragments which retain part of the coiled-coil stalk and 
can thus be trimeric, further seem responsible for mediating IgE synthesis (Chretien et al., 
1990; Sarfati et al., 1984b). It has been suggested that soluble or membrane CD23 
crosslinks membrane IgE and CD21 on the cell membrane of committed B lymphocytes 
and causes activation of IgE synthesis (Sutton & Gould, 1993) (Figure 1.5b). The 
25 kD 
fragment which does not contain any sequences from the stalk region appears to be 
inactive, whereas accumulation of the 16 kD species which lacks the RGD sequence 
suppresses ongoing and IL4-induced IgE synthesis (Sarfati et al., 1992; Mossalayi et al., 
1992; Delespesse et al., 199 1). 
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1.3.5 Cell Adhesion 
Since CD23 belongs to an animal lectin superfamily, it may serve as an adhesion 
molecule that enhances cell-cell interactions in the immune system (Spiegelberg, 199 1). 
Furthermore, the presence of the reverse "RGD" sequence -a potential integrin recogn'tion 
motif involved in cell adhesion- in the C-terminal sequence of CD23 implies that the 
molecule is involved in cell adhesion (Grangette et al., 1989; Ruoslahti & Pierschbacher, 
1986). 
Early studies reported that CD23-positive lymphocyte cell lines such as RPMI- 
8866 and Wil-2, and the monocyte line U937, grow in clumps in vitro when healthy 
(Spiegelberg, 1991). The possible adhesion role of CD23 was further reported in 
transfection. experiments of several cell lines which did not previously express CD23. Cell 
lines such as Burkitt lymphoma, BL41 and Daudi, as well as the T cell line CEM were 
transfected with cDNA for CD23 and all formed cell aggregates upon expression of CD23 
(Kikutani et al., 1989). Another report shows that introduction of the EBV-encoding 
EBNA2 gene which induces activation of CD23 expression in Burkitt lymphoma cells, 
results in formation of large cell aggregates (Wang et al., 1990). Nevertheless, a 
contradictory study argues against the involvement of CD23 in mediating homotypic B 
cell adhesion. Expression plasmids of the 45 kD CD23 gene were transfected in insect 
cells. Cell aggregates are not observed upon cell growth, although CD23 is successfully 
expressed on their cell membrane (Jansen et al., 1991). All but the last of the above 
reports suggest that CD23 is involved in cell adhesion but none show whether binding is 
due to CD23 molecules interacting with each other in adjacent cells, or to CD23 
recognising another surface ligand. 
The homotypic cell adhesion properties of CD23 were further studied in terms of 
its Property of proteolysis to soluble fragments (Moulder, Barton & Weston, 1993). 
According to this report, homotypic B lymphocyte adhesion is diminished in serum-free 
media. Cells resume cell to cell adhesion once resuspended in media containing 10% foetal 
calf serum (FCS) or soluble CD23. Since soluble CD23 has previously been reported to 
possess proteolytic activity, these authors investigated whether proteolysis is essential for 
homotypic cell adhesion. Proteases chymotrypsin and elastase promote cell contact only in 
cells expressing CD23 and both cleave CD23 at Ala80 to release the 37 kD soluble 
fragment. Interestingly, although serum does not itself show any proteolytic activity 
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towards CD23, B cells grown in media free of foetal calf serum release 25 kD CD23 
whereas addition of FCS switches proteolysis to release the 37 kD fragment, thus 
providing a similar effect to chymotrypsin and elastase. Furthermore, TLCK and 
lactoperoxidase which prevent CD23 cleavage also inhibit cell to cell adhesion. Addition 
of chymotrypsin and elastase to lactoperoxidase-treated cells reverse the process and 
promote cell adhesion. The report claims that the 37 kD but not the 25 kD soluble CD23 
fragment may be involved in homotypic cell adhesion. The 37 kD fragment retains part of 
the stalk and may be trimeric, so it is tempting to think that it may be responsible for 
bridging more than one molecule on the surface of adjacent cells. It is then proposed that 
such cell adhesion may involve binding of CD23 to a surface receptor other than CD23. 
Furthermore, it has recently been shown that 45 kD CD23 incorporated into fluorescent 
liposomes binds to CD21 expressed in RPMI 8226 cells and addition of soluble 
recombinant 37 kD CD23 fragments inhibit CD23 binding to CD21 (Re1jic R., personal 
communication). 
It has further been established that CD23 is spatially associated with the MHC 
Class-11 molecule HLA DR on the surface of B lymphocytes (Bonnefoy et al., 1988). The 
two proteins are co-localised in patches around the circumference of B cells, and both 
antigens are seen concentrated and co-localised at the areas of interaction among cells 
forming homotypic clusters (Flores-Romo et al., 1990). Since HLA DR is involved in 
antigen presentation it has been examined whether CD23 is involved in the same process 
and whether it promotes physical interaction between B cells and T cells (Flores-Romo et 
al., 1990). Indeed, monoclonal antibodies binding to the lectin domain of CD23, IgE and 
IgE-derived fragments which map the IgE binding site all inhibit presentation of antigen to 
T cell s (Flores-Romo et al., 1990). Furthermore, certain monoclonal antibodies to CD23 
can inhibit T-B conjugate cell adhesion in T cells which express CD4 (Shields et al., 
1992). Another study supports the correlation between T-B cell adhesion, IgE synthesis 
and HLA DR antigens. Monoclonal antibodies against cell adhesion molecules CD2, CD4, 
LFA-1 as well as HLA DR blocks EL-4-induced IgE production (Vercelli et al., 1989b). 
These findings, along with the observation that purified recombinant CD23 binds 
specifically to T lymphocytes (Pochon et al., 1992), point towards the existence of a 
receptor for CD23 on T cells. 
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The involvement of CD23 in cell to cell contact and regulation of IgE production 
are explained by the finding that the cell surface glycoprotein CD21 is a ligand for CD23 
(Aubry et al., 1992). Expressed on B cells, basophils, FDCs and some T cells, CD21 
(CR2) is the receptor for Epstein-Barr virus and complement (C3dg and other C3 
fragments) (Tanner et al., 1987; Nemerow et al., 1987; Weis et al., 1984; Delcayre et al., 
1991). Recombinant 45 kD CD23 incorporated into fluorescent liposomes binds to 
hampster kidney cells BHK-21 transfected with CD21 (Aubry et al., 1992). The 
interaction is specifically inhibited by anti-CD21 and anti-CD23 monoclonal antibodies. 
Liposome-carrying CD23 reacts with a subtype of the CD21 molecule. Binding of CD21 
with recombinant soluble CD23 or anti-CD21 antibody increases IIL-4-induced IgE 
production from blood mononuclear cells (Aubry et al., 1992). 
The interaction of CD23 with CD21 is linked to autostimulatory growth of 
transformed cells. Epstein-Barr virus binds to CD21 to enter the B cell where EBNA-2 
upregulates viral LMP-1. Both proteins synergise to promote expression of CD21 and 
CD23 (Wang et al., 1990; Wang et al., 1991). Soluble CD23 can then act as growth 
factor interacting with CD21 (Sutton & Gould, 1993). 
The CD23 and CD21 pair could further be involved in the survival of gen-ninal 
centre B cells from apoptosis. CD23 expressed on the surface of follicular dentritic cells 
(Liu et al., 199 1), binds to CD21 -positive germinal centre B cells (Bonnefoy et al., 1993). 
An IgG Fc cell surface receptor on an antigen presenting cell binds to an immune complex 
containing IgG and an immune complex is subsequently bound to membrane IgM on an 
adjacent B cell. This connection is thought to be enhanced by the CD21-CD23 interaction 
(Fearon & Carter, 1995) (Figure 1.6). Surface IgM mediates signal transduction, which is 
enhanced by CD21 spatial affiliation with CD19 on the B cell membrane. This surface 
association helps to lower the threshold required for signal transduction to take place 
(Fearon & Carter, 1995). Furthermore, the presence of C3 fragments on the immune 
complex to which CD21 may bind, also serves to crosslink the complexes and augment B 
cell activation, rescue from apoptosis, and hence clonal amplification of B lymphocytes 
selected by antigen (Bonnefoy et al., 1993; Sutton & Gould, 1993). 
The interaction between CD21 and CD23 may also serve in T cell -B cell 
adhesion. Such interaction may enhance binding of HLA DR - antigen complexes to T 
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Cell adhesion through CD23 and CD21 may serve to mediate B cell selection, activation 
and rescue from apoptosis in the germinal centre. An IgG Fc receptor on the surface of a 
FDC presents an antigen-immune complex to the B cell antigen -receptor complex IgM 
amd Ig a and b chains. These a and b chains mediate signal transduction, further enhanced 
by CD19. CD19, a protein spacially associated with CD21 may help lower the threshold 
for B cell activation and enhance B cell survival. The linking of CD23 to CD21 results in 
cell-cell contact and promotes the presentation of the antigen-immune complex to B cells. 
Furthermore, upon complement activation C3 fragments bound to antigen may enhance 
the contact of this complex (Sutton & Gould, 1993). 
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shown in an in vivo model that intact IgG and Fab fragments of a rabbit polyclonal 
antibody to CD23 cause 90% inhibition of antigen- specific IgE production (Flores-Rorno 
et al., 1993). Furthermore, it has been shown that in the absence of T cells, soluble CD23 
(Henchoz et al., unpublished observations, quoted in Flores-Romo et al., 1993) and EBV 
(Thyphronitis et al., 1989) enhance IgE production in B cells. These findings together 
with the study showing that CD23 is induced by EL-4 and specific allergen in T cells (Prinz 
et al., 1990) lead to a proposed cell adhesion model where T cell-associated CD21 binds 
to membrane CD23 expressed on B cells, promoting cell to cell contact and facilitating 
antigen presentation, EL-4 secretion and production of IgE (Flores-Romo et al., 1993). 
1.3.6 An Intergin as a Third Receptor for CD23? 
As previously discussed, CD23 plays a role in adhesion of B cells to each other 
(Spiegelberg, 1991; Kikutani et al., 1989). The detection of a reverse RGD sequence in 
CD23 was brought about by the use of antibody BB 10 which recognizes the adhesion 
tripeptide sequence DGR (Grangette et al., 1989). The same antibody, BB 10, precipitates 
both CD23 as well as glycoprotein 63, a fibronectin-like protein expressed in Leishmania 
Donovani promastigotes which also contains an RGD (L-arginine-L-glycyl-L-aspartyl) cell 
attachment sequence (Rizvi et al., 1988; Pierschbacher, Hayman & Ruoslahti, 1981; 
Buttoý & McMaster, 1988). 
Incubation of eosinophils with BBIO, anti-fibronectin antibody and anti-CD23 
antibody as well as polyclonal antibodies to RGD sequence all inhibit IgE-dependent 
cytotoxicity against parasites, suggesting the importance of this tripeptide in CD23 
functions (Grangette et al., 1989; Capron et al., 1986). The reverse "RGD" sequence is 
distinct from the IgE binding site and lies in the C-tern-tinal extracellular sequence flanking 
the CD23 lectin domain (Delespesse, Sarfati & Hofstetter, 1989; Bettler et al., 1992) 
(Figure 1.1). It has been suggested that adhesive sequences may be useful in low affinity 
receptors to facilitate and enhance their functions (Ruoslahti & Pierschbacher, 1986). 
These adhesion proteins bind to ligands which are members of the integrin superfamily, 
and may therefore play a role in cell signaling (Ruoslahti & Pierschbacher, 1986). 
Thus, CD23 may have a third ligand specific to its DGR sequence, probably an 
integrin, which may mediate its role in cell adhesion as well as in cell growth and 
differentiation. Indeed, the tripeptide RGD is also found in epidermal growth factor 
I 
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receptor and P-transforming growth factor precursor and the inverted DGR sequence is 
present in fibroblast growth factor (Ruoslahti & Pierschbacher, 1986). These findings 
suggest a possible involvement of the inverted RGD sequence found in CD23 in B cell 
growth factor activity (Gordon et al., 1989; Ruoslahti & Pierchbacher, 1986). This 
possibility however, is contradicted by the finding that the 16 kD fragment, which does 
not contain the inverted RGD sequence, also possess growth factor properties (Mossalayl 
et al., 1992). 
1.3.7 Rescue of Germinal Centre Cells from ADQPtOSiS 
CD23 and its soluble fragments have been implicated in promoting the survival of 
gern-un centre B cells from apoptosis. Germinal centre B cells undergo apoptosis, a fon-n 
of programmed cell death, unless they receive a positive signal for survival. The positive 
signal is provided by their interaction with an antigen held by follicular dendritic cells Jew 
& Mandel, 1978). B cell survival from apoptosis is promoted by immobilised polyvalent 
antibodies to surface antigen receptors or by soluble antibody to CD40 (Liu et al., 1989). 
As follicular dendritic cells in the outer zone of the gern-ýinal centre are rich in 
CD23 it has been suggested that CD23 may play a role in the survival process (Gordon et 
al., 1989a). Indeed, a subsequent study claims that supernatants containing the 25 kD 
soluble CD23 fragment in combination with IL-1 a, which is inactive by itself, promote the 
survival of germinal centre B lymphocytes (Liu et al., 1991). It has thus been suggested 
that CD23 may serve two vital functions in germinal centres: one as a membrane molecule 
on FDCs through adhesion and a second as a soluble factor promoting differentiation of 
rescued B lymphocytes. However, a recent study argues against proposals that CD23 acts 
as a growth factor for B and T cells. According to the authors, the absence of CD23 does 
not impair B- and T-cell development in CD23-deficient mice (Yu et al., 1994). 
The involvement of CD23 in B cell survival was further supported by the discovery 
that CD21, the complement receptor on B cells, FDCs and some T cells and basophils, is a 
ligand for CD23. (Aubry et al., 1992). It was further suggested that the CD23-CD21 
interaction may contribute to the rescue of germinal centre B cells from apoptosis. To 
confirm the importance of the ligation of CD21 with CD23, a recent study showed that, 
similarly to soluble CD23, certain CD21 monoclonal antibodies suppress apoptosis of 
germinal centre cells and promote their differentiation (Bonnefoy et al., 1993). They also 
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upregulate expression of the proto-oncogene bcl-2, a property also assigned to soluble 
CD23 and UA supernatants as well as anti-CD40 monoclonal antibodies (Liu et al., 1989-, 
Liu et al., 199 1). 
Based on the above findings, a model has been proposed in which FDC membrane 
CD23 linking to CD21 on the surface of B cells facilitates the binding of antigen-immune 
complexes to B cells (Figure 1.6, as described earlier). Such binding is believed to 
promote B cell activation, rescue from apoptosis and differentiation into plasmacytes 
(Bonnefoy et al., 1993). 
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1.4 RECEPTOR-MEDIATED ENDOCYTOSIS 
RECEPTOR FOR IgE 
AND THE LOW AFFINITY 
The purpose of this study is to investigate CD23-mediated endocytosis of ICE and Z: ý 
the cellular components involved in this process. CD23 has been reported to mediate 
processing of IgE-antigen complexes and presentation of antigen to T cells (PIrron et al., 
1990). Its B cell surface spatial association with HLA DR antigens, which are responsible 
for binding processed antigen and presenting it to T cells, further suggests its involvement 
in antigen presentation (Bonnefoy et al., 1988). Furthermore, the homology between 
CD23 and other C-type animal lectins and its proposed trimeric structure implies its 
capacity to mediate endocytosis and processing of its ligand much like the 
asialoglycoprotein receptor and the chicken hepatic lectin (Beavil et al., 1992; Kehry & 
Yamashita, 1989; Yokota et al., 1992). 
Another feature pointing towards CD23-mediated endocytosis is the presence of a 
5 amino acid sequence in the cytoplasmic region of the a isoform (Yokota et al., 1992). 
This peptide is responsible for mediating endocytosis and targeting the receptor to coated 
pits. Such a sequence is present in the cytoplasmic domains of other cell surface receptors 
such as the transferrin receptor, the low density lipoprotein and the mannose-6-phosphate 
receptor which are endocytosed via coated pits (Vega & Strominger, 1989; Davis et al., 
1987; Lobel et al., 1989; Jing et al., 1990). 
1.4.1 Endocytosis by C-type Animal Lectins 
Based on the structural similarities between CD23 and other C-type animal lectins, 
it is suggested that CD23 may indeed internalise and process its ligand much like C-type 
lectins do. The asialoglycoprotein receptor is a classic example of a C-type animal lectin 
found to possess structural features similar to CD23, and is known to exist in a trimeric 
form on the hepatocyte membrane and to form hexamers in solution (Halberg et al., 
1987). The asialoglycoprotein receptor is a transmembrane glycoprotein found in 
hepatocytes, which has specificity for terminal galactose residues in asialoglycoproteins 
whose terminal sialic acid residues on their N-linked oligosaccharides are removed 
(Schwartz, 1984). It is thus implicated in binding and clearing serum glycoproteins. Its 
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role in glycoprotein metabolism and degradation was thus linked to its ability to interrialise 
its ligand and transport it into lysosomes for degradation. 
As for CD23, ligand binding requires calcium at a concentration between 0.1-2mM 
(Schwartz et al., 198 1; Weigel, 1980). Binding of asialoglycoproteins is effective above 
pH 6.5 thus rendering ligand-receptor dissociation in a mildly acidic compartment possible 
(Harford et al., 1983; DiPaola & Maxfield, 1984; for review see Spiess, 1990). The 
receptor is expressed by parenchymal hepatocytes which contain 100,000 to 500,000 
binding sites per cell (Hubbard & Stukenbrok, 1979). Receptor-ligand binding takes place 
within 1 minute and internalisation occurs within 2 minutes. An additional 4 minutes are 
required for dissociation of the complex and reappearance of the receptor at the cell 
surface (Schwartz, Fridovich & Lodish, 1982). The dissociated asialoglycoproteins 
themselves reach lysosomes for degradation within 5 to 15 minutes. As a receptor can 
have a mean lifetime of 30 hours, a single receptor can internalise up to 250 
asialoglycoprotein molecules (Spiess, 1990). 
Electron microscopy and double immunogold labelling has been applied to identify 
the site where the asialoglycoprotein receptor and its ligand dissociate following their 
endocytosis (Geuze, Slot & Strous, 1983). The receptor-ligand complex is internalised in 
clathrin-coated vescicles and enter endosomal compartments where ligand and receptor 
dissociate in mildly acidic conditions. The receptor is further accumulated in tubular 
vesicles which contain no ligand and transported back to the surface membrane where it 
binds and internalises more asialoglycoproteins. The endosomal ligands are further 
processed into secondary lysosomes wherein they are degraded. 
The asialoglycoprotein receptor is endocytosed and recycled constitutively. Even 
in the absence of ligand a portion of the receptor is always found in the cell cytoplasm. 
However, ligand binding increases the rate of endocytosis. Upon exposure of hepatocytes 
to glycoprotein, a rapid depletion of cell surface binding sites is followed by a rapid 
reappearance of receptors which originate from endocytosed receptor-ligand complexes 
(Ciechanover, Schwartz & Lodish, 1983; Schwartz, Steer & Kempner, 1984). Upon 
treatment with lysosomotropic agents, which neutralize the endosomal pH, receptor-ligand 
complex internalisation is unaffected but receptor recycling to the cell surface is 
preveýted. This results in loss of cell surface binding sites with or without the presence of 
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ligand (Tolleshaug & Berg, 1979; Tycko, Keith & Maxfield, 1983; Schwartz, Steer & 
Kempner, 1984). 
The chicken liver glycoprotein receptor is another C-type animal lectin which 
mediates endocytosis of glycoproteins which contain agalacto-al -acids. It is also known to 
be a trimer of identical subunit polypeptides (Loeb & Drickamer, 1987). It has extensive 
homology to the asialoglycoprotein receptor, and binds, intemalises and degrades 
glycoproteins containing N-acetylglucosamine residues (Kawasaki & Ashwell, 1977; 
Verrey & Drickamer, 1993). Kinetic studies reveal that uptake of glycoproteins by the 
chicken hepatic lectin is constant at a rate of 2.5 x 105 molecules of ligand per cell per 
hour. The above studies further suggest that the receptors are utilized several times during 
a six hour incubation indicating that they are recycled to the cell surface as in the 
asialoglycoprotein receptor in the mammalian system (Mellow, Halberg & Drickamer, 
1988). 
1.4.2 Endocytosis by Other Cell Surface Receptors 
1.4.2A The Human Transferrin Receptor 
The human transferrin receptor is a 180 kD glycoprotein found in many cell types. 
It binds diferric transferrin and mediates iron uptake into the cell (Trowbridge & 
Shackelford, 1985). It has been reported that the receptor-ligand complex is concentrated 
in clathrin-coated pits upon endocytosis. The complex is transferred into a mildly acidic 
endosomal compartment in which iron is dissociated from tranferrin. The complex is 
returned to the cell surface where it dissociates in order for the transferrin receptor to 
endocytose iron-loaded transferrin molecules (Hopkins & Trowbridge, 1983; van 
Renswoude et al., 1982; Dautry-Varsat, Ciechanover & Lodish, 1983). 
Receptor-mediated endocytosis by the transferrin receptor is drastically reduced in 
mutant proteins lacking 10 amino acids in their cytoplasmic domain. The importance of 
tyrosine 20 within this region was shown by point mutation experiments (Jing et al., 
1990). Substitution of Tyr20 by glycine reduces transferrin receptor endocytosis by 80%. 
Introduction of the 10 amino acid region into tail-less mutant receptors completely lacking 
the cytoplasmic domain restores receptor-mediated endocytosis and iron uptake (Jing et 
al., 1990). As discussed above, the importance of a five-amino acid sequence in receptor- 
mediated andocytosis has been reported for the cytoplasrrAc sequence of CD23 (Yokota et 
0 
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al., 1992), the mannose phosphate receptor (Lobel et al., 1989) and the low density 
lipoprotein receptor (Lehrman et al., 1985). 
1.4.2B The Insulin Receptor 
Extracellular insulin is known to regulate nuclear processes such as cell growth, 
mRNA production and gene transcription (Goldfine et al., 1985; Koontz & Iwahashi, 
198 1; Lee K. L. et al., 1986; Taub et al., 1987). 
Binding of insulin to its cell surface receptor triggers endocytosis of the receptor- 
ligand complex (Smith & Jarett, 1987). The receptor-mediated internalisation of insulin 
results in accumulation of intact functional insulin in the nucleus as tested by direct binding 
assays (Soler et al., 1989; Smith & Jarett, 1987). Nuclear accumulation of insulin is 
detectable after 30 minutes of incubation and continues in a linear fashion for 3 hours. The 
translocation. of insulin to the nucleus is time, temperature and insulin concentration- 
dependent as examined by 1251 labelling (Smith & Jarett, 1987). Immunoelectron 
microscopic analysis was also used to localise intact insulin and insulin receptors on the 
cell surface and inside the cell (Smith & Jarett, 1987). Within 90 minutes incubation at 
370C, insulin is accumulated in the nucleus where it is associated with heterochromatin. It 
is believed that receptor-mediated endocytosis of insulin by its cell surface receptor, its 
nuclear localisation and association with components of the heterochromatin induces 
nuclear regulatory functions previously attributed to insulin. 
Immunoelectron microscopy further shows that insulin receptors are not detected 
in the nucleus but are localised in endosomes and microvilli in the cytoplasm (Smith & 
Jarett, 1987). It is proposed that insulin receptors may be recycled back to the cell surface 
where they may bind and internalise more insulin molecules. 
1.4.2C The Human Chorionic Gonadotropin 
The human Chorionic Gonadotropin (hCG) is bound to its cell surface receptor, 
internalised and transported to the nucleus of ovarian luteal cells (Rajendran, Menge & 
Menon, 1983). These cells bind hCG with high affinity and specificity. Upon addition of 
hCG the cells respond by producing progesterone in a time, temperature and 
concentration-dependent manner (Menon & Rajendran, 198 1). 
At least a fraction of the receptor-bound hCG is endocytosed and a part of the 
internalised hCG is transported to the nucleus (Rao, Mitra & Carman, 198 1; Rajendran, 
Menge & Menon, 1983). Fluorescence microscopy studies have been used to provide 
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direct visual evidence for the intracellular localisation of hCG (Rajendran, Mencre & 
Menon, 1983). Cells kept at 40C during incubations show fluorescence only on the cell 
periphery, whereas after 10 minutes incubation at 370C the fluorescent-labelled hCG is 
clustered in bright patches around the cell membrane, exibiting the phenomenon of 
capping, the prelude to endocytosis. After I hour at 370C the fluorescent hCG is seen 
inside the cell as well as on the cell membrane. Upon longer incubation for up to 3 hours 
the hormone is concentrated in the nucleus. Since the study relies on the observations 
under a conventional rather than a confocal microscope, the nuclear localisation of hCG 
was confirmed by examination of isolated nuclei rather than whole cells. The study makes 
no attempt to study the intracellular path and fate of the receptor for hCG. 
1.4.3 CD23 Constitutive Endocytosis 
The structural similarities of CD23 with other C-type animal lectins have led to the 
belief that CD23 should also mediate endocytosis and processing of its ligand. 
Furthermore, it is evident that it is an important link in IgE-antigen processing and antigen 
presentation to T helper cells (Flores-Romo et al., 1990; Pirron et al., 1990). 
Further supporting these suggestions, a recent study provides strong evidence for 
the intracellular fate of CD23 (Grenier-Brossette et al., 1992). Incubation of RPMI 8866 
cells, an EBV-immortalized B cell line, at 370C for up to 24 hours results in accumulation 
of a 16 kDa by-product of CD23 degradation in the cell cytoplasm (Figure 1.7a). This 
fraction is immunoprecipitated by monoclonal antibodies to the CD23 lectin domain but 
not by EBVCS I antibody which recognizes a portion of the stalk region, strongly 
suggesting that the molecule breaks down to separate the lectin domain from the rest of 
the protein (Figure 1.7b). Trypsin digestion to remove all surface proteins leaves the 16 
kDa fragment as the predominant species precipitated by an antibody to the lectin domain 
(Figure 1.7c). Furthermore, incubation of the cells at pH 2.8 does not reduce or remove 
the 16 kDa fragment suggesting that it is not associated with the external face of the 
plasma membrane (Figure 1.7d). When the cells are incubated at 370C for various time 
intervals and then subjected to trypsin digestion to cleave surface proteins, the amount of 
iodinated intact 45 kDa CD23 is increasingly protected from trypsin with time (Figure 
1.7c). These findings strongly suggest that a fraction of surface CD23 is constitutiN'elý, 
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internalised. Indeed, quantitative measurements reveal that approximately 15% of the 
CD23 molecules initially at the cell membrane are internalised by 6 hours. 
To confirm the intracellular fate of the protein, the cells are incubated with 
chloroquine, which inhibits proteolytic degradation of internalised proteins directed to 
acidic intracellular compartments. Treatment with chloroquine results in drastic reduction 
of the 16 kDa fragment without affecting endocytosis of the intact membrane form. The 
above findings suggest that upon its internalisation, CD23 is directed into an acidic 
cytoplasmic compartment where it is cleaved to produce a 16 kDa fragment which 
includes the lectin domain. 
Further experiments also show that a monoclonal antibody to the lectin domain 
enhances the rate of formation as well as the amount of the 16 kDa fragment that 
accumulates intracellularly (Grenier-Brossette et al., 1992) (Figure 1.7e). This latter 
finding is in line with previous work indicating the ability of antibodies to CD23 to inhibit 
IgE binding and antigen presentation both in the human and the mouse systems (Kehry & 
Yamashita, 1989; Pirron et al., 1990). It has thus been proposed that, similarly to 
monoclonal antibody binding, the IgE-antigen complex may be endocytosed and processed 
via its binding to cell membrane CD23. Furthermore, as discussed earlier, the cytoplasmic 
signal sequence present in the a isoform of CD23 is known to mediate endocytosis and 
targeting of cell surface receptors to coated vesicles (Yokota et al., 1988; Yokota et al., 
1992). The a isoform is found exclusively in B lymphocytes and this may be explained in 
terms of its proposed function in receptor-mediated endocytosis of IgE-antigen complexes 
and antigen presentation. Additionally, the hypothesis that only the a isoform may be 
capable of internalising its ligand could explain the observation that only a fraction of cell 
membrane CD23 undergoes endocytosis (Grenier-Brossette et al., 1992). 
Finally, the spatial association of CD23 and HLA DR antigens further enforces the 
view that CD23 is involved in antigen focusing (Bonnefoy et al., 1988). However, apart 
from their cell membrane association, the functional relation and co-operative involvement 
of the two proteins in receptor-mediated endocytosis has not yet been explored. 
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Figure 1.7 
Cleavage of CD23 in RPMI 8866 cells results in the formation of a 16 kDa fracment 
(Grenier-Brossette et al., 1992). Cells were labelled with 1251 and incubated in culture 
medium at 370C for 24 hours or at various time intervals. Cells were then lysed, CD23 
immunoprecipitated and analyzed by SDS-PAGE and autoradiography. 
a. Spontaneous cleavage of CD23 into a 16 kDa fragment occurs after incubation at 
370C for 9 to 24 hours. 
b. Immunoprecipitation of CD23 by a group of monoclonal antibodies. Antibodies 
directed to the lectin domain EBVCS 2 (Lane B), EBVCS 4 (Lane C), EBVCS 5 (Lane 
D) and mAb25 (Lane E) immunoprecipitate the 16 kDa fragment. Antibody EBVCS I 
(Lane 1) which binds to the stalk region does not precipitate the 16 kDa fragment. 
Antibody IOT4a to CD4 was used as a control (Lane F). 
C. Internalization of native CD23 at different time intervals followed by trypsin 
digestion to remove surface protein. The 16 kDa fragment is protected from the protease. 
The 45 kDa species protected from trypsin digestion increases with incubation at 370C. 
d. The 16 kDa fragment is located intracellularly. 
Panel A: Cells kept in isotonic buffer pH: 7.4 (Lane A) or at pH: 2.8 (Lane B). Low pH 
does not remove the 16 kDa fragment indicating that the fragment is not associated with 
the external face of the plasma membrane. 
Panel B: After cell disruption by hypotonic shock, soluble material was separated from 
microsomes. The microsomal fragtion (Lane A) contains the 45 kDa CD23 amd a small 
contaminating amount of the 16 kDa fragment. The cytosolic fraction contains the 16kDa 
fragment (Lane B). 
e. Monoclonal antibody mAb25 induces endocytosis and formation of the 16 kDa 
fragment as early as 3 hours incubation at 370C. 
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1.4.4 Spatial Association of CD23 and HLA DR 
The studies implicating CD23 in antigen processing and presentation are 
complemented by the finding that CD23 and HLA DR are spatially associated on the 
surface of B lymphocytes (Bonnefoy et al., 1988). 
The HLA DR is one of three types of Class 11 MHC antigens. The Class 11 major 
histocompatibility complex (MHC) proteins are involved in binding processed antigen that 
is aquired through endocytosis into an endosomal compartment (Germain, 1986). The cell 
membrane protein comprises two polypeptides, the a and P chains of molecular weight 36 
and 28 kDa respectively (Brown et al., 1988). Upon formation, class 11 (X and 0 chains are 
assembled in the endoplasmic reticulum with a third peptide, the 7 chain or invariant chain 
(Ii). The trimer travels as a unit from the endoplasmic reticulum to the Golgi and trans- 
Golgi region, and most of the invariant chain dissociates from the U/P complex before it 
reaches the cell surface (Cresswell et al., 1987). The dissociation of the invariant chain has 
been shown to require low pH and proteolytic activity, conditions which also favour 
denaturation and fragmentation of intemalised antigens (Nowell & Quaranta, 1985; Blum 
& Cresswell, 1988; Nguyen & Humphreys, 1989). The invariant chain blocks binding of 
endogenous antigens to the class 11 MHC protein complex, and upon its removal in the 
acidic and proteolytic environment of the endosomal compartment, the UJP complex can 
bind peptides. The uJP complex then transports the peptide to the B lymphocyte surface 
for presentation to T cells (Neefies & Ploegh, 1992). Recent work shows that peptide 
binding to Class 11 MHC occurs in CPL (compartment for peptide loading), a specialized 
subset of the endosomal network. Such a vescicle is distinct from endosomes and 
lysosomes (Amigorena et al., 1994; Tulp et al., 1994; West, Lucocq & Watts, 1994). 
The finding that CD23 and HLA DR antigens are spatially associated on the 
surface of B lymphocytes further supports the involvement of CD23 in intracellular 
trafficking of IgE -antigen complexes and antigen presentation (Bonnefoy et al., 
1988). 
The study shows that certain antibodies to HLA DR partially inhibit the binding of IgE to 
CD23 in RPMI 8866 cells thus suggesting a possible physical or spatial cell surface 
association between CD23 and HLA DR. Antibodies to HLA DP and HLA DQ, the other 
two types of MHC Class 11, are unable to inhibit IgE binding. However, some anti-HLA 
DR antibodies also have no effect on the binding of IgE and anti-CD23 antibodies to 








CD23 and HLA DR are spatially associated on RPMI 8866 cells. Radioiodinated cells 
were solubilized with digitonin lysis buffer or crosslinked with DSP and solubilized with 
NP-40 lysis buffer. Cell lysates were immunoprecipitated with mAb25 to CD23 (A), mAb 
135 to HLA D (B) or normal mouse Ig as a control (C). Immunoprecipitated proteins 
were revealed by autoradiography. Arrows show the migration of FcF-RII (45 kDa) and 





Topographical distribution of CD23 and MHC Class 11. RPMI 8866 cells or tonsilar B 
cells pre-cultured for 48 hours with IL-4 were labelled in suspension with BU38 (IgGI) 
antibody to CD23 and BU27 antibody to MHC Class II (IgG2b), followed by FITC- 
conjugated sheep anti-mouse IgGl. Then cells were labelled with biotinylated sheep anti- 
mouse IgG2b followed by streptavi din -Texas Red (Flores-Romo et al., 1990). 
a. RPMI 8866 cells: A confocal optical section of a cell. Left, MHC Class 11. Right, 
CD23. 
b. Tonsillar B cells: A cluster of 3 cells all staining for MHC Class 11 (left) and the 
same cluster staining for CD23 (right) at the oint of contact of the three cells. C) tn p 
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Crosslinking experiments using DSP followed by lysis and immunoprecipitation 
with anti-HLA DR or anti-CD23 antibodies attempt to provide evidence for the cell 
surface partnership between CD23 and HLA DR. The use of the detergent digitonin was 
also utilized since it preserves noncovalent associations among polypeptides of complex 
receptors. Crosslinking experiments show that the 28 and 36 kDa subunits of HLA DR are 
immunoprecipitated along with the intact 42 kDa CD23 by antibodies to CD23 as well as 
by anti-HLA DR antibodies (Figure 1.8). The use of digitonin results in precipitation of all 
three peptides representing the two HLA DR subunits and the intact membrane CD23 
(Figure 1.8). 
The possibility that such spatial association of HLA DR and CD23 is a 
consequence of the transformation of B cells by Epstein-Barr virus is excluded by 
immunoprecipitation experiments on normal B lymphocytes. Indeed, IL-4-induced CD23 
on normal tonsil B cells is co-precipitated with the two HLA DR subunits as in EBV- 
transformed B cell lines, indicating that IIL-4-induced CD23 is also spatially associated 
with the HILA DR dimer (Bonnefoy et al., 1988). 
The spatial relation between MHC Class 11 molecules and cell surface receptors is 
not an observation unique to the CD23 antigen. Earlier studies report the spatial 
association of MHC Class 11 with Fc receptors in rodents, since antibodies to MHC Class 
11 inhibit binding of IgG complexes (Dickler & Sacks, 1974; Schirrmacher, Halloran & 
David, 1975; Barsten, Miller & Abraham, 1975). However, these studies concluded that 
antibody binding to MHC results in a conformational change which in turn causes 
association of MHC antigens with the Fc receptors. 
Association between HLA Class I antigens and insulin receptors has also been 
reported (Due, Simonsen & Olsson, 1986). As in the case of CD23, crosslinking, lysis and 
immunoprecipitation result in the co-precipitation of both HLA Class I subunits as well as 
insulin receptors (Fehlmann et al., 1985; Samson, Cousin & Fehlmann, 1986). 
Furthermore, antibodies to HLA Class I proteins have been found to block the binding site 
for the Epidermal Growth Factor on the surface of A431 cells (Schreiber, Schlessinger & 
Edidin, 1984). 
So far there has been little functional explanation for these spatial associations of 
the major histocompatibility complex proteins with cell surface receptors. However, as the 
Fc receptors, the insulin receptor and the EGF receptor are known to endocytose and 
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process their ligands, it is possible that such association of these receptors with MHC 
antigens may be explained in the context of receptor-mediated endocytosis and, in some 
cases, antigen presentation. From the study of CD23 it is known that not all cell surface 
CD23 is associated with HLA DR antigens (Bonnefoy et al., 1988). It is thus possible that 
such spatial association exists only with CD23 isoform a on the surface of B lymphocytes, 
since isoform a possesses the cytoplasmic signal sequence responsible for receptor- 
mediated endocytosis and targeting to coated vesicles (Yokota et al., 1992). It is not 
known whether the spatial association between CD23 and HLA DR ocurs intracellularly 
upon antigen loading to HLA DR, on the cell surface prior to or during IgE-antigen 
binding to CD23, or throughout the lifespan of both proteins. 
One study addressing the functional relationship between HLA DR and CD23, 
shows that a monoclonal antibody to HLA DR induces 50-60% suppression of 
lymphoblastoid cell growth (Kabelitz & Janssen, 1989). The same antibody also down- 
regulates CD23 expression on the cell surface. It should be pointed out that this antibody 
does not inhibit IgE or monoclonal antibody binding to CD23. This down-regulatory 
effect is attributed specifically to HLA DR since antibodies to HLA DQ and DP do not 
inhibit lymphoblastoid B cell growth or down-regulate CD23 expression. Furthermore, in 
freshly isolated resting B cells, this monoclonal antibody suppresses activation by Epstein- 
Barr virus. It is thus implied that MHC Class-11 may serve as a transducer of B cell 
signaling by down-regulating the expression of CD23. 
Further to these findings, a more recent study implicates the topographical 
relationship of CD23 and MHC Class 11 DR with the role of CD23 in antigen presentation 
(Flores-Romo et al., 1990). The study shows that antibodies shown to directly or 
indirectly map within the lectin homology domain of CD23 prevent allogeneic mixed 
lymphocyte responses (B-T collaboration in antigen presentation). The same observations 
were made for IgE and IgE peptides which include the CF-3 domain, the location of the 
CD23 binding site. It is also shown that antibodies EBVCS I and EBVCS5 which are not 
directed to the IgE binding site do not block mixed lymphocyte responses. The same study 
further provides visual evidence for the topographical localisation of HLA DR and CD23 
on the surface of B lymphocytes. The use of dual immunofluorescence in order to 
simultaneously label CD23 and HLA DR and observation under a laser-scanning confocal 
microscope shows that the two antigens gather in discrete patches on the circumference of 
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cells (Figure 1.9a). On the surface of many cells both CD23 and HLA DR gather on one 
pole and their surface location is seen to be the point of contact with other cells which 
grow in clusters upon stimulation by IIL-4 (Figure 1.9b). These results address a second 
functional relationship between CD23 and HLA DR by implicating their topographical 
association in alloantigen responses and in regulation of IgE production. 
1.4.5 CD23 and the Immune Response 
It is clear from recent studies that CD23 is involved at the major crossroads of the 
IgE immune response. Whether as a membrane receptor for IgE-antigen complexes, as an 
adhesion molecule through its binding to CD21 or as a soluble factor crosslinking cell 
surface molecules, it certainly seems to be a key player in the regulation of IgE synthesis. 
Most of these roles of CD23 have not as yet been proven. 
Positive signalling for IgE synthesis occurs at low IgE concentrations and upon 
IgE binding to an antigen entering the system (Figure 1.10). The binding of the complex to 
the a isoform of CD23 on the surface of B lymphocytes triggers antigen presentation via 
MHC Class-11 to aT cell specific for the antigen (Pirron et al., 1990; Yokota et al., 1992). 
This complex involves aT cell receptor/CD3 complex and CD2, CD4 and LFA-1 as 
adhesion molecules which facilitate binding of the MHC-antigen complex (Vercelli et al., 
1989b). Binding of CD23 to CD21 may also enhance B cell -T cell contact for the 
purposes of antigen presentation (Flores-Romo et al., 1993; Sutton & Gould, 1993). In 
response to antigen presentation, T cells produce IL-4 and express the CD40 ligand which 
bridges T cells with CD40-expressing IgE-committed cells. The IgE-committed cells 
differentiate into plasmacytes capable of secreting IgE (Liu et al., 1991; Noelle, Ledbetter 
& Ruffo, 1992). 
CD23 further plays a role in the immune response whose function is to select B 
cells and to rescue them from apoptosis (Bonnefoy et al., 1993). The IgE-antigen complex 
binds to the high affinity receptor on Langerhans cells and on FDCs in germinal centres. 
The complex is presented to aB cell through bridging to membrane IgM (Sutton & 
Gould, 1993). The ligation of CD23 on the antigen presenting cell to CD21 on the B cell 
surface is thought to promote or enhance antigen presentation. The antigen-activated B 
cells receive IL-4 and other growth signals from mast cells which respond to IgE-antigen 























Network for the regulation of IgE synthesis. Positive signalling is shown in thin arrows and 
negative signalling in thick arrows. At low concentrations of IgE: a. An antigen (X) is 
recognized by IgE. b. The IgE-antigen complex binds to FcF_RI on mast cells. c. Mast cells 
produce IL-4. d. Expression of FccRIIb and CD40 and class switching to IgE on an 
antigen -activated B cell. e. Release of sCD23 from B cell. f. sCD23 crosslinks CR2 and 
mIgE and promotes survival of the IgE-committed cell. g. CD40-Ligand induces B cells 
differentiation into plasmacytes. h. Secretion of IgE. i. IgE binds to antigen. j. IgE-antigen 
bind to CD23a on aB cell. k. Antigen presentation to a homologous T cell. I. CD40-ligand 
expression on T cells. m. IgE-antigen binds to FcF_RI on Langerhans cells. n. Antigen 
presentation to aB cell through crosslinking of FcF-RI-IgM and CD23-CD21. At high 
concentrations of IgE: o. IgE inhibits formation of sCD23. p. Inhibition of crosslinking of 
CR2 and mIgE by sCD23. q. No crosslinking of CD23b on the B cell. r. &s. IgE is 
degraded upon antigen presentation on B or mast cells. t. Saturation of FcF_RI and FcERII 
sites on Langerhans cells. 
FcfRI-IgE-X 
60 
signals, B cells express CD23 isoform. b and CD40 and undergo class-switching to express 
cell surface IgE. Expression of CD23 induces release of soluble CD23 fragments capable 
of bridging surface IgE to CD21 on the B cell surface and promoting its survival from 
programmed cell death (apoptosis) (Aubry et al., 1992; Sutton & Gould, 1993). Binding 
of the IgE-committed cell to an antigen-specific T cell as described above, causes it to 
differentiate into a plasmacyte secreting IgE (Liu et al., 199 1; Noelle, Ledbetter & Ruffo, 
1992). 
At high concentrations of IgE, the IgE-antigen complex can shift the system into 
shutting down IgE production (Figure 10). Once IgE levels reach a threshold of 
saturation, the binding of lgE-antigen complexes to CD23 on the surface of B cells 
stabilize CD23 and prevent proteolysis and release of CD23 soluble fragments (Lee, Rao 
& Conrad, 1987; Luo et al., 1991). No soluble fragments would thus be available to 
crosslink CD21 and membrane IgE on the surface of IgE committed cells. The IgE- 
antigen complex itself may also bind to CD21 via C3dg on the immune complex. It is 
possible that this association prevents crosslinking of CD21 and membrane IgE by soluble 
CD23. Furthermore, the IgE-antigen complex can crosslink membrane CD23 and inhibit 
secretion of IgE (Scherr et al., 1989). 
At the level of antigen presentation to T cells, IgE complexes down-regulate IgE 
synthesis both by crosslinking CD23 on the surface of B cells, causing endocytosis and 
subsequent degradation of IgE (Chen, 199 1). Similarly, binding of the complex to the high 
affinity receptor on mast cells results in endocytosis and degradation of IgE. 
Finally, a high concentration of IgE may saturate high and low affinity receptor 
binding sites in FDCs thus preventing cell contact with B cells through CD21 and CD23, 
and inhibiting activation of B cells and their rescue from apoptosis (Sutton & Gould, 
1993; Bonnefoy et al., 1993). 
This work is dedicated to the study of a single step in the overlapping regulatory 
pathways of the IgE network: the mechanism of uptake and intracellular route of CD23 
and IgE in B lymphocytes, and the identification of the molecules involved in this process. 
Antigen presentation is a turning point in IgE regulation and the response to allergens. 
The 
study of the intracellular path of both CD23 and IgE is thus linked to the critical 
functions 
of antigen processing, presentation and the regulation of IgE. 
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Chapter 2: Materials & Methods 
2.1 CELL CULTURES 
In all experiments, RPMI 8866 EBV-transformed lymphoblastoid cells were grown 
in suspension in RPMI 1640 medium supplemented with 10% heat- inactivated foetal 
bovine serum, 2mM L-glutamine, 100iu/ml penicillin, 100ýtg/ml streptomycin at 370C 
under 5%CO2/95% air in a Jouan IG150 humidified incubator. Foetal Bovine Serum was 
divided into 50ml aliquots in sterile containers and heat-inactivated in a water bath at 
520C for 30 minutes. It was immediately frozen at -200C and thawed out just before use. 
Media, serum, L-glutamine and antibiotics were all purchased from Gibco-BRL. In all 
experiments RPMI 1640 medium was used as described above fortified with Ca2+ to a 
final concentration of I. OmM. Phosphate buffered saline (PBS) (tissue culture grade, 
without NaNA was purchased from Gibco-BRL and was fortified with I. OmM Ca2+ and 
0.1 %NaN3, where appropriate. 
Live cells were washed in suspension by centrifugation at 200g for 3.5 minutes at 
40C. All centrifugations were performed in a Beckman TJ-6R desktop refrigerated 
centrifuge. Paraformaldehyde or glutaraldehyde-fixed cells were washed in suspension by 
centrifugation at 150g for 5 minutes at either 40C or room temperature. 
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2.2 ANTIBODIES 
Monoclonal antibody MHM6 to the lectin domain of CD23 was a gift from Dr. 
Kevin Moulder and Dr. Gary Christie, SmithKline Beecham Pharmaceuticals and antibodý! 
EBVCS1 specific for the stalk region was supplied by Dr. Sugden, Madison, WI, USA. 
Antibody EBVCS5 was from Becton Dickinson. Antibody BU38 and conjugates were 
bought from The Binding Site Limited, Birmingham. Antibody IOB8 was purchased from 
Immunotech. ) Marseille, France and antibody B6 from Coulter Clone, Luton, Beds. All 
anti-CD23 monoclonal antibodies were raised in mice. Monoclonal antibody to HLA DR 
raised in mice was purchased from Dako Ltd., High Wycombe. 
Secondary anti-mouse antibody IgG(Fab')2 fragments were purchased from Dako 
Ltd., High Wycombe, Bucks. Polyclonal antibody IgG coupled to cyanin (Cy5) was 
purchased from Chernicon International Inc., Temecula, CA, USA. Polyclonal anti-mouse 
IgG Fab conjugated to R-phycoerythrin (R-PE) was from Southern Biotechnology 
Associates Inc., Birmingham, AL., USA. 
Mouse IgG2a monoclonal antibody to clathrin a-light chain was a gift from Dr. 
Ernst Ungewickell, Max-Planck Institut, Munich, Germany. HB5 mouse monoclonal 
antibody to CD21 was kindly provided by Mr. Rajko Re1jic, King's College London. It 
was purified from 11135 hybridoma cell line obtained from ATTCC (American Type Tissue 
Culture Collection). Goat polyclonal antibody to clathrin and polyclonal anti-goat IgG 
antibody directly coupled to rhodamine were purchased from Sigma Immunochernicals. 
DiBAC4(5), DAMP reagent and anti 2,4 dinitrophenyl antibody conjugated to rhodamine 
were from Molecular Probes Ltd., Eugene, Oregon, USA. 
Secondary antibodies conjugated to colloidal gold were purchased from British 
BioCell International. 
IgE was kindly provided by Dr. James McDonnell, King's College London. It has 
been isolated from the blood serum of a myeloma patient and purified by HPLC to >99% 
purity. It was stored at 40C in PBS-0.05% NaN3 and extensively dialyzed in PBS-ImM 
Ca2+ before use. Anti-IgE monoclonal antibodies and conjugates raised in goat were 
purchased from Vector Labs. 
Recombinant soluble 37 kD CD23 extracellular fragment was a gift from Mr. 
Rajko Re1jic, King's College London. It was subcloned into an E. coli expression vector 
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and its expression induced by IPTG (isopropylthio-p-D-galactoside). The soluble fragment 
was expressed in the form of inclusion bodies, isolated from the Ecoli pellet, purified and 
refolded. It was stored frozen in a cocktail of protease inhibitors to prevent proteolysis at - 
200C until just before use. Preliminary studies performed on the protein show that it exists 
in a dimeric form in solution. 
All commercially obtained antibodies came in various buffers containing 0.1- 117c 
sodium azide (NaN3) as a preservative. Sodium azide causes inhibition of the oxidative 
phosphorylation of live cells, which would prevent capping and internalisation of antigen- 
antibody complexes. In order to prevent inhibition of the cell metabolism all antibodies 
were extensively dialyzed in sterile, azide-free buffer. The buffers used, varied in 
accordance to manufacturers' indications. Following dialysis, the antibodies were filtered 
through a sterile 0.2gm pore filter (Millipore). They were divided into aliquots and stored 
frozen at -200C until immediately before use. 
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2.3. INSTRUMENTATION AND TECHNIQUES 
2.3.1 The Flow CytOmeter 
The flow cytometer is used to rapidly measure light scatter and fluorescence on 
cells, as they pass in a fluid stream, one by one, through a sensing point where an 
illuminating beam is applied. This is achieved by injecting the sample suspension into a 
channel through which liquid is flowing. Upon illumination by a laser beam the cells 
generate scattered and fluorescent light which is collected by detectors (Figure 2.1). The 
photodetectors translate the photon pulses into electronic signals which are processed by a 
computer and are presented as graphic displays and statistical analyses of the 
measurements. 
The fluidic system of a flow cytometer delivers cells one by one to a specific point 
which is intersected by the illuminating beam. The sample suspension is passed from the 
sample pool to the centre of an enclosed channel through which liquid is flowing (Figure 
2.2). There are thus two fluid lanes, the sheath fluid line and the sample line which feed the 
flow chamber. The sheath fluid is constantly flowing and is controlled on the sheath 
reservoir by regulated air pressure. A pressure regulator acts on the sample chamber to 
control sample flow rate. 
The cells are rapidly passed through the flow chamber or analytical chamber onto 
which a laser beam is applied. The scattered light generated by the illumination is gathered 
by two collection lenses. The first lens collects light from I to 20 degrees off the laser 
beam axis, as this minimizes the effect of refractive index changes and maximizes the 
dependence of the forward scatter measurements on cell size (Figure 2.3). 
The light is passed through the second collection lens and on to a 500nm short 
pass dichroic mirror placed at 450 to the incident beam (Figure 2.3). This mirror reflects 
wavelengths shorter than 500nm towards the right angle scatter detector and allows 
longer wavelengths to pass towards a 560nm shortpass dichroic mirror. At this stage, 
wavelengths greater than 560nm are reflected at 450 towards the phycoerythrin 
fluorescence detector and through a bandpass filter which transmits a limited range of 
wavelengths centered at 578nm with a 25nm half-peak bandpass. The shortpass mirror is 
permeable to shorter wavelengths between 500-560nm which are passed on through a 
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530nm bandpass filter with a 30nm half-peak bandpass and on to the fluorescein 
fluorescence detector. 
The fluorescence detectors are photomultiplier tubes capable of detecting weak- Cý 
fluorescence. Light falling onto the detectors generates a current which is fed to a filterin2 
preamplifier. The output pulses of the prearnplifier are too fast to allow measurement and 
display circuits to function properly so the signals are fed to a log amplifier. The loc, 
amplifier increases the resolution of weak signals and of the dynamic ranges of 
measurements so that weak and strong signals can be displayed on the same scale. The log 
amplifier also corrects spectral overlap of the emission from two fluorochromes. The held 
voltages are then digitized and the analogue to digital converter transforms the continuous 
voltage analogue range into a scale which is represented by a binary number. The result of 
digital conversion is a list of numbers stored in computer memory where analysis of data 
and display are allowed. 
2.3.2 Fluorophores Used in Flow Cytometry 
In flow cytornetry, immunofluorescence techniques have been developed which 
allow the fluorescence intensity of up to three fluorophores to be detected simultaneously 
on the same cell. In these studies, two-colour immunofluorescence has been used to trace 
cellular antigens. Due to technical restrictions and cost considerations of dual laser 
operation, these techniques must accomodate the use of only a single laser to excite both 
fluorophores. 
For this reason, the most common combination of fluorophores used in flow 
cytometry is fluorescein (FITC) and R-phycoerythrin (R-PE). The advantage of this 
combination of fluorophores is that both can be excited at 488nm (Table 2.1) so that only 
one laser is required for both. Another advantage of this fluorophore combination is that 
I 
their emission maxima are distinctly different, with fluorescein emitting green light and 
phycoerythrin emitting orange light. Furthermore, the 560nm dichroic mirror and the two 
bandpass filters in front of the photornultiplier tubes provide good optical separation of the 
two signals (Figures 2.3 & 2.4). The spectral overlap of FITC reaching the PE detectors is 
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Figure 2.1 
A generalised flow cytometer. The cells generate scattered and fluorescent light. Light Is 
collected by detectors which translate the photon pulses into electronic signals. The 
computerised signals are processed into graphic displays and statistical analysis of the 
measurements. 
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The fluidic system in a flow cytometer. The sheath fluid line flows continuously and meets 
the sample line in the flow chamber. Flow rates are regulated by pressure regulators. 
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Figure 2.3 
The optical configuration for the measurement of scattered light, fluorescein 
isothiocyanate (FITC) and phycoerythrin (PE) immunofluorescence. The first dichroic 
mirror reflects wavelengths shorter than 500nm. Longer wavelengths are allowed to pass 
towards a mirror which reflects wavelengths below 560nm towards the PE detector and 
through a bandpass filter centered at 578nm. The 560nm mirror allows wavelengths 
between 500 and 600 to reach the FITC detector through a 530nm bandpass filter. 
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Figure 2.4 
Filter transmission profile for the separation of FITC and PE fluorescence. Spectral curves 
display the fluorescence emission spectra of FITC and PE upon exitation at 488nm. 
Although the bandpass filters transmit separate wavelengths, the emissions from the two 
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A logarithmic dot plot or cytogram of RPMI 8866 cells. The intensity of forward scatter 
(FSC) (x-axis) is plotted against the intensity of right angle scatter or side scatter (SSC) 
(y-axis) for each cell. Each cell is represented by a dot. 
The dot plot defines the cell population by shape and size. The ellipsoid region drawn 
around the RPMI 8866 cells is used to define the cell population of interest for flow 
cytometric measurements. Histograms, dot plots and statistical analysis in the present 
study are based on data collected from RPMI 8866 cells within this region. 
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TABLE 2.1 
FLUOROPHORES USED TO LABEL CELLS 
FLUOROPHORE EXCITATION MAX EMMISSION MAX LABELS 
(nm) (nm) 
Fluorescein 495 520 Proteins 
(FITC) 
Tetramethy1rhodamine 557 570 Proteins 
(TRITC) 
R-Phycoerythrin 564,495 576 Proteins 
(R-PE) 
Cyanin 650 667 Proteins 
(Cy5) 
Propidium Iodide 495,342 639 Nucleic Acids, 
DNA, Some dsRNA 
DiBAC4(5) 595 615 Lipid-rich regions, 
i. e. membranes 
2.3.3 Flow Cytometric Analysis 
Forward and right angle scatter measurements are used to discriminate 
morphologically different cells. This is useful in samples where more than one cell types 
are present. Scatter measurements are also used to discriminate cells from debris and also 
live from dead cells in live sample preparations. A cytogram of forward versus right-angle 
scatter can differentiate cells of different shapes and sizes and also the cells of interest 
from debris. In order to measure the fluorescence of the cells of interest, it is necessary to 
use gating techniques. A gate or window is drawn to select cells for accumulation in the 
fluorescent histogram. A cytogram for RPMI 8866 cells and the window drawn to select 
the cells is shown in Figure 2.5. Identical cytograms were used in Chapters 3,4,5 and 6 to 
select the cells and produce flow cytometric data. 
The fluorescent histogram of cell count versus fluorescence intensity can be 
displayed using linear or logarithmic amplification of signals. In logarithmic amplification 
negative cells occupy the first decade of the display which is only a quarter of the channel 
7-2 
resolution. Logarithmic histograms also allow intensely and weakly staining cell 
populations to be displayed on the same scale. 
In flow cytometric measurements the establishment of a negative control is 
essential. A negative control is used to establish a threshold on the immunofluorescence 
histogram above which cells are considered positive for antibody staining. A suitable 
negative control could be a sample which has not received primary antibody. The negative 
signal should thus be the sum measurement of nonspecific staining of the cells by 
secondary antibody, autofluorescence of cells and the background optical noise of the 
cytometer. It is usual to set the threshold at a position so that less than 5- 10% of the cells 
counted in the negative control are above the marked minimum. 
The threshold marker is used in arithmetic histogram statistics to establish two 
commonly used measurements in analysis of cellular subsets with antibodies. The most 
reliable measurement is the percentage of cells in a population which are labelled for a 
given antigen. The marker is set so that the percentage of cells stained in experimental 
samples can be detennined by counting the number of events above the set threshold. The 
second measurement is the relative fluorescence intensity in different samples. This 
statistic is only valid if the cell samples which are measured display fluorescence signals in 
similar patterns or on the same cell compartment. For instance, internal fluorescence 
intensity cannot be measured against surface fluorescence since light passing through a cell 
will be hindered or absorbed by intracellular structures before or after exciting an internal 
fluorophore giving an erroneous fluorescence intensity signal. 
2.3.4 The Confocal MicroscQpe 
The characteristic difference distinguishing confocal microscopy from conventional 
light microscopy is the shallow depth of field (0.5-1.5gm) which allows infori-nation to be 
collected from a well-defined optical section enabling the confocal microscope to provide 
images free of out-of-focus information. The use of a confocal microscope provides 
optical rather than actual sectioning, and precludes the need to physically section and 
destroy a specimen in order to obtain clear images within a translucent cell. Serial optical 
sections may be obtained by moving the focal plane progressively through the specimen as 
the objective lens is positioned closer to or further from the sample. 
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Two important features in a confocal microscope provide this capability. First, the 
specimen is illuminated by a finely focused point. Depending on the wavelength of light, 
objective lens and confocal microscope settings the size of the focused point may be as 
small as 0.25gm in diameter and 0.5gm deep. This point source of light exposes an 
extremely small volume of the specimen to incident light at any time thus restricting, 
sources of reflected light or fluorescence emission. Second, in front of the device which 
detects the return signal, the confocal aperture is used to allow passage of light emitted 
from the focal plane and to spatially filter light originating from areas of the sample above 
or below the focal plane (Figure 2.6). 
Fluorescent light emitted from the specimen is passed through a dichroic mirror 
and directed through a filter block which removes reflected or incident light from the beam 
and only allows fluorescent light to reach the confocal aperture. The fluorescent light 
confocal aperture allows passage of light from the focal plane and blocks light emitted 
from planes above and below it. Finally, the photomultiplier tubes detect light transmitted 
through the fluorescent channel. By scanning a point detector through the image plane to 
measure the image intensity of each object point, an image can be built point by point. The 
image is stored in a computer and displayed on a television screen, thus reproducing the 
fluorescent signal of the observed plane within the specimen. 
2.3.5 Fluorophores Used in Confocal Microscopy 
In these confocal microscopy experiments, an MRC 600 confocal microscope 
(BioRad) was fitted with a Krypton/Argon-mixed gas laser, which allows the possibility of 
triple excitation (Table 2.2). It emits three lines, so that up to three fluorophores can be 
measured simultaneously on the same specimen (Figure 2.7). For all experiments, the 
images produced resulted from the observation of an average of 100 cells. Each cell was 
examined by scanning optical sections approximately lgrn in thickness each. The cell was 
divided in approximately 10-15 optical sections all of which were scanned, examined and 
occasionally recorded in order to detect possible internal fluorescence. 
The most commonly used fluorophore is fluorescein isothiocyanate (FITC) which 
is widely available linked with antibodies and a variety of other probes (Figure 2.6). 
Another fluorophore used in combination with fluorescein is tetramethy1rhodamine 












General features of a confocal microscope. 
Upon illumination, light is passed through a dichroic mirror and a filter block which 
eliminates reflected and incident light. Confocal aperture allows passage of fluorescent 
light from the focal plane. Photomultiplier tubes collect light from the fluorescent channel. 
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Figure 2.7 
Fluorescence excitation and emission spectra of common fluorochromes used in confocal 
microscopy. The use of krypton/argon mixed gas laser allows the detection of three 
fluorochromes in the same specimen. The krypton/argon laser errfits three lines at 488nm 
(blue), 568nm (yellow) and 647nm (red). The three lines are selected from the same laser 
beam with minimum spectral overlap. 
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fluorescein (Figure 2.6). To that end, when excitation of fluorescein only is to be detected, 
the light which maximally excites FITC will only produce 5% excitation of TRITC. The 
major advantage of this combination is that separate images of the same sample plane can 
be displayed to simultaneously distinguish between different antigens. 
TABLE 2.2 
FILTER SPECIFICATIONS USED WITH THE MRC 600 CONFOCAL MICROSCOPE 
Krypton/Argon-Mixed Gas Laser: 
RHS Block: 
K2 Block: 







Dichroic Recflector 660nm 
Emission Filter 690nm 
Dichroic Reflector 560nm 
Green Emission 522nm 
Red Emission 585nm 
Laser excitation lines 488nm 
568nm 
647nm 
Best Pass-Through Emission 
Green 500-550nm 
Red 570-640nm 
Far Red >600nm 
In order to label cellular compartments, two fluorescent dyes are used, propidium 
iodide and DiBAC4(5). Propidium iodide (PI) emits red fluorescence and can 
be detected 
by the same fluorescence detector as rhodamine. It intercalates 
between the bases M- 
double stranded DNA to produce red fluorescence and label the cell nucleus. 
It also binds 
less strongly to double stranded RNA also lightly labelling the mitochondria. 
Its low non- 
specific binding to the cytoplasm at high enough concentrations allows 
the general 
structure of the cytoplasm to be displayed. Propidium 
iodide does not freely cross an 
intact plasma membrane; however, when the cell dies or 
is fixed using an aldehyde, the 
integrity of the cell membrane fails and PI is able to enter and stain nucleic acids. 
The dye 
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DiBAC4(5) also produces red fluorescence and it binds to lipid-rich regions such as cell 
membranes (Table 2.1). Its binding affinity reflects the electrical potential difference across 
the relevant membrane. This dye can also enter fixed unpermeabilised cells and stain the 
nuclear envelope, the outer membrane and the cytoplasmic organelles. 
The third fluorophore used is cyanin (Cy5) which absorbs light at 650nm and emits 
in the far red region (Table 2.1, Figure 2.6). It is also available commercially conjugated to 
antibodies or bound to streptavidin. Excitation and emission maxima for all fluorophores 
used in confocal microscopy experiments are shown in Table 2.1. 
2.3.6 The Electron Microscope 
The electron microscope offers a significant improvement in resolving power over 
visible or fluorescent light microscopes. Its principle is based on the fact that electrons 
display wave properties much like visible light, ultraviolet light and x-rays, with a 
wavelength much smaller than that of visible light. 
The source of illumination in an electron microscope is an electron gun. In an 
electron gun a small v-shaped piece of wire is subjected to a large voltage. The current 
that flows causes thermionic emision of electrons. The electron beam is condensed by 
passing through two electron lenses and focused onto the specimen (Figure 2.8). The 
electrons pass through an objective lens which magnifies the specimen image. As electrons 
cannot travel more than a very small distance in air since they are stopped by collision with 
gas molecules, the interior of an electron microscope has to be kept in vacuum. The actual 
vacuum required is 10-4 mmHg and it is obtained by means of vacuum pumps. 
The specimen image is processed through a series of intermediate lenses which 
allow the magnification to be changed over a wide range. The final image is projected 
through a projector lens which corresponds to the eye piece of a light microscope (Figure 
2.8). Since the human eye is not sensitive to electrons, the final image is projected either 
on a viewing screen coated with a fluorescent material or onto a photographic film in a 
camera if the image is to be recorded. The fluorescent screen on which the image appears 
is viewed through thick leaded glass windows in the chamber at the bottom of the 
microscope column. For critical focusing the image can be examined through a low power 
binocular microscope mounted outside the glass window. 
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2.3.7 Cell Processing and Sectioning for Electron Microscopy 
Small objects like macromolecules can be directly examined under an electron 
microscope without elaborate preparation by negative staining or shadowing. However, 
this is not possible for whole cells. Since living tissue consists of more than 70% water, 
the high vacuum in the chamber would dehydrate cells by evaporation causing them to 
collapse and their intricate structure to be destroyed. Furthermore, most of the electrons 
passing through a whole cell would encounter atoms on their way through and be 
scattered. Since an object becomes visible if it scatters electrons, the image of a whole cell 
would thus appear dark, with little detail. The only way this can be dealt with is by 
sectioning whole cells. In order to avoid loss of detail the sections should be no more than 
0.1 ýtm thick and ideally, they should be around 50-70nm. 
The first step taken to stabilize the fragile cell structure is to use a "fixative", 
usually an aldehyde which forms cross-linkages between amino groups on the protein 
molecules so that the proteins of the cell are converted into a stable, cross-linked network. 
A further fixative used is osmium tetroxide OsO4 which reacts with several functional 
groups including double bonds in unsaturated fatty acids in lipids and proteins. Cells 
grown in suspension are more difficult to process through dehydration and embedding. 
They are therefore embedded in BSA which is crosslinked with glutaraldehyde to produce 
a gel-like material. Alternatively, ultra-low temperature agarose can be used which forms a 
gel-like solid at temperatures lower than 370C (Sigma Immunochemicals). This is done to 
entrap the cells for further processing. BSA or agarose-encapsulated cells are then 
dehydrated in ethanol-water mixtures of increasing concentrations starting with 30% and 
ending up in pure ethanol. The pellet is then infiltrated with resin-ethanol mixture (50-50) 
for I hour and is then transferred into pure resin overnight. The cell pellet is then 
transferred in pure resin, placed in polypropylene mould and polymerised at constant 
temperature (50 or 700C) for 24 hours and allowed to cool. The result is a small block of 
resin ýn gelatin capsules with the tissue inside and this can be sectioned. 
The apparatus for sectioning tissues is an ultramicrotome (Figure 2.9). In a 
microtome, a knife is kept stationary and the specimen is moved over it, being advanced 
by a fixed distance at each cutting stroke (Figure 2.9a). The specimen advance is brought 
about by a very fine screw-drive, operated by a ratchet mechanism. The knife used is 
79 
commonly a glass edge prepared by carefully breaking up plate glass with a glass cutter. 
Polished diamond knives are also used. 
The tip of the block containing the embedded tissue has to be carefully trImmed to 
a trapezoid shape with a razor blade, while watching through a low power dissectina 
microscope. The diameter of the trapezoid should be no more than 0.5mm. As the sections 
are very fragile and impossible to handle, they are floated on the water surface of a small 
container (boat) fitted on one side of the knife (Figure 2.9b). The water level is adjusted 
so that the meniscus exactly meets the knife edge. The sections, which are floated 
adhering to each other as a long continuous ribbon, can be picked up in copper or nickel 
grids which are sometimes coated with a plastic support film. 
As cells and tissues have low intrinsic electron-scattering power, little detail of 
their structure can be made out in the electron microscope. In order to increase section 
electron- scattering power, two heavy metal chemicals are commonly used which are 
applied directly onto the sections just before observation. Uranyl acetate chiefly combines 
with proteins and nucleic acids and lead citrate is taken up by lipid-containing membranes. 
The grids can be directly inserted into the vacuum specimen chamber for examination. 
The property of heavy metals to strongly scatter electrons and thus be detectable 
under an electron microscope, has been used in immunocytochernical studies to detect 
various cell components. Antibodies to various antigens are commercially available which 
are conjugated to colloidal gold particles of different diameter. As the resolving power of 
the electron microscope is about Inm, antibodies conjugated to colloidal gold as small as 
0.2nm in diameter can be detected, although antibodies are commonly conjugated to gold 
particles of 5,10,15,20 and sometimes 30nm in diameter. 
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Figure 2.8 
A section of the column of a high resolution electron microscope. The interior of the 
microscope is evacuated by high-performance pumps. The illuminating system consists the 
electron gun and the condenser lens. The electron gun is the source of illumination and the 
condenser lens narrows the electron beam that irradiates the specimen. The image is 
viewed on the fluorescent screen through a thick glass screen and low-power binoculars 
for critical focusing. The electron gun and lenses have to be lined up accurately and the 











Basic layout of a microtome. 
a. The plastic-embedded specimen is attached to the microtome and is advanced 
bý, a 
fixed distance over the stationary knife. 
b. The knife is loaded with a water-containing boat to which sections are floated as 
they are sliced. 
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2.4 EXPERIMENT 1: ANTIBODY-INDUCED ENDOCYTOSIS OF CD23 
2.4.1 Flow CytometU 
Monoclonal antibodies tested were BU38, IOB8, MHM6, EBVCS5 and B6. These 
antibodies bind to the lectin-like domain (Bonnefoy et al., 1990). Monoclonal antibody 
EBVCS I was also tested which recognizes a different epitope and has been shown to bind 
to the stalk region of the protein and fails to inhibit IgE binding as well as IL-4-induced 
IgE synthesis (Gordon et al., 1987; Bonnefoy et al., 1990). 
To test each antibody, samples containing lx106 cells each were washed once in 
cold RPMI 1640 medium fortified with I. OmM CaC12. The samples were incubated with a 
monoclonal antibody to CD23 diluted to Igg/ml in 150gl calcium-fortified medium for I 
hour at 40C. At the same time, the negative control was suspended in medium containing 
no primary antibody and allowed to stand at 40C for I hour. Following two washes in 
cold RPMI 1640, ImM CaC12, all samples were incubated with medium containing 
40Rg/mI of fluoresceinated secondary antibody (IgG Fab - FITC) for 45 minutes at 40C. 
Samples were then washed three times in cold, calcium-fortified RPMI 1640 medium and 
finally resuspended in RPMI-1mM CaC12 which was pre-warmed at 370C. The cells were 
allowed to intemalise CD23 for 0,3 and 5 hours in a 370C incubator. At the end of each 
incubation samples were washed once in phosphate buffered saline (PBS) solution, IMM 
CaC12-0- I% NaN3, pH 7.2, to arrest cell growth and stop intemalisation of CD23. 
Stripping of cell fluorescence presented a particular challenge as monoclonal antibodies to 
CD23 protect the receptor at the cell surface against trypsin (Bonnefoy et al., 1992); thus 
acid stripping which removes surface-bound antibodies was employed rather than 
chymotrypsin treatment. A trypan blue exclusion test perfon-ned after each treatment 
show6d a total loss of 5-10% of the labelled cells. For each incubation time, two samples 
were prepared. One set of samples were suspended in PBS of physiological pH to allow 
for the measurement of total surface and internal fluorescence. The second set of samples 
in each antibody experiment were incubated in 150mM NaCl-20mM HCI solution, pH 1.7 
for 3 minutes at room temperature, to strip off antibodies bound on the surface of the 
cells. Acid stripping was used in samples incubated for 3 and 5 hours at 370C to remove 
surface fluorescence and measure the fraction of cells which showed intemalised protein. 
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This was compared with the total fluorescent population in samples suspended in 
physiological buffer which were previously labelled with antibodies and incubated at 370C 
for the same time intervals. Cells were finally washed three times in PBS-IMM CaC], )- 
0.1% NaN3, pH 7.2 at room temperature and fixed in 0.5ml 2% paraformaldehyde freshly 
dissolved in PBS-1% BSA-ImM CaC12, pH 7.2 for 20 minutes at room temperature. The 
samples were washed twice in PBS-l% BSA-ImM CaC12402% NaN3, pH 7.2 at room 
temperature, resuspended in 0.5m] of that buffer and fluorescence distribution was 
measured on a Becton-Dickinson Flow Cytometer. 
2.4.2 Confocal Microscqpy 
RPMI 8866 cells were placed in samples, each containing 5xlO5 cells and washed 
once in cold RPMI 1640 medium. Samples were incubated for I hour at 40C with I ýtg/n-fl 
BU38 monoclonal antibody to the lectin domain of CD23 in a total volume of 200ýtl in 
medium. Another set of samples were incubated with I gg/ml MHM6 monoclonal antibody 
to the lectin domain of CD23 in a total volume of 200gl in medium. Control samples were 
not labelled with BU38 or MHM6 antibodies but were suspended in 200gl cold medium 
for I hour. After 2 washes in cold RPMI 8866 medium all samples were incubated in 
150RI of a fluoresceinated IgG(Fab')2 diluted 1: 50 in medium. This second incubation was 
carried out for 45 minutes at 40C and was followed by two washes in cold medium. The 
cells were resuspended in RPMI 1640 medium prewarmed at 370C and incubated in a 
370C humidified incubator for different time intervals of 0,2,4,6 and 8 hours. Control 
samples were incubated at 370C for 8 hours. After the incubations the samples were 
washed twice in cold PBS buffer, pH 7.2 at 40C and fixed in 2% formaldehyde-PBS, pH 
7.2, for 15 minutes at room temperature. Following one wash in PBS the samples were 
suspended in 100gl Citifluor fluorescence preservative containing glycerol and PBS (Agar 
Scientific) which prevents fast fluorescein fading during illumination. For obervation, 10[d 
of the fixed cell suspension of samples incubated with MHM6 antibody to the lectin 
domain of CD23 was combined on a poly-L-lysine-coated glass slide with 5ul of 
propidium iodide diluted to Igg/ml in PBS (Sigma Immunochemicals). Propidium iodide 
binds to double-stranded DNA and labels the cell nucleus. It also reacts with nucleic acid- 
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containing vesicles in the cytoplasm and lightly illuminates the cytoplasm thus making the 
boundaries of the nucleus less clearly defined. Poly-L-lysine (BDH) is used In microscopic 
observations of suspension cells and causes them to adhere lightly to the coated surface. In 
order to further prevent the cells from floating, the coverslip was lightly held while the 
sides of the slide were cleaned of excess solution. The slides were sealed with nail varnish 
and observed under a BioRad MRC 600 confocal microscope. Following a test of 
different dyes, it was found that the specimens showed optimal intracellular structure 
detail if observed in DiBAC4(5) (Molecular Probes). As above, 10gl of fixed cells 
previously incubated with BU38 antibody to the lectin domain of CD23 were combined 
with 5gl of DiBAC4(5) (Img/ml stock solution in methanol) freshly diluted to 10ýLg/nfl in 
Citifluor-glycerol-PBS solution. DiBAC4(5) binds to all intracellular membranes and 
permeates fon-nalin-fixed tissue. It successfully labels the nuclear envelope and outer 
membrane and also provides some cytoplasmic membrane detail. Binding of the dye to the 
nucleolus membrane was very weak. 
2.4.3 Electron Microscopy 
RPMI 8866 cells were divided into three samples, each containing 2.4x]07 cells 
and washed once in cold RPMI medium. Samples 1 and 2 were incubated for 2 hours at 
40C with 3ml of cold medium containing 25ýtl of MHM6 monoclonal antibody specific for 
the lectin domain of CD23. Sample 3 was suspended in 3ml cold medium containing no 
antibody and was also kept at 40C during the incubation. After one wash in cold medium 
all three samples were incubated for one hour in 2ml medium containing 50gl IgG Fab 
antibody fragment conjugated to 5nm gold. Both the primary and secondary antibody 
incubations were performed on a rocker at 40C. 
Cells were further washed once in medium and samples 2 and 3 were suspended in 
5mls of pre-warmed RPMI 1640 medium. The samples were placed on tissue culture 
plates and allowed to internalise and process CD23 for 10 hours in a 370C incubator. 
During this incubation sample 1 was kept at 40C. Following 10 hours incubation, all cells 
were washed once in cold PBS buffer and immediately fixed in 2.5% glutaraldehyde- 
100m. M cacodylate buffer, pH 7.2, for 2 hours at 40C (glutaraldehyde (25% v/v), sodium 
cacodylate and 2% osmium tetroxide in ampules were bought from Agar Scientific). After 
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one wash in 100m. M cacodylate buffer pH 7.2, the preparations were osmicated in 117c 
OS04-IOOmM cacodylate buffer for 45 minutes at room temperature. The cells were 
suspended and then washed twice in IOOmM cacodylate buffer. To the samples 200PI of 
4% BSA-50m-M Tris-150mM NaCl, pH 7.4, was added and to each one 20ýtl of 2517c 
glutaraldehyde was added to crosslink BSA and produce a gel-like cell pellet. The cells 
were pelleted by immediate mixing and centrifugation for 5 minutes at 500g. The cell 
pellets were dehydrated in 30% ethanol and cut into small cubes I MM3 in volume. The cell 
cubes were incubated in 50%, 70%, 90% and 95% ethanol by gently rotating them for 15 
minutes each rinse. They were finally rotated for 3 10-minute intervals in 100% ethanol 
(Brodsky et al., 1989). All encapsulation and dehydration steps were performed at room 
temperature. Cell pellets were suspended in 50% LR White resin (London Resin 
Company, distributed by Agar Scientific) - 50% ethanol and gently rotated at room 
temperature for I hour. They were further suspended in pure LR White resin and rotated 
overnight at room temperature. The next day, the pellets embedded in LR White resin 
were placed in gelatin capsules and incubated at 520C for 24 hours. Ultrathin sections of 
50-70nm thickness were cut and mounted on nickel grids. Sections collected on grids 
were stained in uranyl acetate for 1.5 minutes in the dark, washed with distilled water, 
dried and further incubated in lead citrate for 2 minutes. Sections were finally rinsed in 
distilled water, dried on filter paper and observed under an Electron Microscope. 
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2.5 EXPERIMENT 2: INTRACELLULAR CO-LOCALISATION OF THE CD23 
LECTIN DOMAIN AND STALK REGION 
2.5.1 Flow CytomgtU 
RPMI 8866 cells were harvested and aliquoted in samples containing jxI06 cells 
each. Cells were washed once in calcium-fortified medium and incubated for I hour at 
40C with EBVCS I monoclonal mouse antibody to the stalk region of CD23 at 
concentration of Iýtg/ml diluted in medium. Following two washes in cold medium the 
cells were incubated for 45 minutes in 200gl medium containing 40gg/ml anti-mouse 
IgG(Fab) coupled to R-phycoerythrin (IgG Fab - R-PE) at 40C. After four washes in 
medium, the cells were incubated in 150ýtl of medium containing Igg/ml BU38 antibody 
to CD23 lectin domain directly coupled to fluorescein (BU38-FITC) for I hour at 40C. 
Samples were washed three times and resuspended in pre-warmed, calcium-fortified 
medium. The cells were allowed to internalise CD23 for 0,2.5 and 5 hours at 370C. At 
the end of each incubation cells were washed twice in PBS, 1mM Ca2+, 0.1% NaN3 to 
arrest cell metabolism and stop internalisation of CD23. Stripping of cell fluorescence was 
performed as described previously. For each incubation time, one sample was subjected to 
acid stripping to remove surface fluorescence and allow for the measurement of the cells 
showing internal fluorescence only, while another sample was suspended in PBS, pH 7.2, 
to exibit total fluorescence. Cells were fixed in 2% paraformaldehyde-PBS and suspended 
in PBS-BSA, as described above. 
2.5.2 Confocal Microscopy 
2.5.2A Double Fluorescent Labelling: Lectin. Domain and Stalk Region 
RPMI 8866 cells were divided into samples each containing 5xlO5 cells and 
washed once in medium. Samples were incubated for I hour at 40C with EBVCS I 
monoclonal mouse antibody to the stalk region. After two washes, the cells were labelled 
for 45 minutes at 40C with 150gl of a polyclonal anti-mouse antibody conjugated to 
rhodamine (IgG-TRITC) freshly diluted 1: 50 in medium. Following four washes in cold 
medium the samples were incubated at 40C with Igg/ml BU38 monoclonal antibody to 
87 
the CD23 lectin domain directly coupled to fluorescein (BU38-FITC). A control sample 
was suspended in 200ýtl medium for I hour without EBVCSI and was washed and 
incubated with secondary antibody followed by BU38-FITC as the rest of the samples. It 
was left at 40C which other samples were incubated at 370C. Cells were washed three 
times in cold medium and finally resuspended in pre-warmed medium and incubated at 
370C in a humidified incubator for 0,29 4 and 6 hours. Following each incubation cells 
were washed twice in PBS-ImM Ca2+-O. I% NaN3 and incubated in 2% 
paraformaldehyde- I mM Ca2+-PBS, pH 7.2 for 15 minutes at room temperature. After one 
wash in PBS, cells were suspended in 100ýtl Citifluor fluorescence preservative containing 
glycerol and PBS and mounted on poly-L-lysine-coated slides, as previously described 
(This Chapter, section 2.4.2). 
2.5.2B Triple Fluorescent Labelling: Lectin Domain and Stalk Region 
Confocal. n-dcroscopy was used to co-localise the lectin domain and stalk region of 
CD23 with respect to the cell structure following triple fluorescent labelling. RPMI 8866 
cells were divided into aliquots each containing 5xIO5 cells and washed once in cold 
medium. Samples were incubated with 200ýd medium containing EBVCSl monoclonal 
antibody diluted to Igg/ml, for I hour at 40C. Following two washes in medium, samples 
were incubated in 150g]. medium containing a polyclonal anti-mouse antibody conjugated 
to cyanin (IgG-Cy5) (1: 20 dilution). After four washes in medium, the cells were 
incubated at 40C with 200gI medium containing Igg/ml BU38 antibody directly 
conjugated to FITC (BU38-FITC). The cells were washed three times in cold medium and 
incubated at 370C in a humidified incubator for 0,2,4 and 6 hours. Following each 
incubation, cells were washed twice in PBS and fixed in 2% paraformaldehyde, PBS, 
2+ ImM Ca , 0.1% azide 
for 15 minutes at room temperature. Following one wash in 
calcium-fortified PBS, the cells were resuspended in Citifluor fluorescence preserver and 
mounted along with DiBAC4(5) on poly-L-lysine-coated slides as described before (This 
Chapter, section 2.4.2). 
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2.5.3 Electron Microscopy 
Cells were divided into 5 samples containing Ix 107 cells each and washed once in 
cold RPMI medium containing ImM CaC12- Samples 1,2 and 3 were labelled with 2ml of 
cold medium containing 75gl of EBVCS 1 (Img/ml in stock solution) monoclonal antibody 
to the stalk region for 1 hour at 40C. Samples 4 and 5 were suspended in 3n-fl cold 
medium containing no antibody and were also kept at 40C during the incubation. After 2 
washes in cold medium all 5 samples were incubated for I hour in 2ml medium containing t: ) 
50ýtl anti-mouse IgG Fab antibody fragment bound to 5nm gold. Following two washes in 
cold medium, in samples 1,2,3 and 4 the lectin domain of CD23 was labelled on the 
surface of B lymphocytes with 2ml medium containing 50ý0 of monoclonal antibody BU38 
(Img/ml stock solution) conjugated with biotin for I hour at 40C. After two washes at 
40C samples 1,2,3 and 5 were further labelled with 75ýtl anti-biotin antibody bound to 
l0nm gold in a final volume of 2" for I hour at 40C and then washed twice in cold 
medium. Samples 2 and 3 were suspended in 20ml warm medium and allowed to cap and 
internalise CD23 at 3.5 and 10 hours respectively at 370C. Samples 1,4 and 5 were kept 
at 40C during the incubations. 
After incubations, cells were fixed in 5ml of 2.5% glutaraldehyde-4% sucrose- 
I mM CaC12- I OOMM cacodylate buffer, pH 7.2 for I hour at room temperature. Following 
fixation, all samples were osmicated in 1% osmium-100mM cacodylate buffer (Agar 
Scientific) for 40 minutes at room temperature and washed 3 times in 100MM cacodylate 
buffer. Ultra-low temperature agarose was prepared (Sigma Immunochemicals), 3% in 
100mM cacodylate buffer at 50-600C. Once it was mixed, it was cooled to 370C and 
added to the samples. As the temperature was lowered the agarose produced a gel-like 
cell pellet. The cells were pelleted by immediate mixing and centrifugation 
for 5 minutes at 
500g. The cell pellets were dehydrated in 30% ethanol and cut in small cubes, lmm3 
in 
volume. The cell cubes were dehydrated in 30%, 50%, 70%, and 
95% ethanol at roorn 
temperature by gently rotating them for 15 minutes each rinse. They were finally rotated 
for 3 10-minute intervals in 100% ethanol (Brodsky et al., 1989). All encapsulation and 
dehydration steps were performed at room temperature. Cell pellets were suspended 
in 
50% Lemix-Epoxy resin - 50% ethanol and gently rotated at room temperature 
for 1.5 
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hour. They were further suspended in pure Lemix-Epoxy resin (Fisons) and stirred 
overnight at room temperature. The next day, the pellets embedded in fresh Lemix-Epoxv 
resin were placed in gelatin capsules and incubated at 700C for 24 hours in order to 
polymerise. Ultrathin sections of 50-70nm thickness were cut and mounted on nickel 
grids. Sections from control samples and the sample incubated for 3.5 hours at 370C were 
collected on grids, stained in uranyl acetate for 10 minutes in the dark, washed with 
distilled water, dried and further incubated in lead citrate for 5 minutes. Sections were 
finally rinsed in distilled water, dried on filter paper and observed under an Electron 
Microscope. Sections from samples incubated for 10 hours at 370C were not incubated in 
uranyl acetate or lead citrate, but observed under the electron microscope directly after 
being cut. 
For calibration purposes, the electron microscope was standardised by 2160 
lines/mm diffraction grating grid. The size of 5 and 10 nm gold particles embedded on a 
specimen grid was calculated using a diameter eyepiece measuring lupe. 
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2.6 EXPERIMENT 3: INTRACELLULAR CO-LOCALISATION OF HLA DR 
AND CD23 
2.6.1 Flow Cytometry 
2.6.1 A CD23 Endocytosis via HLA DR 
Samples containing jx106 RPMI 8866 cells each were washed once in calcium- 
fortified medium and incubated for 1 hour at 40C with 200gl medium containing Iýtg/ml 
IOB8 antibody to the lectin domain of CD23. Following three washes with cold medium, 
cells were incubated for 45 minutes at 40C with antimouse IgG Fab fragment directly 
coupled to fluorescein diluted to 40gg/ml in 200ýtl medium. After four washes in medium 
specimens were incubated for I hour at 40C in 200pl medium with or without Iýtg/ml 
CR3/43-11 mouse monoclonal antibody to HLA DR antigens. Negative control samples 
were not incubated with IOB8 antibody but were treated with IgG-Fab-FITC, followed by 
CR3/43 antibody and kept at 40C while others were incubated at 370C. After three 
washes the samples were resuspended in warm medium and incubated at 370C for 0,3 
and 6 hours. As previously, there were two samples assigned for each incubation interval. 
Specimens were treated for surface fluorescence removing and fixation as in previous flow 
cytometry experiments. 
2.6.1 B HLA DR Endocytosis 
Flow cytometry was employed to investigate the contribution of CD23 monoclonal 
antibody to intemalisation of HLA DR. Samples containing I x106 cells were washed once 
and incubated for 1 hour at 40C with or without IOB8 antibody to CD23 at IRg/ml in 
200gl. medium. After three washes the cells were incubated for I hour at 40C in 20041 
medium containing Iýtg/ml CR3/43-II monoclonal antibody to HLA DR directly coupled 
to fluorescein (CR3/43-11-FITC). Control samples were treated with 1OB8. They were 
not, however, incubated with CR3/43 but were suspended in streptavidin-FITC to allow 
for detection of non-specific surface binding. The sample was kept in ice while others 
were incubated at 370C. After three washes, specimens were resuspended in warrn 
medium and incubated for 0,3, and 6 hours at 370C in a humidified incubator and 
afterwards treated for surface fluorescence stripping and fixation as described above. 
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2.6.1 C CD23 and HLA DR Endocytosis 
Double immunofluorescence was used to assess the portion of cells showing 
internal CD23 and HLA DR. As described above, cells harvested and aliquoted at IxIO6 
cells per sample were incubated for I hour with IOB8 mouse antibody to CD23 followed 
by two washes and a further 45-minute incubation with anti-mouse IgG Fab coupled to R- 
phycoerythrin (IgG Fab-R-PE). After four washes, the cells were incubated for I hour in 
medium containing CR3/43-11 antibody to HLA DR directly conjugated to fluorescein. 
The cells were incubated at 370C for 0,3 and 6 hours, acid-stripped and fixed as 
previously described. 
2.6.1 D HLA DR Recycling 
Samples containing IxIO6 cells were washed once as above and incubated for I 
hour at 40C in 200ýtl medium containing l[Lg/ml CR3/43-11 monoclonal antibody to HLA 
DR. After three washes, specimens were resuspended in warm medium and incubated for 
0,4, and 8 hours at 370C in a humidified incubator. The control was not treated with 
CR3/43 but incubated at 370C for 8 hours. After two washes in cold medium all samples 
were incubated for 45 minutes with anti-mouse 1gG Fab coupled to fluorescein. Samples 
were washed three times in PBS- I %BSA and fixed as described above. 
2.6.2 Confocal Microscopy 
2.6.2A CD23 Endocytosis via HLA DR 
Confocal microscopy was employed to visually confirm that HLA DR antigens 
mediate endocytosis of CD23. After 2 washes in cold RPMI 1640 medium, cells (5xlO5 
cells per sample) were incubated with medium containing I ýtghnl EBVCS I monoclonal 
antibody to the stalk region of CD23, which does not enhance CD23 endocytosis, for I 
hour at 40C. Following two washes in cold RPMI medium the antibody was further 
conjugated to a fluoresceinated secondary antibody (IgG Fab - FITC) diluted in 200ý11 
medium to 40gg/n-fl, for 45 minutes at 40C. Monoclonal antibody to HLA DR antigens 
CR3/43-11 (in 200gl medium, at Igg/ml) was then linked on the B cell surface for I hour 
at 40C. In a control sample, the cells were suspended in 20ORI medium without EBVCS 
I 
monoclonal antibody but treated with IgG Fab - FITC and anti-HLA DR antibody as the 
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rest of the samples. The control was kept at 40C during incubations. Other controls were 
treated with EBVCS I and IgG Fab-FITC but the anti-HLA DR antibody incubation was 
omitted. These samples were incubated as the other samples for 0,2,4 and 6 hours at 
370C. Following three washes in cold medium, cells were resuspended in RPMl 1640 
medium and allowed to internalise HLA DR for 0,21 4 and 6 hours at 370C. Samples 
were fixed in 2% paraformaldehyde in PB S-I mM Ca2+-O. I% NaN3 buffer, pH 7.2 for 15 
minutes at room temperature, washed once in cold PBS and mounted on poly-L-lysine- 
coated slides, as described above (This Chapter, section 2.4.2). Specimens were observed 
under the confocal microscope to search for endocytosed C1323. 
2.6.2B Triple Fluorescent Labelling: CD23 and HLA DR Endocytosis 
Cells were divided into samples, each containing 5xlO5 cells and washed once in 
cold medium. Samples were incubated with I gg/ml EBVCS I mouse antibody to CD23 for 
I hour at 40C. Following two washes, cells were suspended in 200n-d medium with 
60ýtg/ml of a polyclonal anti-mouse antibody conjugated to cyanin (IgG-Cy5). After four 
washes in medium, the cells were incubated at 40C with 200gl medium containing I gg/ml 
CR3/43-11 antibody directly conjugated to FITC (CR3/43-FITC). After three washes in 
cold medium the cells were incubated in medium at 370C in a humidified incubator for 0, 
2ý 4 and 6 hours. Following each incubation, cells were washed twice in PBS and fixed in 
2% paraformaldehyde-PBS-ImMCa2+-O. I%NaN3 for 15 minutes at room temperature. 
Following one wash in calcium-fortified PBS, the cells were resuspended in Citifluor 
fluorescence preserver and mounted along with DiBAC4(5) dye on poly-L-lysine-coated 
slides, as described before (This Chapter, section 2.4.2). 
2.6.3 Electron Microscopy 
Cells were divided into 5 samples containing Ix 107 cells each and washed once in 
cold RPMI medium containing ImM CaC12- Samples 1,2,3 and 4 were labelled with 2ml 
of cold medium containing 75ml of IOB8 (Img1ml in stock solution) monoclonal antibody 
to the lectin domain for I hour at 40C. Sample 5 was suspended in 3mI cold medium 
containing no antibody and was also kept at 40C during the incubation. After 2 washes in 
cold medium all 5 samples were incubated for I hour in 2ml medium containing 50ýfl anti- 
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mouse IgG Fab antibody bound to 5nm gold. Following two washes in cold medium, in 
samples 1,2, and 3 HLA DR was labelled on the surface of B lymphocytes with 2n-d 
medium containing 50gl of monoclonal antibody CR3/43 (Img/n-d stock solution) for I 
hour at 40C. Sample 4 was not incubated with CR3/43 antibody but was kept in ice 
incubating with medium. Samples 2 and 3 were suspended in 20ml warm medium and 
allowed to cap and internalise CD23 at 3.5 and 10 hours respectively at 370C. Sample 4 
was incubated at 370C for 3.5 hours. Samples I and 5 were kept at 40C during the 
incubations. 
After incubation, cells were fixed in 5mls of 2.5% glutaraldehyde-4% sucrose- 
ImM CaCl2-IOOnIM cacodylate buffer, pH 7.2 for I hour at room temperature. Following 
fixation, all samples were osmicated in I%osmium-IOOmM cacodylate buffer for 40 
minutes at room temperature and washed 3 times in IOOmM cacodylate buffer. The cells 
were incubated in agarose, dehydrated and cut in sections as described in the previous 
E. M. experiment. 
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2.7 EXPERIMENT 4: ENDOCYTOSIS OF IgE AND CD23 
2.7.1 Flow Cytometry 
2.7.1 A IgE Internalisation via sCD23 
Samples containing IxIO6 RPMI 8866 cells each were washed once in calcium- 
fortified medium and incubated in 200gl medium containing 20ýtg/mj IgE. Following 3 
washes in cold medium, the cells were incubated for 45 minutes in 200gI containing goat 
anti-IgE monoclonal antibody covalently bound to FITC diluted 1: 20. Control samples 
were suspended in 200gI medium without IgE and then treated with anti-IgE antibody as 
the other samples. They were kept at 40C thoughout all incubations. For each sample two 
aliquots were prepared. Following three washes, one set of aliquots were incubated for 45 
minutes at 40C with 200gI medium containing 5[LI 37 kD recombinant soluble CD23 
(sCD23) (2mg/mI stock concentration). The other set of aliquots were incubated in 200[tl 
cold medium to which no recombinant sCD23 was added. All samples were washed three 
times in medium and incubated for 0,3, and 6 hours at 370C. As previously described, 
there were two samples for each incubation interval. At the end of each incubation 
specimens were washed twice in medium and twice in calcium-fortified PBS. Surface 
fluorescence removing and fixation were performed as in previous flow cytometry 
experiments. 
2.7.113 IgE and CD23 Endocytosis 
Cells harvested and aliquoted at IxIO6 per sample were washed once in medium 
and incubated for 1 hour with EBVCS 1 mouse antibody to the CD23 stalk and after two 
washes the antibody was coupled with anti-mouse IgG Fab conjugated to R- 
phycoerythrin. All concentrations were as in previous experiments. After four washes in 
medium, cells were incubated with 20091 medium containing 20ýtg/ml IgE followed by 
anti-IgE-FITC, as described above. Control samples were incubated with EBVCSl and 
IgG Fab-R-PE, followed by anti-IgE-FITC only. In other control samples, EBVCS I was 
not added, but cells were treated with IgG Fab-R-PE secondary antibody, followed by IgE 
and anti-IgE-FITC antibody. After three washes, all cells were incubated for I hour at 
40C with 200ýtl medium containing 5gl 37 kD recombinant sCD23 (2mg/ml stock 
concentration). Following three washes, the cells were incubated for 0,3 and 6 hours at 
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370C, acid stripped and fixed as previously shown. All controls were kept at 40C while 
other samples were incubated at 370C. They were fixed as the other samples. 
2.7.1 C Cell Surface Expression of CD21 and IgE 
RPMl 8866 cells were harvested and aliquoted at IxIO6 per sample. They were 
washed once in medium and incubated for I hour with HB5 mouse antibody to CD21 
(Iýtg/ml and 5gg/ml in two separate samples) and after two washes the antibody was 
coupled with anti-mouse IgG Fab conjugated to FITC. Another set of cells were incubated 
with 200gI medium containing anti-IgE-Biotin, washed twice and incubated with 
streptavidin-FITC as described in previous experiments. Control samples were treated 
with secondary antibody or streptavidin-FITC to show non-specific labelling of the 
secondary antibody on the cell surface. All cells were treated with fixative and washed 
once prior to detection. 
2.7.2 Confocal Microscopy 
2.7.2A Triple Fluorescent Labelling: IgE and mCD23 
Cells were divided into samples each containing R105 cells washed once in cold 
medium and incubated with I gg/ml EBVCS I mouse antibody to CD23 for I hour at 40C. 
Following two washes, cells were suspended in 200m]. medium with 60ýtg/ml of a 
polyclonal anti-mouse antibody conjugated to cyanin (IgG-Cy5). After four washes in 
medium, the cells were incubated at 40C with 200gI medium containing 20gg/ml IgE for I 
hour. Following three washes, specimens were incubated for 45 minutes in anti-IgE 
antibody directly conjugated to FITC, as described above. Control samples were set up 
which were incubated with only secondary antibodies. Other control samples were set up 
to which EBVCS I was not added but were treated with IgG-Cy5 secondary antibody, 
followed by IgE and anti-IgE antisera. Following two washes in medium, samples were 
incubated for I hour at 40C with 200gl medium containing 5gl 37 kD recombinant CD23 
(sCD23) (2mg/mI stock concentration). After three washes in cold medium the cells were 
incubated in medium at 370C in a humidified incubator for 0,2,4 and 6 hours. Following 
each incubation, cells were washed twice in PBS and fixed in 2% paraformaldehyde, PBS, 
2+ I mM Ca , 
0.1% azide for 15 minutes at room temperature. Following one wash in 
calcium-fortified PBS the cells were resuspended in Citifluor fluorescence preserver and 
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mounted along with DiBAC4(5) dye on poly-L-lysine-coated slides as described before 
(This Chapter, section 2.4.2). 
2.7.2B Triple Fluorescent Labelling: mCD23 and sCD23 
Cells were divided into samples each containing 5xIO5 cells washed once in cold 
medium and incubated with I gg/ml EBVCS I mouse antibody to the stalk region of CD23 
for I hour at 40C. Following two washes, cells were suspended in 200n-d medium with 
60ýtg/ml of a polyclonal anti-mouse IgG antibody conjugated to cyanin (IgG-Cy5). After 
three washes in cold medium, samples were incubated for I hour at 40C with 20041 
medium containing 25[tl 37 kD recombinant CD23 conjugated to biotin (sCD23-biotin) 
(0.4mg/ml stock concentration). Following two washes in medium, cells were incubated 
for I hour at 40C with 200[LI medium containing streptavidin conjugated to FITC (1: 10 
diluted). After four washes in medium, the cells were incubated at 40C with 200gl 
medium containing 20gg/ml IgE for 1 hour. Control samples were incubated with only 
secondary antibodies. To other control samples EBVCS I was not added, but were treated 
with IgG-Cy5 secondary antibody, followed by sCD23-biotin, streptavidin-FITC and IgE. 
After three washes in cold medium, the cells were incubated in medium at 370C in a 
humidified incubator for 0,2,4 and 6 hours. Following each incubation, cells were washed 
twice in PBS and fixed in 2% parafon-naldehyde-PBS-ImM Ca2+-O. I% azide for 15 
minutes at room temperature. Following one wash in calcium-fortified PBS, the cells were 
resuspended in Citifluor fluorescence preserver and mounted along with DiBAC4(5) dye 
on poly-L-lysine-coated slides as described before (This Chapter, section 2.4.2). 
2.7.2C Triple Fluorescent Labelling: IgE and Clathrin 
Three-colour immunofluorescence was combined with post-fixation labelling to 
co-localise IgE and clathrin. Cells were incubated with IgE followed by anti-IgE 
monoclonal antibody bound to FITC and, after three washes, recombinant sCD23 was 
added as described above. Samples were incubated for 0,1 and 2 hours at 370C in a 
humidified incubator. At the end of each incubation, cells were washed twice in PBS- I MM 
Ca2+_I % NaN3, pH 7.2 and incubated in permeabilization buffer (Becton-Dickinson) for 
20 minutes at 40C. The cells were incubated for I hour at 40C with anti-clathrin 
monoclonal antibody (mouse IgG2b) diluted 1: 60 in 200ýtl PBS-l% BSA. Negative 
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controls were treated the same as other samples; they were, however, incubated in PBS- 
1% BSA with either no anti-clathrin antibody or no IgE. Following two washes at room 
temperature samples were incubated for 45 minutes at 40C with anti-mouse IgG directlý' 
coupled to Cy5 (IgG-Cy5) diluted 1: 50 in 200ýtl PBS-l% BSA. After two washes at 40C 
samples were fixed in 2% paraformaldehyde, PBS- I mM Ca2+-I% NaN3 for 15 minutes at 
room temperature. Specimens were washed once in PBS, resuspended in Citifluor 
fluorescence preserver and mounted along with DiBAC4(5) dye on poly-L-lysine-coated 
slides as described above (This Chapter, section 2.4.2). Slides were sealed with nail 
varnish and observed under the confocal microscope to co-localise CD23 and HLA DR 
with clathrin-coated vesicles. 
2.7.2D Double FLuorescent Labelling: IgE, CD23 and Acidic Vesicles 
Two-colour immunofluorescence was also employed to visualise the possible co- 
localisation of IgE with acidic vesicles. In a parallel experiment, CD23 was localised 
within RPMI 8866 cells along with DAMP label for acidic vesicles. The one set of samples 
were labelled with IgE and anti-IgE monoclonal antibody conjugated to FITC, as 
described in the flow cytometry experiment (This Chapter, section 2.7.1 A). Another set 
was incubated with EBVCS I antibody to the stalk region of CD23 and IgE, as described 
in section 2.7.2B. Both sets of samples were then treated with recombinant 37 kD sCD23 
and incubated for 4.5 hours at 370C in a humidified incubator. Cells were then incubated 
for 30 minutes at 370C with medium containing 50ýtM 3-(2,4-dinitroanilino)-3'-amino-N- 
methyl-dipropylamine (DAMP reagent, Molecular Probes), which has been shown to 
concentrate in intracellular compartments with low pH (Anderson et al., 1984). After one 
wash in cold medium and two washes in PBS-ImM Ca2+-I% NaN2, pH 7.2 specimens 
were incubated in permeabilization buffer (5% diethylene glycol, 1.5% formaldehyde, 
PBS, pH 7.2) (Simultest IKM Lysing Solution, Becton-Dickinson) for 20 minutes at 40C. 
The cells were incubated for I hour at 40C with anti-2,4-dinitrophenol IgG rabbit 
antibody directly coupled to rhodamine at O. lmg/mI in PBS-l% BSA-ImM 
Ca2+ 
(Molecular Probes). Negative controls were set up in which no DAMP reagent was added: 
these samples were treated as the rest for all other steps. After two washes at 
40C samples 
were fixed in 2% paraformaldehyde, PBS-ImM Ca2+-I% 
NaN3 for 15 minutes at room 
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temperature. Specimens were washed once in PBS and mounted on poly-L-lysine slides as 
described above (This Chapter, section 2.4.2). Slides were sealed with nail varnish and 
observed under the confocal microscope to localise IgE in acidic vesicles. 
2.7.3 Electron Microscopy 
Cells were divided into 6 samples containing 1x 107 cells each and washed once in 
cold RPMI medium containing ImM CaC12. Samples 1,2,4,5 and 6 were labelled with 
2ml of cold medium containing 50RI of EBVCSl (1mg/ml in stock solution) anti-CD23 
mouse monoclonal antibody to the stalk region for I hour at 40C. Sample 4 was 
suspended in 3ml cold medium containing no antibody and was also kept at 40C during 
the incubation. After 2 washes in cold medium samples 1,2,3,4 and 6 were incubated for 
I hour in 2ml medium containing IgE (20ýtg/ml final concentration) Following two washes 
in cold medium, samples 1,2,3,4 and 5 were labelled with 2ml medium containing 50gl 
of biotinylated goat anti-IgE monoclonal antibody (1mg/ml stock solution) for I hour at 
40C. Following two washes, samples 1,2 and 3 were incubated in 2ml medium containing 
70gl streptavidin bound to l0nm gold and 45gl anti-mouse IgG antibody bound to 5nm 
gold. Sample 4 was incubated with 60gl anti-mouse IgG bound to 5nm gold and samples 
5 and 6 were treated with 90ýtl streptavidin bound to 10nm gold. After two washes, all 
samples were incubated with 50gl recombinant sCD23 (2mg/ml stock solution) for 45 
minutes at 40C. Samples 2 and 3 were suspended in 20ml warm medium and allowed to 
cap and internalise CD23 and IgE at 4 and 10 hours respectively at 370C. Samples 1,4,5 
and 6 were kept at 40C during the incubations. 
After incubation, cells were fixed in 5ml of 2.5 % glutaraldehyde-4% sucrose- I mM 
CaC12-100MM cacodylate buffer, pH 7.2 for I hour at room temperature. Following 
fixation, all samples were osmicated in 1% osmium-100mM cacodylate buffer for 40 
minutes at room temperature and washed 3 times in IOOmM cacodylate buffer. The cells 
were incubated in agarose, dehydrated and cut in sections as described previously. 
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Chapter 3: Antibody-Induced Endocytosis of CD23 
3.1 INTRODUCTION 
lodination and immunoprecipitation were used in a recent study, which suggests 
that CD23 on the membrane of B lymphocytes is constitutively endocytosed (Grenier- 
Brossette et al., 1992). The authors claimed that antibodies raised against the CD23 lectin 
domain enhance both the rate and the amount of CD23 endocytosis. Furthermore, they 
suggested that CD23 accumulates in an acidic compartment where it is cleaved to a 16 kD 
fragment (see figure 1.7, Chapter 1). This fragment includes the whole of the lectin 
domain as it is immunoprecipitated by all antibodies that bind to the head region. 
In the present study the effect of antibodies to CD23 in enhancing endocytosis of 
membrane CD23 was investigated. The pattern of CD23 endocytosis was studied using 
flow cytometry. Various monoclonal antibodies directed to the lectin domain or the stalk 
region of CD23 were screened for their ability and efficiency in internalising the membrane 
antigen. Flow cytometry further provided a statistical assessment of the percentage of cells 
showing significant internal fluorescence after three and five hours incubation at 370C. 
Confocal microscopy and immunofluorescence provided visual confirmation of 
antibody-induced capping of CD23 on the B cell surface, its internalisation and 
intracellular localisation of the protein. To afford a preliminary indication of the 
intracellular fate of CD23, the cell structure was visualised using propidiurn iodide which 
defines the nucleus and DiBAC4(5) which binds to all membranes but does not penetrate 
the nuclear envelope. 
Finally, immunogold labelling and electron microscopy allowed examination of the 
intracellular compartment into which the label for CD23 accumulates. 
I 
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3.2 FLOW CYTOMETRY 
Figures 3.1 to 3.6 show histograms of cell fluorescence intensity versus relative 
cell number. These histograms represent the efficiency of different monoclonal antibodies 
in internalising CD23. Panel a in all histograms represents samples kept at 40C during all 
incubations. The curves coloured in grey represent the negative controls which were 
treated with secondary antibody Fab fragment directly coupled to FITC. The signal is a 
combination of very low levels of non-specific binding of the antibody to the cell surface 
and perhaps a small amount of autofluorescence, a common consequence of aldehyde 
fixation. The red curve exibits successful antibody labelling of CD23 on the surface of 
RPMI 8866 cells, whereas the green curve demonstrates efficient fluorescence removing 
using acid stripping. Panels b and c show samples incubated a 370C for 3 and 5 hours 
respectively. In these histograms, the grey curves are the acid stripped samples from Panel 
a, which are used to define the threshold for surface fluorescence removal. 
In figures 3.1,3.2, and 3.3 representing monoclonal antibodies IOB8, B6 and 
EBVCS5,, respectively, the green histograms in panels b and c match the acid stripped 
controls (grey). This shows that, following incubation of cells with these antibodies for 3 
and 5 hours and upon surface fluorescence removal, there is little or no detectable internal 
fluorescence. It is thus concluded that these antibodies do not appear to induce 
endocytosis of CD23. Antibody EBVCS I to the stalk region appears to behave somewhat 
differently, showing very low positive endocytosis (Figure 3.4b); however, no further 
conclusions can be drawn from this observation which can be attributed to variations in 
the efficiency of the acid washing procedure (Figure 3.4). In figures 3.5 and 3.6, for 
antibodies BU38 and MHM6 respectively, the green curves in panels B and C are distinct 
from the acid stripped controls and show low but detectable intracellular fluorescence. 
The internal fluorescence detected in figures 3.5 and 3.6 is considerably lower than the 
total fluorescence in the red histograms. However, the intensity detected does not 
constitute an accurate measure, since internal fluorescence is affected by absorption of 
light passing through membranes and multiple organelles giving, as a result, a lower 
intensity signal. Thus, the most appropriate measurement to be made from statistical 
analysis of the histograms is the approximate percentage of cells that show 
internal 
fluorescence. For this measurement, a gate is set to exclude at least 95% of the negative 
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control and count positive events above this threshold. Such statistics are represented in a 
bar graph in figure 3.7. They demonstrate the percentage of cells showing endocytosed 
CD23 after 3 and 5 hours incubation at 370C. Out of all antibodies tested for their 
contribution in enhancing CD23 internalisation, BU38 seems to be the most efficient. 
Indeed, 48% of all cells labelled with BU38 exibit internal fluorescence after 3 hours at 
370C. Following 5 hours incubation, 52% of all detected cells show internal fluorescence. 
Antibody MHM6 also enhances endocytosis with 48 and 27% of all cells detected 
showing internal fluorescence after 3 and 5 hours at 370C, respectively. The decrease in 
the percentage of cells showing endocytosis between 3 and 5 hours at 370C may be due to 
the decay of the fluorescent label internally or possibly to its recycling on the cell surface. 
To that end, MHM6 may be more efficient in triggering endocytosis and targeting of 
CD23 to its intracellular destination. 
Both BU38 and MHM6 target the lectin domain of CD23 (Schwartz-Albiez & 
Moldenhauer, 1989). Antibody EBVCS 1, which is specific for the stalk region (Gordon et 
al., 1987; Bonnefoy, Shields & Mermod, 1990), is inefficient in promoting intemalisation 
of CD23. However, it is not possible to predict the efficiency with which an antibody 
internalises CD23 by its lectin domain specificity. Indeed, antibodies IOB8 and B6 are also 
directed towards the lectin domain but are even less efficient in promoting endocytosis. 
Antibody EBVCS5 is also specific for the lectin domain but recognises an epitope on that 
region that is distinct from the IgE binding site (Gordon et al., 1987). 
Interestingly, previous studies have attributed special properties to the two 
antibodies found here to promote endocytosis of CD23- MHM6 and EBVCS4 antibodies 
are known to act as growth factors in phorbol ester-primed induced B cells (Gordon et al., 
1986a; Guy & Gordon, 1987) MHM6 can also deliver a stimulatory signal to B cells 
induced with IL-4 (Gordon et al., 1989b). It has also been found that Fab' monomers of 
MHM6 are as effective as the intact antibody in promoting DNA synthesis in phorbol 
ester-primed tonsilar B cells (Gordon et al., 1987). Antibodies EBVCS2, EBVCS4, 
mAb25 and mAb48 to the lectin domain of CD23 are also known to inhibit IL-4-induced 
IgE synthesis by peripheral blood and tonsillar mononuclear B cells, whereas EBVCSI 
antibody to the stalk region had no effect (non-stimulatory antibodies) (Bonnefoy Shields 
& Mermod, 1990). Antibody mAb 135 and IgE have a down-regulatory effect on IgE 
synthesis (Luo et al., 1991). However, four antibodies (MHM6, BU38, LAI and LA2) 
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have been defined as stimulatory for phorbol ester-primed B cell activation (Sch"'artz- 
Albiez & Moldenhauer, 1989). Futhermore, stimulatory antibodies encourage proteolysis 
of membrane CD23 on the surface of phorbol ester-activated cells (Guy & Gordon, 1987). 
IgE and non-stimulatory antibodies down-regulate B cell activation and seem to stabilise 
membrane CD23 (Luo et al., 1991; Lee, Rao & Conrad, 1987; Bonnefoy, Shields & 
Mermod, 1990). Stimulatory antibodies such as BU38 and MHM6 would naturally have 
no effect on B cell activation in EBV-transformed cells such as the ones used in this study. 
It is however tempting to speculate that CD23 proteolysis and production of soluble 
fragments, which may bind back to the B cell surface, could be a prerequisite for CD23 
internalisation. Alternatively, since all stimulatory antibodies are known to recognise the 
same epitope (Schwartz-Albiez & Moldenhauer, 1989), their effect may be due to the 
location of this epitope and the implication of the binding of such antibodies in 
crosslinking of adjacent CD23 trimers. Such binding may cause capping and endocytosis. 
Binding of this category of antibodies may cause conformational changes in CD23 that 
render some part of the structure susceptible to proteolysis. On the other hand, binding of 
other non-stimulatory antibodies and IgE to CD23 may encourage engagement of two 
lectin domains of the same trimer and therefore no crosslinking would take place. Such 
binding would further stabilise the membrane CD23 form to protect the sites susceptible to 
proteolysis. 
Perhaps the property of MHM6 and BU38 to promote CD23 intemalisation lies 
both in their ability to encourage CD23 proteolysis as well as in the recognition of the 
specific lectin domain epitope which includes the IgE binding site. 
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Figure 3.1 
Fluorescence histograms for IOB8 monoclonal antibody efficiency in enhancing 
endocytosis of CD23. 
a. Red histogram shows surface labelling of RPMI 8866 cells with 10138 antibodý, 
followed by IgG Fab-FITC. Green histogram exibits surface fluorescence quenching of a 
sample labelled on the cell surface and acid-washed. Grey histogram is a negative control 
incubated with IgG Fab-FITC only, showing absence of non-specific fluorescence labelling 
on the cell surface. 
b. Samples incubated at 370C for 3 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 3 hours. Green histogram shows internal fluorescence after 
incubation at 370C and acid stripping. 
C. Samples incubated at 370C for 5 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 5 hours. Green histogram shows internal fluorescence after 
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Fluorescence histograms for B6 monoclonal antibody efficiency of enhancing endocytosis 
of CD23. 
a. Red histogram shows surface labelling of RPMI 8866 cells with B6 antibody 
followed by IgG Fab-FITC. Green histogram exibits, surface fluorescence quenching of a 
sample labelled on the cell surface and acid-washed. Grey histogram is a negative control 
incubated with IgG Fab-FITC only, showing lack of non-specific fluorescence labelling on 
the cell surface. 
b. Samples incubated at 370C for 3 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 3 hours. Green histogram shows internal fluorescence after 
incubation at 370C and acid stripping. 
C. Samples incubated at 370C for 5 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 5 hours. Green histogram shows internal fluorescence after 
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Fluorescence histograms for EBVCS5 monoclonal antibody efficiency in enhancing 
endocytosis of CD23. 
a. Red histogram shows surface labelling of RPMI 8866 cells with EBVCS5 antibody 
followed by IgG Fab-FITC. Green histogram exibits surface fluorescence quenching of a 
sample labelled on the cell surface and acid-washed. Grey histogram is a negative control 
incubated with IgG Fab-FITC only, showing lack of non-specific fluorescence labelling on 
the cell surface. 
b. Samples incubated at 370C for 3 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 3 hours. Green histogram shows internal fluorescence after 
incubation at 370C and acid stripping. 
C. Samples incubated at 370C for 5 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 5 hours. Green histogram shows internal fluorescence after 
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Fluorescence histograms for EBVCS I monoclonal antibody efficiency in enhancing 
endocytosis of CD23. 
a. Red histogram shows surface labelling of RPMI 8866 cells with EBVCS I antibodv 
followed by IgG Fab-FITC. Green histogram exibits surface fluorescence quenching of a 
sample labelled on the cell surface and acid-washed. Grey histogram is a negative control 
incubated with IgG Fab-FITC only, showing absence of non-specific fluorescence labelling 
on the cell surface. 
b. Samples incubated at 370C for 3 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 3 hours. Green histogram shows internal fluorescence after 
incubation at 370C and acid stripping. 
C. Samples incubated at 370C for 5 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 5 hours. Green histogram shows internal fluorescence after 



























Fluorescence histograms for BU38 monoclonal antibody efficiency in enhancinýa 
endocytosis of CD23. 
a. Red histogram shows surface labelling of RPMI 8866 cells with BU38 antibody 
followed by IgG Fab-FITC. Green histogram exibits surface fluorescence quenching of a 
sample labelled on the cell surface and acid-washed. Grey histogram is a negative control 
incubated with IgG Fab-FITC only, showing lack of non-specific fluorescence labelling on 
the cell surface. 
b. Samples incubated at 370C for 3 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 3 hours. Green histogram shows internal fluorescence after 
incubation at 370C and acid stripping. 
C. Samples incubated at 370C for 5 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 5 hours. Green histogram shows internal fluorescence after 
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Fluorescence histograms for MHM6 monoclonal antibody efficiency in enhancing 
endocytosis of CD23. 
a. Red histogram shows surface labelling of of RPMI 8866 cells with MHM6 
antibody followed by IgG Fab-FITC. Green histogram exibits surface fluorescence 
quenching of a sample labelled on the cell surface and acid-washed. Grey histogram is a 
negative control incubated with IgG Fab-FITC only, showing lack of non-specific 
fluorescence labelling on the cell surface. 
b. Samples incubated at 370C for 3 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 3 hours. Green histogram shows internal fluorescence after 
incubation at 370C and acid stripping. 
C. Samples incubated at 370C for 5 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 5 hours. Green histogram shows internal fluorescence after 
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Bar graph displaying the percentage of cells showing endocytosed CD23 after 3 and 5 
hours incubation at 370C. Different monoclonal antibodies exhibit different efficiencies in 
inducing intemalisation of CD23- Each measurement was the average of repeated 
experiments (For MHM6, BU38, EBVCS1, EBVCS5, IOB8 and B6 it was 3,4,3,1.2 and 
1 respectively). Errors were typically +1-5%. 
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3.3 CONFOCAL MICROSCOPY 
Figures 3.8 to 3.13 are optical sections, approximately I gm in thickness, of RPMI 
cells labelled with fluoresceinated BU38 (Panel a) or NIHM6 (Panel b) monoclonal 
antibody to CD23 and incubated at various time intervals at 370C. Propidiurniodide marks 
the location of the nucleus (Panel b). However, a higher concentration of the dye is here 
used to cause some non-specific labelling of the cytoplasm by PI in order to define the 
general cell structure. DiBAC4(5) binds to all cytoplasmic membranes and clearly 
distinguishes the nucleus which it does not penetrate (Panel a). The nuclear area is thus 
indicated by the lack of red dye labelling inside the cell. In figure 3.8a and 3.8b, samples 
were kept in ice during all incubations and show cell surface fluorescence only, indicated 
in green patches located around the cell periphery. Although the cells were maintained at 
40C during incubations, antibody crosslinking of CD23 and strong capping on the cell 
periphery are often visible, especially in the case of monoclonal antibody BU38 (Figure 
3.8b). After 2 hours incubation at 370C, extensive capping is observed with fluorescence 
concentrated in one area of the cell surface (Figures 3.9). Green indentations originate 
from the capped areas and extend towards the cytoplasm, indicating the starting of 
monoclonal antibody-induced endocytosis of CD23. The cell optical sections displayed in 
this study were chosen after extensive observation of many cells and scanning of optical 
sections of whole cells. An example of such a series of optical sections of a cell is shown 
in Figure 3.10. It shows capping, the beginning of endocytosis from capped regions and 
cytoplasmic fluorescence. Extensive internal fluorescence, mostly detached from the 
capped lymphocyte surface areas is observed after 4 hours at 370C (Figures 3.10). The 
fluore, scence is localised in the cell cytoplasm and is distinct from the region labelled by 
propidium iodide as the nuclear area (Figure 3.11 b). In figure 3.11 a, green fluorescence is 
localised within the membranous cytoplasmic area labelled by DiBAC4(5) and is clearly 
separate from the nucleus which is indicated in black. After 6 hours at 370C, fluorescence 
is still localised within the cytoplasm and seems to be contained in distinct cytoplasmic 
regions located in the cytoplasmic area adjacent to the nucleus (Figure 3.12). Surface 
fluorecence is notably decreased and capping is less frequently observed. Upon 
internalisation, capping seems to break down into more regional patching on the cell 
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surface. In cells incubated for 8 hours at 370C, the intensity of the fluorescent cytoplasmic 
regions containing the internalised fluorescence is notably decreased and in most cells it is 
hardly visible (Figure 3.13). Surface fluorescence is also substantially diminished and 
capping is rarely observed. A control shown in figure 3.14 exibits negligible fluorescence 
in samples incubated with anti-mouse IgG-FTTC only and incubated at 370C for 8 hours. 
Confocal images in figures 3.8 to 3.14 exhibit surface BU38 (Panel a) and MHM6 
(Panel b) antibody binding to CD23, capping and endocytosis of the membrane protein. 
They also show intense fluorescence accumulation in the cell cytoplasm, fluorescence 
concentration in small cytoplasmic areas and gradual loss of fluorescence intensity both on 
the cell surface and intracellularly. The gradual decrease of cytoplasmic fluorescence 
intensity suggests that the intracellular journey of endocytosed CD23 follows the 
endosomal network, where fluorescence-conjugated membrane CD23 would be degraded. 
This observation is in line with an earlier report claiming that the 16 kD CD23 proteolytic 
fragment accumulates in an acidic vesicle (Grenier-Brossette et al., 1992). 
Since in this experiment CD23 is indirectly labelled with fluorescein, it is 
reasonable to question whether the primary and secondary antibodies stay attached to the 
lectin domain of CD23 throughout the endocytotic pathway. It can be argued that, once 
inside the acidic and proteolytic environment of a late endosome or lysosome, the MHM6 
or BU38 antibody may separate from CD23, or the fluoresceinated polyclonal may get 
detached from the primary antibody. However, the same antibody-induced endocytosis 
experiment was also performed using BU38 monoclonal antibody to CD23 with covalently 
linked fluorescein (not shown here). The confocal images and observations in all 
experiments were identical (Figures 3.8 to 3.14 for BU38-IgGFab-FITC and MHM6- 
IgGFab-FITC, data not shown here for BU38-FITC). Furthermore, both BU38 and 
MHM6 form strong complexes with the lectin domain of CD23, and such complexes have 
proven to be relatively resistant to acid stripping buffers using pH higher than 2.0, which 
were tested for the purposes of flow cytometric analysis in the previous section. Removing 
CD23-bound antibodies on the cell surface using protease digestion has also proved 
unsuccessful, since the presence of these monoclonal antibodies protects CD23 from 
proteolytic digestion (Grenier-Brossette et al., 1992; author's own observations). Since 
the pH in the lysosomal pathway drops in late endosomes to 5.0, it is possible that the 
CD23-antibody complex may resist disassembly further into the endosomal pathway, 
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where the combination of pH drop and protease action may finally cause protein 
degradation. 
One way of directly following endocytosis of CD23 would be to perforrn similar 
antibody-induced intemalisation experiments using a cell system in which a recombinant 
membrane CD23 species is expressed with a custom-made covalent label, such as biotin, 
which can be traced at all times and may be resistant to the acidic and proteolytic 
conditions of the endosomal pathway. A biotinylated recombinant CD23 would be 
particularly appropriate, since the bond between streptavidin and biotin is one of the 
strongest known in nature and the complex is resistant to dissociation. The fluorescent 
label would thus follow the intracellullar processing of the membrane receptor more 
closely than a monoclonal antibody. 
BU38 and MHM6 monoclonal antibodies thus crosslink CD23 on the cell surface 
of B lymphocytes and promote its endocytosis into the cell cytoplasm. Upon endocytosis 
capping ceases and surface fluorescence is decreased and displayed only in regional 
patches. Internal fluorescence is concentrated into distinct cytoplasmic areas, within which 
it gradually becomes less intense. Experiments were also done to show lack of endocytosis 
of CD23 by monoclonal antibodies B6 and EBVCS I after 3 and 6 hours at 370C. No 
capping or endocytosis of CD23 was observed by these antibodies (data not shown). 
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Figure 3.8 
Confocal optical sections displaying CD23 labelling on the cell surface of RPMI 8866 
cells. Samples were incubated with BU38 or MHM6, followed by fluoresceinated goat 
anti-mouse IgG Fab. They were kept in ice while other samples were incubated at 370C. 
Optical section thickness: -1 gm 
a. Monoclonal antibody BU38. Labelling of all cytoplasmic membranes with 
DiBAC4(5). 
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Figure 3.9 
Confocal optical sections displaying CD23 redistribution (capping) and internalisation in 
RPMI 8866 cells. Samples were incubated with BU38 or MHM6, followed by 
fluoresceinated goat anti-mouse IgG Fab. They were incubated for 2 hours at 370C. 
Optical section thickness: -Igm 
a. Monoclonal antibody BU38. Labelling of all cytoplasmic membranes with 
DiBAC4(5). 





A series of 8 consecutive optical sections (a-h) of the cell in Figure 3.9b showing capping 
and endocytosis of CD23 in RPMI 8866 cells. Indentations originate from fluorescent 
capped regions towards the cell cytoplasm. The focal point moves by -1.3gm for each 
section. Optical section thickness: -1 ýLrn. 









Confocal. optical sections displaying MHM6-induced endocytosis of CD23 in RPMI 8866 
cells. Samples were incubated with BU38 or MHM6, followed by fluoresceinated goat 
anti-mouse IgG Fab. They were incubated for 4 hours at 370C. Optical section thickness: 
-I [tm 
a. Monoclonal antibody BU38. Labelling of all cytoplasmic membranes with 
DiBAC4(5). 






Confocal optical sections displaying cytoplasmic localisation of CD23 in RPMI 8866 cells. 
Samples were incubated with BU38 or MHM6, followed by fluoresceinated goat anti- 
mouse IgG Fab. They were incubated for 6 hours at 370C. Optical section thickness: 
-1grn 
a. Monoclonal antibody BU38. Labelling of 0 cytoplasmic membranes with 
DiBAC4(5). 






Confocal optical sections displaying cytoplasmic localisation of CD23 in RPMI 8866 cells. 
Samples were incubated with BU38 or MHM6, followed by fluoresceinated goat anti- 
mouse IgG Fab. They were incubated for 8 hours at 370C. Optical section thickness: 
-1ýtm 
a. Monoclonal antibody BU38. Labelling of all cytoplasmic membranes with 
DiBAC4(5). 





Confocal optical sections of a control sample displaying lack of non-specific surface 
labelling in RPMI 8866 cells. Samples were incubated with a fluoresceinated goat anti- 
mouse IgG Fab only. They were incubated for 8 hours at 370C. Optical section thickness: 
-I ýtm 
a. Labelling of all cytoplasmic membranes with DiBAC4(5). 
b. Staining of the nucleus with Propidium Iodide. 




3.4 ELECTRON MICROSCOPY 
Figure 3.15 shows labelling of monoclonal antibody MHM6 on the surface of 
RPMI cells. Antibody MHM6 was chosen after a series of binding experiments due to its 
higher affinity for the CD23 lectin domain. As MHM6 is linked with a polyclonal antibody 
conjugated to 5nm gold, distinct 5nm gold particles are scattered on the cell periphery 
(Figures 3.15 and 3.16, thin arrows). In spite of extensive observation, it has been 
impossible to localise accumulation of gold particles on one area of the cell membrane, 
indicating antibody-induced capping of CD23 on the cell surface, as seen in confocal 
images (Figures 3.8b, 3.9a & 3.9b). There several reasons for this limitation. A section 
prepared for electron microscopical observation is 50-70 nm thick, whereas a confocal 
optical section has an approximate thickness of lRm. This 20-fold reduction in section 
thickness results in fewer events recorded per section and thus antibody capping is a lot 
harder to visualise. Furthermore, in a confocal image it is possible to observe the whole 
cell at different optical levels, a convenience which makes capping as well as any cell 
labelling much simpler to locate. In electron microscopy the 50nm section represents one 
sample out of 300 such sections comprising a single cell. Multiple attempts to show 
reasonable cell surface gold labelling for CD23 have been made, with the present images 
constituting the most successful labelling to this date. 
One of the problems encountered in labelling cell surface antigens with antibodies 
conjugated to gold of different sizes before embeddment, is that multiple washing steps 
result in loss of gold-conjugated antibodies from the cell surface due to the centrifugal 
force. Indeed, gold particles are considerably heavier than the equivalent fluorescent 
conjugates utilised in flow cytometry and confocal microscopy. Following extensive tests, 
the combination of MHM6 and secondary polyclonal antibody conjugated to 5nm gold 
showed optimum surface labelling of CD23. Experiments using gold particles of larger 
diameter showed that it is increasingly difficult to maintain appreciable binding of the 
gold-conjugated antibody with larger gold particles (author's own observations). Another 
way of overcoming this difficulty would be to use the gold-conjugated antibody after 
fixation and embeddment, on 50nm thin sections. Many attempts performing post- 
embeddment labelling of CD23 on the cell surface and intracellularly have been 
unsuccessful. It seems that the antigen, as well as the primary antibodies attached to it 
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before embeddment, lose their conformational integrity during tissue processing and 
cannot be recognised by any antibodies after embeddment. Furthermore, the use of 
fixatives recommended for post-embeddment labelling resulted in poor preservation of the 
cell structure. 
Although the sample was kept at 40C during the incubations at 370C, endocytosis 
of CD23 appears to have started even in cells kept in ice (Figure 3.16). Endocytosed 
vesicles rich in gold particles are often observed (Figure 3.16, thick arrows). These 
plasmalemmal pits are found in the peripheral cytoplasm, indicating that MHM6- 
crosslinked membrane CD23 is starting to internalise. The 5nm gold-conjugated antibody 
is associated with the inner membrane, suggesting that at this stage in the process of 
endocytosis, gold is still attached to the lectin domain of membrane CD23 (Figure 3.16a & 
3.16b, thick arrows). It is further possible that these gold-rich vesicles are indeed still 
associated with the outer cell membrane and thus the vesicles shown represent extensions 
of the cell membrane towards the cytoplasm. 
After 10 hours incubation at 370C to allow internalisation of CD23, very little cell 
surface gold labelling is apparent (Figure 3.17). As previously observed in confocal 
images, CD23 seems to accumulate in the cytoplasm (Figure 3.17a, thick arrows). Unlike 
the plasmalemmal pits, these gold-rich vesicles do not appear to contain gold associated 
with their inner membrane. The round or oval-shaped cytoplasmic vesicles into which gold 
is concentrated (Figure 3.17a & 3.17b, see thick arrows) are lightly stained by uranyl 
acetate and lead citrate (see Chapter 2) and seem to include membranes and small 
structures. These gold-containing vesicles are distinct in shape and size from mitochondria 
which are also visible in the cytoplasmic area (indicated with M). The gold-containing 
vescicles are often localised in groups around the same area of the cytoplasm and in close 
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proximity to each other in the area adjacent to the nucleus (Figure 3.17b, thick arrows). It 
is tempting to speculate that they may be part of an interacting vesicular network. The 
most obvious interpretation is that they may be components of the lysosomal pathway, 
comprising late endosomes and early and late lysosomes. It is not easy to identify these 
cytoplasmic structures from photographs of the endosomal and lysosomal vescicles, as 
these organelles may differ in structure in various cell types. However, a common 
characteristic of the endosomal cytoplasmic structures is their content of sub-vesicles and 
membranes (see Chapter 4, figure 4.20). 
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In a control experiment RPMI 8866 cells were not treated with MHM6 but were 
incubated with IgG-5nm and kept in ice at all times (Figure 3.18). It shows the absence of 
non-specific binding of IgG-5nm gold on the plasma membrane. 
A question to be addressed is whether the 5nm gold-conjugated antibodies are 
still attached to CD23 throughout their intracellular route. In the lysosomal environment, 
the combination of low pH (5.0) and protease action may cause conformational changes to 
either or both primary and secondary antibodies resulting in loss of binding of antibodies 
to CD23 and formation of antibody-gold aggregates. This event may occur in the late 
endosomes or lysosomes, where acidic and proteolytic conditions exist. Sin-filar findings of 
gold aggregation in lysosomes, and in endosomes to a lesser extent, were found in similar 
internalisation studies for CD21 and CD20 (Pulczynski, Boesen & Jensen, 1994; see figure 
4.20). Indeed, in endosomal cytoplasmic structures which contain gold particles and do 
not possess the morphology of the lysosomes, there is minor aggregation. It is thus very 
likely that CD23 stays attached to gold-conjugated antibodies until it reaches the 
proteolytic and low pH conditions of endosomal compartments, where the complex is 
expected to dissociate. The endosomal fate of the protein has been previously suggested 
(Grenier-Brossette et al., 1992; see figure 1.7, Chapter 1). According to the authors, 
CD23 accumulates in an acidic compartment where it is cleaved to a 16 kD fragment 
consisting the lectin domain. The intracellular formation of the 16 kD breakdown fragment 
starts after 3 hours at 370C and accumulates for up to 20 hours (see Figure 1.7). These 
results are in line with the findings of the present study, where gold conjugates are found 
aggregated in a cytoplasmic compartment after 10 hours incubation at 370C. 
A more precise way of follow the intracellular route of CD23 after antibody- 
induced endocytosis would be by using post-embeddment labelling. As mentioned above, 
multiple attempts to trace membrane and intracellular CD23 with primary and secondary 
antibodies proved unsuccessful. This was probably due to the loss of protein conformation 
after treatment and embedding as well as to the use of paraformaldehyde rather than 
glutaraldehyde, resulting in poor tissue preservation. In the present experiments, post- 
embeddment labelling was thus abandoned. However, the above results, taken together 
with the recent immunoprecipitation study on constitutive endocytosis of CD23 (Grenier- 
Brossette et al., 1992), strongly suggest that certain antibodies to CD23 (BU38 and 
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MHM6) enhance its capping, endocytosis and targetting to an endosomal compartment, 
where the protein is cleaved to a I&D fragment. 
138 
Figure 3.15 
Electron micrographs of a sample kept at 40C during incubations. CD23 was labelled with 
MHM6 antibody, followed by IgG conjugated to 5nm gold. Cell surface distribution of 
gold particles at time 0. N: Nucleus, C: Cytoplasm, PM: Plasma Membrane, Thin arrows 
show location of gold clusters on the cell membrane. Scale bars: 0.5grn 
a. Section of a whole cell exhibiting binding of gold-conjugated MHM6 on the cell 
surface. Magnification: 33,510x, Igm=33.51mm. 

















Electron micrographs of a sample kept at 40C during incubations, showing the beginning 
of antibody-induced endocytosis of CD23. Cell membrane-bound gold (thin arrows) and 
gold-rich plasmalemmal pits (thick arrows) in the peripheral cytoplasmic area. CD23 was 
labelled with MHM6 antibody, followed by IgG conjugated to 5nm gold. N: Nucleus, C: 
Cytoplasm, A Mitochondrion, PM: Plasma Membrane. Scale bars: 0.5ýtm. 
a. Part of a section showing a gold-rich cytoplasmic plasmalemmal pit in the 
cytoplasm. Magnification: 33,510x, Igm=33.51mm. 
b. Part of a section showing two gold-containing vesicles located in the cytoplasm. 










Electron micrographs of a sample labelled with MHM6, IgG-5nm gold and incubated at 
370C for 10 hours. Gold is accumulated within multivesicular cytoplasmic bodies located 
in the juxtanuclear area (thick arrows). N: Nucleus, C: Cytoplasm, M: Mitochondrion, PM: 
Plasma Membrane. 
a. Section of a whole cell showing gold concentrated in a network of cytoplasmic 
vesicles located next to the nucleus. Magnification: 13,800x, Igm=13.80mm. Scale bar: 
Logm. 
b. Part of the section from a showing the morphology of the gold-containing 
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Electron micrograph of a control sample labelled with IgG conjugated to 5nm gold only, 
and kept in ice during incubations. It shows lack of non-specific polyclonal antibody 
binding on the cell surface. N: Nucleus, C: Cytoplasm, PM: Plasma Membrane. 






Antibodies BU38 and MHM6 directed to the lectin domain of CD23, which have 
been previously found to stimulate B cell growth and promote membrane CD23 
proteolysis, induce capping and endocytosis of membrane CD23. The intracellular route of 
CD23 seems to be through the endosomal pathway and its final destination is a 
cytoplasmic vesicular network located in the juxtanuclear area. 
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Chapter 4: Intracellular Co-Localisation of the CD23 Lectin Domain and 
Stalk Region 
4.1 INTRODUCTION 
Some antibodies to the CD23 lectin domain promote CD23 endocytosis (see 
Chapter 3). The protein seems to accumulate in an acidic compartment, and fragments into 
a 16 kD peptide (Grenier-Brossette et al., 1992). This 16 kD proteolytic fragment 
corresponds to the lectin domain since it is recognised by antibodies directed to that 
region. 
These findings inspired the quest to find whether or not the lectin and stalk regions 
of CD23 follow the same intracellular route. A stimulatory antibody to the lectin domain 
(BU38) known to enhance internalisation of CD23 is utilised to induce CD23 endocytosis 
and label the lectin homology region. The same samples are also labelled with antibody 
EBVCS 1, which is specific for the stalk region. The intracellular routes of both labels are 
followed. 
Flow cytometry is used to indicate the extend of internalisation of both lectin and 
stalk regions after 2.5 and 5 hours incubation at 370C, and measure the percentage of cells 
showing internal fluorescence labels for either or both antibodies. 
EBVCS 1 antibody to the stalk region is incapable of enhancing CD23 endocytosis 
on its own (Chapter 3). It is thus endocytosed through BU38 crosslinking, and the process 
of endocytosis of both labels is followed by confocal microscopy. 
The fate of the label for the lectin and stalk regions is examined through electron 
microscopy. Examination of the cell ultrastructure permits the intracellular localisation of 
both parts of the molecule. 
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4.2 FLOW CYTOMETRY 
In these two-colour flow cytometric measurements, CD23 stalk regions are 
labelled with EBVCS I antibody followed by a polyclonal Fab antibody fragment 
conjugated to Phycoerythin (R-PE). CD23 lectin domains are then directly coupled to 
BU38 antibody which is covalently linked to fluorescein. The cells are allowed to 
internalise CD23 for 0,2.5 and 5 hours at 370C and information for the intemalisation of 
each fluorescent label is collected. Figure 4.1 shows fluorescence histograms for the R- 
PE-labelled EBVCS I antibody. The same samples were also labelled with BU38-FITC 
and the fluorescence histograms for the FITC label are shown in figure 4.2. In figure 4.1 a, 
a R-PE-positive sample kept at 40C at all times shows successful cell surface labelling by 
EBVCS 1 on the CD23 stalk regions (red histogram). Figure 4.1 a also shows the negative 
control (grey), a sample labelled with secondary antibody conjugated to PE, followed by 
BU38-FITC. The control is a combination of background cell surface labelling caused by 
the secondary antibody and low levels of autofluorescence. A small fluorescence overlap 
from the FITC label is subtracted prior to fluorescent counts. The green histogram in 4.1 a 
is a sample showing small levels of remaining cell surface fluorescence after acid stripping 
to display successful surface fluorescence removal of R-PE-conjugated antibody. Samples 
labelled with both antibodies were incubated at 370C for 2.5 and 5 hours and the 
histograms for the R-PE-labelled stalk region of CD23 are shown in figure 4.1 b (2.5hrs) 
and 4.1 c (5hrs). Histograms in red show total surface and internal fluorescence, whereas 
green histograms correspond to detectable internal fluorescence after acid stripping. The 
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grey histograms are samples labelled with all antibodies, kept at 40C at all times and 
subjected to an acid wash in order to define the threshold for surface fluorescence 
removing. In figure 4.1b and 4.1c, the green curves are distinct from the acid stripped 
controls showing detectable levels of internal fluorescence for EBVCSl. Antibody 
EBVCS1 has been previously shown not to significantly enhance endocytosis of CD23 
when used on its own (see Chapter 3). In the present experiment, it is internalised by the 
crosslinking of BU38 antibody binding to the lectin domain. Endocytosis seems to be in 
progress between 2.5 and 5 hours. Indeed, the histogram corresponding to detectable 
internal fluoresence after 5 hours incubation at 370C becomes more intense and separates 
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further from the histogram for the acid washed control (Figure 4.1 c) compared to the 
histogram incubated for 2.5 hours at 370C (Figure 4.1b). As discussed in previous 
experiments, internal fluorescence is harder to detect than cell surface fluorescence, since 
its intensity is reduced by the opaque cell structure. 
Fluorescence histograms for the fluorescein-labelled BU38 antibody are displayed 
in figure 4.2. In figure 4.2a, the negative control is shown in the grey histogram. It is a 
sample labelled with EBVCS1 and polyclonal antibody Fab fragment conjugated to R- 
phycoerythrin, followed by streptavidin directly bound to FITC in order to establish the 
threshold for non-specific fluorescein labelling on the B cell surface. The acid stripped 
sample in figure 4.2a (green histogram) does not match the negative control shown in grey 
as seen in all previous experiments. As previously explained, this sample was incubated 
with all antibodies, kept at 40C at all times and acid stripped to remove surface 
fluorescence. The green histogram indicates that most, but not all surface fluorescence is 
quenched during the acid wash. Multiple attempts to improve cell surface fluorescence 
removal in this and later experiments have proven consistently unsuccessful. 
A similar acid wash experiment was also carried out using CR3/43 monoclonal 
antibody to HLA DR antigens (see Chapter 5). The antibody that was directly conjugated 
to FITC, was acid washed and in these experiments gave a similar degree of success in 
fluorescence removal. Acid washing breaks the top layer of non-covalent interactions of 
antibodies in membrane protein-antibody complexes by affecting the antibody three- 
dimensional structure and thus interfering with the antibody binding site. Perhaps in 
monoclonal antibodies directly bound to fluorescein, the fluorescein moieties may partially 
protect the antibodies against denaturation. This, in combination with the specific and 
strong interaction between monoclonals and their ligands, makes acid washing less 
successful. However, acid stripping in cells labelled with BU38 antibody followed by an 
appropriate polyclonal Fab fragment conjugated to fluorescein, did not present the same 
limitations. This difference may be due to the fact that the interaction between BU38 and a 
fluoresceinated polyclonal is weaker and less specific, and thus may more easily be broken. 
To take account of this acid washing limitation, the threshold for cell surface 
removal for BU38-FITC endocytosis has to be set slightly higher than for the PE-labelled 
EBVCSI. Acid stripped samples incubated at 2.5 and 5 hours at 370C show detectable 
levels of internal fluorescence (Figure 4.2b & c). The histograms are certainly distinct 
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from the acid stripped controls shown in grey. In line with previous flow cytometry 
experiments (Chapter 3), BU38 monoclonal antibody to the lectin domain enhances 
endocytosis of CD23. As observed with BU38-induced endocytosis of EBVCSI, 
endocytosis of CD23 lectin domain progresses further between 2.5 and 5 hours incubation 
at 370C (Figure 4.2b & c). 
The total fluorescence intensity of the surface-labelled control sample in figures 
4.1 a and 4.2a is decreased in samples incubated for 2.5 and 5 hours at 370C (Figures 4.1 b 
and c&4.2b and c, red histograms). Total fluorescence intensity in the samples incubated 
at 370C is the combination of cell membrane and internal fluorescence. This reduction in 
total fluorescence intensity for both FITC and PE are a combination of internal 
fluorescence, which is hindered by the opaque cell structure, possible degradation of the 
fluorescence label in an endosomal compartment and CD23 proteolysis on the surface of B 
cells. 
Statistical analysis of both figures 4.1 and 4.2 show that 39% of all detected cells 
show internalised antibody BU38 after 2.5 hours. During the same incubation time 
interval, 24% of cells show internal label for the stalk region. After 5 hours incubation at 
370C7 50% of cells show internal BU38-FITC and 38% of all cells show internal 
EBVCS I -IgGFab-PE label for the stalk region. 
These results confirm that EBVCS I antibody, which previously has been shown 
not to enhance endocytosis (Figures 3.4 and 3.7) is internalised with the addition of BU38 
antibody for the lectin domain. However, these results do not confirm surface labelling and 
endocytosis of both antibodies in the same cells. As discussed above, internal BU38 is 
indeed detected internally in 38% of cells, whereas the EBVCS I label is found internally in 
24% of the cells after 2.5 hours at 370C, suggesting that at least 14% of cells feature 
endocytosed BU38 only. 
To examine the intracellular co-existence of both labels, 2-dimensional dot plots of 
the same samples were analysed. Figure 4.3 shows the distribution of the RPMI cell 
population in relation to both fluorophores. It is a series of plots of the fluorescence 
intensity of FITC-labelled BU38 antibody versus the intensity of R-PE-labelled EBVCS I- 
The threshold gates are set according to the acid-stripped control sample in figure 4.3b, 
which excludes background fluorescence shown in the lower left of each dot plot. On the 
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lower right, cells are counted which exhibit fluorescene intensity for FITC, and on the 
upper left quadrant fall cells which show fluorescence for R-phycoerythrin only. Finally, 
the upper right quadrant is set to count cells showing fluorescence for both FITC and R- 
PE. 
Figure 4.3a shows the fluorescence distribution of the control sample which is 
labelled for both lectin and stalk regions of CD23 and kept at 40C at all times. In this 
sample, 95% of all cells detected are labelled for both antibodies. In figure 4.3b a sample 
was treated as in 4.3a and then acid stripped to allow the setting of threshold gates to 
account for the efficiency of acid stripping in removing the two fluorescent labels from the 
surface. After the setting of these gates, 87% of all cells detected fall within the lower left 
quadrant. Dot plots in figures 4.3c and 4.3e show total surface and internal fluorescence in 
samples incubated at 370C for 2.5 and 5 hours respectively. After both incubations, over 
95% of cells still show fluorescence for both FITC and R-PE labels. In figure 4.3d, a 
sample incubated at 370C for 2.5 hours and acid washed to reveal internal fluorescence 
only, exhibits a change in fluorescence distribution from the acid stripped control in figure 
4.3b. Statistical calculations are the average of two experiments. All percentage 
calculations were substracted from the values calculated from the acid-washed control (in 
Figure 4.3b). The fluorescence intensity of the cell population has a tendency to shift 
towards the upper right quadrant, indicating the intracellular movement of both fluorescein 
and R. -phycoerythrin. According to statistics calculated from these plots, 27% of all cells 
show significant intracellular intensity for both lectin and stalk labels, whereas 17% of all 
cells exhibit mostly fluorescein-conjugated BU38 but lower levels of EBVCSI-bound R- 
PE. After 5 hours at 370C, over 38% of all cells detected fall in the upper right quadrant, 
indicating the presence of both labels, and 14% of cells are located within the lower right 
quadrant, corresponding to internal FITC only. In both acid washed samples (Figure 4.3d 
& 4.3f) a negligible number of cells (0-3.5%) show internal R-phycoerythrin-labelled 
EBVCS1 antibody only. This observation is in fine with our previous findings that 
EBVCSl antibody does not, on its own, enhance endocytosis of CD23. It is therefore 
internalised as a result of binding of BU38 antibody to the lectin domain of membrane 
CD23. 
In the above experiment, it is shown that antibody BU38, which enhances 
internalisation of CD23, also causes intracellular accumulation of EBVCS I antibody to the 
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stalk region. After 2.5 hours incubation at 370C, 27% of all cells detected show 
internalised labels for lectin and stalk region of CD23. After 5 hours, the percentage of 
cells showing endocytosed label for both increases to 38%, thus indicating the progression 
of endocytosis. 
At 2.5 and 5 hour incubation intervals, 17 and 15% of cells respectively are 
statistically found to exhibit internal fluorescence, mostly for the fluorescein-conjugated 
BU38 antibody. There are several possible explanations for the above observation. Firstly, 
it is expected that internalised FITC-labelled BU38 would be observed in more cells that 
R-PE-conjugated EBVCS 1, since EBVCS 1 is not on its own efficient in triggering 
endocytosis of CD23. Areas labelled mostly with antibody EBVCS 1, would not show 
crosslinking and endocytosis of CD23, whereas BU38-FITC rich regions on the surface 
with or without EBVCS I -R-PE would internalise. 
Alternatively, as all surface and total fluorescence dot plots indicate, the vast 
majority of cells were shown to be labelled relatively equally for both the lectin and stalk 
regions. During internalisation, total fluorescence intensity decreased but the fluorescence 
intensity ratio for fluorescein and R-phycoerythrin did not change (Figures 4.3c and 4.3e). 
However, flow cytometry measurements may detect fluorescence intensity on the same 
cell in equal ratios, but fail to show whether the labels are localised together or separately 
on the cell surface. There is thus the possibility that the complex of EBVCS I and 
polyclonal IgG Fab fragment bound to R-phycoerythrin may sterically hinder extensive 
binding of fluoresceinated BU38 on the same CD23 trimer or on the same cell surface 
area. BU38 may bind only to surface areas where the EBVCSI-R-PE complex has not 
saturated all CD23 binding sites. Thus, the detected cell has equal ratios of fluorescence 
intensity for both labels but they are not always localised in the same area of the cell 
surface. Areas which possess enough BU38-FITC and less EBVCSI-R-PE complexes 
would be more likely to be crosslinked and undergo endocytosis and thus, a certain 
percentage of cells would tend to exhibit intracellular fluorescein accumulation and less R- 
phycoerythrin, whereas total fluorescence exhibits a relatively equal distribution of both 
fluorophores on the entire cell population. 
Another possible explanation is that both fluorophores are endocytosed 
simultaneously through the same pathway, but R-PE is shorter-lived than fluorescein. It is 
possible that the PE-conjugated complex is easier to denature in the proteolytic and acidic 
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environment of an endosomal compartment. Yet another possibility is that the intracellular 
route of CD23 may involve separation of the lectin domain from the rest of the protein, 
intracellular accumulation of the lectin domain and recycling of the membrane-anchored 
stalk region to the cell surface. Flow cytometric experiments do not allow us to favour any 
one of these posibilities. Numerous attempts by flow cytometry to show whether recycling 
of either CD23 lectin or stalk region occurs, have proved inconclusive, as the quantitation 
of the cell surface binding sites was complicated by the spontaneous proteolysis of CD23 
which progresses within hours of incubation at 370C. Another complication in 
demonstrating the recycling of CD23 is, as explained in the previous chapter, the 
possibility that BU38 may trigger proteolysis of membrane CD23 as a means of enhancing 
its endocytosis. 
The above results clearly show that both BU38 and EBVCSI are intemalised 
together. This is indicated by the movement of the total cell population towards the upper 
right quadrant in figures 4.3d and 4.3f. While the percentage of cells showing endocytosis 
of each fluorescent label is a statistical rather than an actual assessment and is dependent 
on the threshold settings, visual observation of the process of endocytosis is thus 
necessary to observe the intracellular route of each label. 
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Figure 4.1 
Fluorescence histograms for EBVCSI endocytosis in RPMI 8866 cells incubated with 
antibodies to the lectin and stalk region of CD23. EBVCS I is labelled with anti-mouse 
IgG covalently bound to R-phycoerythrin. 
a. Red histogram shows surface labelling of EBVCS I antibody followed by IgG Fab- 
R-PE. The same sample was also incubated with BU38-FITC (histograms for FITC shown 
in Figure 4.2). Green histogram exhibits surface fluorescence removal of a sample labelled 
on the cell surface and acid-washed. Grey histogram is a negative control incubated with 
IgG Fab-FITC only, followed by BU38-FITC and shows lack of non-specific IgG Fab-R- 
PE fluorescence labelling on the cell surface. 
b. Samples incubated at 370C for 2.5 hours. Grey histogram is a sample surface- 
labelled and acid washed (same as the green histogram in a). Red histogram shows total 
fluorescence after 2.5 hours. Green histogram shows internal fluorescence after incubation 
at 370C and acid stripping. 
C. Samples incubated at 370C for 5 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 5 hours. Green histogram shows internal fluorescence after 
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Fluorescence histograms for BU38-FITC endocytosis in RPMI 8866 cells incubated with 
antibodies to the lectin and stalk region of CD23. Samples were first incubated with 
EBVCS 1, followed by anti-mouse IgG covalently bound to R-phycoerythrin and finally 
labelled with BU38-FITC. 
a. Red histogram shows surface labelling of BU38-FITC antibody. The same sample 
was also incubated with EBVCS 1, and anti-mouse IgG bound to R-PE (histograms for R- 
PE shown in Figure 4.1). Green histogram represents surface fluorescence removal of a 
sample labelled on the cell surface and acid-washed. Grey histogram is a negative control 
incubated with EBVCS 1ý IgG Fab-R-PE, followed by streptavidin-FITC and shows lack 
of non-specific FITC fluorescence labelling on the cell surface. 
b. Samples incubated at 370C for 2.5 hours. Grey histogram is a sample surface- 
labelled and acid washed (same as the green histogram in a). Red histogram shows total 
fluorescence after 2.5 hours. Green histogram shows internal fluorescence after incubation 
at 370C and acid stripping. 
C. Samples incubated at 370C for 5 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 5 hours. Green histogram shows internal fluorescence after 
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Dot plots of intensity of fluorescein versus R-phycoerythrin in RPMI 8866 cells incubated 
with EBVCS1, IgG-R-PE followed by BU38-FITC. The dot plots are divided into four 
quadrants, which are defined by the surface labelled and acid washed controls. The lower 
left contains cells which are negative for both R-PE and FITC. The lower right quadrant 
shows events positive for FITC label, whereas the upper left displays cells labelled for R- 
PE only. Finally, the upper right quadrant exhibits cells positive for both fluorophores. 
a. Distibution of a control sample labelled with both EBVCS 1, IgG Fab-R-PE 
followed by BU38-FITC and kept in ice while others were incubated at 370C. 
b. Distibution of a control sample labelled with both EBVCS 1, IgG Fab-R-PE 
followed by BU38-FITC, kept in ice while others were incubated at 370C and acid 
washed to remove surface fluorescence. 
C. A sample labelled for both fluorophores and incubated at 370C for 2.5 hours. It 
shows total internal and surface fluorescence. 
d. A sample labelled for both fluorophores, incubated at 370C for 2.5 hours and acid 
washed to remove surface fluorescence. It shows internal fluorescence only. 
e. A sample labelled for both fluorophores and incubated at 370C for 5 hours. It 
shows total internal and surface fluorescence. 
LA sample labelled for both fluorochromes, incubated at 370C for 5 hours and acid 
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4.3 CONFOCAL MICROSCOPY 
4.3.1 Lectin and Stalk - Double Fluorescence Confocal Imaging 
Figure 4.4 shows optical sections of RPMI cells labelled with EBVCS I antibody to 
the CD23 stalk region, a whole IgG antibody bound to Rhodamine, followed by BU38 
antibody to the lectin domain directly conjugated to fluorescein. The sample was kept at 
40C at all times and thus shows fluorescence distribution on the cell surface. The areas in 
red show binding of the rhodamine-conjugated EBVCSl antibody to the CD23 stalk 
regions. The surface areas in green indicate binding of the fluoresceinated BU38 on the 
CD23 lectin domains. The yellow patches on the cell circumference are the combination of 
labelling by both antibodies to the same surface area. Most surface areas in figure 4.4 are 
coloured in yellow, indicating the presence of both BU38 and EBVCS I in the same 
patches. 
After 2 hours incubation at 370C, endocytosis of both antibodies is observed 
(Figure 4.5). Fluorescein and rhodamine-labelled areas (shown in yellow) appear to be 
endocytosed together. These intracellular patches are found in the juxtamembrane area 
and do not seem to progress further internally. However, some endocytosed BU38 seems 
to progress on its own inside the cell, pulling the EBVCSI-TRITC conjugate behind it 
(Figure 4.5a, left side). In this region, caused by capping and antibody crosslinking, both 
fluorescent labels are shown to be internalising. BU38-FITC, however, seems to take the 
lead in the formation of a vesicle budding into the cytoplasm. This progression of BU38- 
labelled areas may be due to further extensive crosslinking of BU38 antibodies as capping 
and internalisation proceeds. This extensive crosslinking would result in their subsequent 
separation from the less extensively crosslinked areas which bear both fluorophore labels. 
As seen in figure 4.5a, the budding vescicle (left side) forming from an area labelled for 
both EBVCS1 and BU38, comprises almost exclusively BU38-FITC strong crosslinking. 
Indeed, the BU38-FITC label is associated with the inner membrane of the forming 
vesicle, indicating that it is still attached to the membrane protein. This suggests that its 
progression into a budding vesicle is due to extensive association of BU38 antibodies. As 
suspected, areas associated with relatively high concentration of EBVCSI-TRITC 
conjugates are internalised through the formation of BU38 crosslinking. 
`q 
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In figure 4.6, a sample incubated at 370C for 4 hours exhibits both fluorophores 
internally. In some areas mostly adjacent to the cell membrane, the two labels are 
intracellulary co-localised (Figure 4.6b). In others, there exists a strong internal 
accumulation of fluorescein (Figure 4.6a). The TRITC label on the other hand, is not 
concentrated intracellularly and is mostly found on the cell surface. It is thus possible that 
as FITC-bound BU38 crosslinks further during its endocytosis, it pulls EBVCS I -TRITC 
labelled CD23 (Figure 4.6b). In some cases, however, the rhodamine-labelled areas are left 
behind in the area closer to the cell membrane, being incapable of crosslinking with BU38 
antibodies and may partially prevent BU38 antibodies from internalising CD23. 
Finally, in figure 4.7, after 6 hours incubation at 370C, green fluorescence is 
extensively present inside the cell but its intensity is greatly reduced. Rhodamine, however, 
is no longer visible intracellularly. As discussed in the previous chapter, it thus appears 
that the BU38-crosslinked CD23 follows the intracellular route into endosomal 
compartments, where it breaks down to generate a 16 kD fragment (Grenier-Brossette et 
al., 1992, see figure 1.7). The fate of the TRITC-bound EBVCS I which follows the stalk 
region of CD23 is more difficult to deduce from the above observations. 
There are at least three possible routes for the TRITC-labelled membrane CD23 
clusters. The clusters may stay internally in the original budding vescicles or early 
endosomes where they do not crosslink further and are returned to the cell surface. This 
may only be true for vescicles showing equal distribution of fluorescein and rhodamine, 
since after 4 and 6 hours incubations at 370C the majority of cells have cell surface 
fluorescent patches which contain both fluorophores. Alternatively, the TRITC-bound 
molecules may be collected in early endosomal vesicles, which are located in the 
intracellular area closer to the cell surface, as seen in samples incubated for 4 hours. These 
vesicles may return their contents to the cell surface and then release them in the 
extracellular medium. This possibility may account for the loss of intracellular rhodan-iine- 
fluorescing vescicles after 6 hours incubation at 370C. Finally, it is possible that EBVCS I- 
TRITC-saturated areas move down the endosomal pathway separately from the 
fluoresceinated areas and are degraded at a faster rate. This possibility would have been 
favoured if rhodamine fluorescence accumulated in intracellular areas, as seen for 
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Figure 4.4 
2-colour confocal optical section displaying CD23 lectin domain and stalk region labelling 
on the cell surface of RPMI 8866 cells. Samples were incubated with EBVCS 1, IgG- 
TRITC, followed by BU38-FITC. They were kept on ice while other samples were 
incubated at 370C. Optical section thickness: -2gm. 
BU38-FITC (green) and EBVCSI-IgG-TRITC (red). Co-localisation of the two 





2-colour confocal optical sections displaying CD23 lectin and stalk cell surface 
redistribution and endocytosis in RPMI 8866 cells. Samples were incubated with 
EBVCS1, IgG-TRITC, followed by BU38-FITC. They were incubated for 2 hours at 
370C. Optical section thickness: -2gm. BU38-FITC (green) and EBVCSI-IgG-TRITC 
(red). Co-localisation of the two fluorophores is shown in yellow. 
a. A cell showing the beginning of endocytosis and forming of a vesicle (left). 
b. Cells showing different degrees of progression of endocytosis. Both labels are 
found intracellularly (left), Surface capping featuring both lectin and stalk labels (centre), 






2-colour confocal optical sections displaying CD23 lectin and stalk region endocytosis in 
RPMI 8866 cells. Samples were incubated with EBVCS1, IgG-TRITC, followed by 
BU38-FITC. They were incubated for 4 hours at 370C. Optical section thickness: -2[tm. 
BU38-FITC (green) and EBVCSI-IgG-TRITC (red). Co-localisation of the two 
fluorophores is shown in yellow. 
a. A cell showing intracellular accumulation of the label for the lectin domain only 
(green, centre of cell section). 
b. A cell showing internal labels for both lectin and stalk localised together (yellow, 






2-colour confocal optical sections displaying CD23 lectin and stalk endocytosis in RPMI 
8866 cells. Samples were incubated with EBVCS 1, IgG-TRITC, followed by BU38-FITC. 
They were incubated for 6 hours at 370C. Optical section thickness: -2gm. BU38-FITC 
(green) and EBVCS I -IgG-TRITC (red). Co-localisation of the two fluorophores is shown 
in yellow. 
a. A cell showing intracellular accumulation of the label for the lectin domain only 
(green, centre of cell). The fluorescence intensity of FITC is significantly decreased. 
b. A cell showing internal label for the lectin domain. No trace of internal TRITC is 






A 2-colour confocal optical section of a negative control displaying lack of non-specific 
labelling of secondary antibody IgG-TRITC in RPMI 8866 cells. Samples were incubated 
with IgG-TRITC, followed by BU38-FITC. They were kept at 40C while others were 
incubated at 370C. Optical section thickness: -2Rm. BU38-FITC (green) and EBVCS I- 
IgG-TRITC (red). Co-localisation of the two fluorophores in yellow. 
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fluorescein after 4 hours at 370C, and then gradually decreased. However, rhodamine was 
not observed to accumulate intracellularly on its own. 
In order to interpret the above results, it has to be realised that it is highly likely 
that EBVCS I -IgG-TRITC complexes hinder the binding of BU38-FITC on the same cell 
membrane CD23 trimer. In most cells, the two antibody complexes would therefore label 
separate CD23 trimers in the same membrane area. In this experiment therefore, the 
intracellular separation of the two fluorescing complexes after two hours incubation is 
most likely due to progressive crosslinking of BU38-rich areas rather than separation of 
the lectin and stalk regions of CD23. This is in line with previous observations on 
intracellular proteolysis of endocytosed CD23, which starts to occur after incubation at 
370C for three hours, the possible time that it takes for the endocytosed protein takes to 
reach acidic and proteolytic conditions (Grenier-Brossette et al., 1992; Figure 1.7). 
Separation of lectin and stalk labels in figure 4.5a is observed in a vesicle originating and 
still attached to the cell membrane (see left side). This vesicle could not possibly possess 
acidic or proteolytic properties, as this is a characteristic of late endosomes and lysosomes 
and not of vesicles budding from the cell membrane. 
The above observations on these confocal images lead to the conclusion that 
EBVCSl-IgG-TRITC complexes may partially inhibit binding and crosslinking of BU38- 
FITC on the cell surface. If this is indeed true, then the choice of polyclonal antibody to 
bind to EBVCS I may be crucial in correctly following the intracellular route of both lectin 
and stalk domains of CD23. In this experiment, the antibody chosen is intact IgG directly 
conjugated to TRITC. It is possible that the whole IgG antibodies conjugated to 
fluorophores are so large that their binding sterically hinders the binding and crosslinking 
of BU38-FITC complexes. It is therefore important to try other fluorophores and 
polyclonal antibodies in the hope of overcoming this limitation. 
4.3.2 Lectin and Stalk - Triple FLuorescence Confocal Imaging 
In the quest for a polyclonal antibody which causes less restriction of crosslinking 
of BU38-FITC complexes, a three-colour confocal experiment using an IgG covalently 
linked to Cy5 was carried out. This experiment was designed as before, but the polyclonal 
IgG covalently bound to TRITC was substituted by IgG directly conjugated to the 
fluorophore Cy5, which absorbs and emits in the far red region (see Table 2.1). This also 
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allows the introduction of DiBAC4(5) to label the cell cytoplasm and localise both the 
lectin and stalk region with respect to the cell structure. 
Samples labelled for BU38 and EBVCS I on the cell surface and kept at 40C at all 
times are labelled for both FITC and Cy5, indicating that both antibody complexes bind to 
membrane CD23 in the same cell surface areas (Figure 4.9). However, some areas are 
labelled for the Cy5 only, indicating the presence of EBVCS I antibody only labelling the 
stalk region, whereas in other clusters the labelling for BU38 prevails. It is therefore 
possible that labelling of EBVCS I followed by IgG-Cy5, where extensive, may sterically 
hinder the binding of BU38-FITC in the same area and vice versa. Antibody BU38 
therefore binds to places less saturated by the EBVCSI-Cy5 complex, links with other 
BU38 antibodies and causes capping, including some areas moderately labelled by 
EBVCS I but fails to bind some EBVCS I -saturated clusters. 
Both fluorophore-conjugated antibodies are not necessarily expected to label the 
same CD23 trimer. However, in this experiment, EBVCSI-IgG-Cy5 labelling does not 
appear to significantly prevent BU38-FITC binding in the same CD23 cluster. 
After 2 hours incubation at 370C, strong capping and endocytosis of both 
EBVCSI and BU38 is observed (Figure 4.10). The two antibodies are found in capped 
surface areas together (Figure 4.10, seen most clearly on left cell). They are co- 
internalised into the cytoplasm through indentations originating from the cell surface 
capped regions (Figure 4.10, right cell). At this incubation point, the CD23-bearing 
vesicles are localised in the cytoplasm, rather close to the cell surface (Figure 4.10, right 
cell). 
Figure 4.11 exhibits the intracellular co-localisation of both EBVCSl and BU38 
fluorescent complexes in the cytoplasm. Both labels are concentrated in the cytoplasmic 
area as labelled by DiBAC4(5) (Figure 4.1 lb & c). Both fluorophores are localised 
together and are sometimes shown separately in the cytoplasm (Figure 4.11). They both, 
however, display intense cytoplasmic fluorescence accumulation. The labels for CD23 
lectin and stalk regions are located together and some FITC on its own in the area 
adjacent to the nuclear envelope. The cytoplasmic presence of FITC on its own is 
expected. As discussed above, membrane areas labelled with BU38-FITC only are 
expected to undergo crosslinking and endocytosis, resulting in internal presence of the 
FITC label on its own. The localisation of endocytosed fluorescent labels in the 
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juxtanuclear area was shown in confocal micropraphs (see Chapter 3). Surface capping 
breaks down into regional patching on the cell membrane and features both fluorophores 
localised in the same areas. 
In samples incubated at 370C for 6 hours, fluorescence for the lectin and stalk 
regions is concentrated in distinct cytoplasmic regions (Figure 4.12). At this incubation 
point, as before, the fluorophore for the stalk region is localised in cytoplasmic areas 
containing FITC label for BU38 (Figure 4.12a). The label for the lectin domain, BU38- 
FTIC is shown in cytoplasmic areas on its own. The fluorescence intensity of both 
fluorophores has decreased and the cytoplasmic area in which they are contained is smaller 
than in samples incubated for 4 hours. The fluorescence intensity of Cy5 is decreased even 
more than that of FITC. There may be at least two reasons for this observation, Firstly, 
experiments using Cy5 have shown that it is more susceptible to fading than FITC, and 
even short exposure to a laser beam results in loss of its signal. Furthermore, BU38-FTIC 
complexes may be more resistant to intracellular degradation. Indeed, flow cytometry 
experiments using acid stripping have shown that monoclonal antibodies covalently bound 
to fluorescein like BU38-FITC are more resistant to acid wash than fluorescein- 
conjugated polyclonal antibodies. It is thus possible that BU38-FITC can withstand acidic 
and proteolytic conditions better than IgG-Cy5. Finally, as observed in figure 4.11, 
membrane areas containing BU38-FITC only are expected to intemalise, resulting in more 
endocytosed FITC than Cy5. Surface fluorescence in these samples is notably decreased 
and capping is less frequently observed. 
The success of this experiment in intracellularly co-localising the lectin and stalk 
regions confirms the possibility that perhaps the secondary antibody-fluorophore 
complexes used in previous experiments prevent BU38-FITC binding and crosslinking on 
the surface of B cells. 
It is thus concluded that both the lectin and stalk regions of CD23 are endocytosed 
together and delivered intracellularly to the same distinct cytoplasmic areas, where their 
intensity then decreases. The possibility that the stalk may separate from the lectin domain 
in an endosomal compartment is not easy to examine in this experiment since the Cy5 
fluorescent label (as any label) is unlikely to stay attached to the stalk region after 
exposure to an acidic and proteolytic environment. In this experiment external label for the 
stalk region was not observed on its own on the cell surface after incubation at 370C for 
175 
2,4 or 6 hours, a result that would have indicated its recycling back to the cell surface 
without the lectin domain. 
It is thus concluded that both lectin and stalk regions of CD23 are endocytosed 
and delivered together to the same cytoplasmic areas, where the intensity of their 
fluorescent labels decreases after 6 hours at 370C. 
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Figure 4.9 
A 3-colour confocal optical section displaying CD23 lectin and stalk region labelling on 
the cell surface of RPMI 8866 cells. Samples were incubated with EBVCS 1, IgG-Cy5, 
followed by BU38-FITC. They were kept in ice while other samples were incubated at 
370C. DiBAC4(5) was used to label all cytoplasmic membranes. Optical section thickness: 
-IýIrn. 
a. BU3 8-FITC (green) and EBVCS I -IgG-Cy5 (white). 
b. BU38-FITC (green) and DiBAC4(5) (red). 








A 3-colour confocal optical section displaying CD23 lectin and stalk region capping and 
endocytosis in RPMI 9866 cells. Samples were incubated with EBVCSI, IgG-Cy5, 
followed by BU38-FITC. They were incubated at 370C for 2 hours. DiBAC4(5) was used 
to label all cytoplasmic membranes. Optical section thickness: -I gm. 
a. BU38-FITC (green) and EBVCS 1 -IgG-Cy5 (white). 
b. BU38-FITC (green) and DiBAC4(5) (red). 









A 3-colour confocal optical section displaying CD23 lectin and stalk region endocytosis in 
RPMI 8866 cells. Samples were incubated with EBVCSI, IgG-Cy5, followed by BU38- 
FITC. They were incubated at 370C for 4 hours. DiBAC4(5) was used to label all 
cytoplasmic membranes. Optical section thickness: -I gm. 
a. BU38-FITC (green) and EBVCS I-IgG-Cy5 (white). 
b. BU38-FITC (green) and DiBAC4(5) (red). 








A 3-colour confocal optical section displaying internal CD23 lectin and stalk labels in 
RPMI 8866 cells. Samples were incubated with EBVCS1, IgG-Cy5, followed by BU38- 
FITC. They were incubated at 370C for 6 hours. DiBAC4(5) was used to label all 
cytoplasmic membranes. Optical section thickness: -I gm. 
a. BU38-FITC (green) and EBVCS I -IgG-Cy5 (white). 
b. BU38-FITC (green) and DiBAC4(5) (red). 









A 3-colour confocal optical section of a negative control displaying lack of non-specific 
labelling of secondary antibody IgG-Cy5 in RPMI 8866 cells. Samples were incubated 
with IgG-Cy5, followed by BU38-FITC. They were kept at 40C while others were 
incubated at 370C. Optical section thickness: -Igm. DiBAC4(5) was used to label all 
cytoplasmic membranes. 
a. BU3 8-F1TC (green) and EBVCS I -IgG-Cy5 (white). 
b. BU38-FITC (green) and DiBAC4(5) (red). 







4.4 ELECTRON MICROSCOPY 
An immunoelectron microscopy experiment was performed to follow the 
intracellular routes of both the lectin and stalk regions. 
Figure 4.14 shows cell membrane antibody binding for samples kept at 40C. CD23 
is labelled with EBVCS I directed to the stalk region, followed by a polyclonal antibody 
directly bound to 5nm gold. This is followed by incubation with biotinylated BU38 
antibody directed to the lectin domain and anti-biotin antibody, bound to l0nm gold. The 
cells show diffuse distribution of single gold particles of mostly 5nm in diameter (Figure 
4.14b, 5nm gold indicated by thin arrows, 10nm gold indicated in thick arrows). Small 
clusters of gold are also observed attached to plasmalemmal pits (Figure 4.14a). Although 
equal concentrations of all antibodies were used for all incubations, the 10nm-conjugated 
anti-biotin antibody is not as abundant on the cell surface as the 5nm secondary antibody 
bound to EBVCSI. Possibly, the EBVCSI-IgG-5nm complexes allow binding of 
biotinylated BU38 antibody alone but could sterically hinder binding of anti-biotin gold 
conjugate binding to biotin. This explanation would agree with previous observations in 
this Chapter, where some fluorescent EBVCS I -IgG antibody complexes partially prevent 
binding of BU38-FITC on the cell surface. Adding to the problem, a gold-bound antibody 
is much bigger than a fluoresceinated one, and renders binding of another antibody to the 
same membrane protein trimer almost impossible. 
In this experiment however, monoclonal antibody BU38 must be associated with 
membrane CD23, since endocytosis of 5nm-conjugated EBVCS I is widely observed, even 
in samples which were kept in ice during incubations. As shown previously, EBVCS I is 
ineffective in inducing endocytosis on it own (Figure 3.4). Furthermore, as discussed in 
the previous Chapter, as the size of the gold particle increases, it becomes increasingly 
difficult to maintain antibody-antigen binding. Since this sample was kept at 40C for 10 
hours before fixation, some endocytosis took place even in the cold, resulting in some gold 
labelling of cytoplasmic indentations and vesicles located in the membrane-proximal area 
(Figure 4.14a). In such areas the presence of both 5nm (thin arrows) and 10nm (thick 
arrows) gold is visible, indicating the co-localisation and clustering of both labels on 
membrane CD23. In these vesicles, the presence of 5nm gold exceeds that of the 10nm- 
bound antibody. 
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In figure 4.15, samples incubated for 3.5 hours at 370C show 5 and 10 nm Lgold 
accumulated in plasmalemmal pits and in cytoplasmic vescicles localised in the peripheral 
cytoplasm. At this stage, many of the gold particles are associated with the inner 
membrane of the endocytosed vesicle (Figure 4.15c, 5nm gold thin arrows, 10nm gold in 
thick arrow), indicating that it is still attached to the internalised CD23 and that the 
protein is still associated with the vesicular membrane. The two sizes of gold particles are 
located together in the same vesicles (Figure 4.15c). It thus appears that EBVCS I 
antibody is internalised by BU38 crosslinking and that both lectin and stalk regions are 
simultaneously taken up. Some gold-containing vesicles seem to possess some 
ultrastructural detail (Figure 4.15, thick arrow) which distinguishes them from 
plasmalemmal indentations (Figure 4.15b & 4.15c, open arrow). These organelles contain 
membranous material or smaller vesicles (Figure 4.15b, thick arrow) and may belong to 
the early endosomal network. It is thus possible that CD23 lectin and stalk labels 
accumulate in preliminary endosomal compartments upon their endocytosis. 
After 10 hours at 370C gold particles are found in tubular substructures which are 
in endosomal compartments, multivesicular structures and lysosomes (Figure 4.16, thick 
arrows). Golgi cisternes (G) and mitochondria (M) are free of gold labelling in this and all 
other samples studied. At this time, gold is no longer associated with the inner membrane 
of the cytoplasmic vesicle. Gold particles form aggregates inside the vesicular network 
(Figure 4.16b, long thick-end arrows). The size of the endocytosed gold is hard to assess 
in these aggregates, although gold of 5nm seems to prevail. Some l0nm gold particles are 
also seen, when they are present individually, but they are very difficult to identify in 
aggregates. However, as seen in samples incubated for 0 and 3.5 hours, most gold 
conjugates are those of 5nm (for microscope calibration and measuring of gold particle 
diameter, see Chapter 2). From the morphology of the cytoplasmic vesicles possessing 
endocytosed gold, it can be concluded that EBVCS I -conjugated 5nm gold particles 
follow the same route as the lectin bound antibodies and are delivered to the same 
intracellular compartments. Indeed, gold-rich cytoplasmic vesicles shown in figures 4.16 
and 4.17 are the same in structure, location and appearance as those gold-conjugated to 
MHM6 in the previous electron microscopy experiments (Figure 3.16b, thick arrows). 
Gold aggregation is observed in both experiments (in figures 4.16b & 4.17a, long thick- 
end arrows), suggesting that both lectin and stalk regions of CD23 meet acidic and 
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proteolytic conditions during their intracellular route. A closer look at the gold 
accumulated in these cytoplasmic structures confirms that particles of 5nm (long thin 
arrows) and 10nm (short thick arrows) in diameter are contained in the cytoplasm (FigWe 
4.17a & 4.17b). It thus appears that the stalk region and the lectin domain follow the 
endosomal pathway together. 
An interesting observation is that the gold particles in the control sample and in 
samples incubated at 370C for 3.5 hours are sharp in appearance. The gold is mostly 
associated with the cell surface or with the inner membrane of early endosomal structures. 
At this stage, the endosomal vescicles do not possess a low pH. However, after 10 hours 
incubation at 370C, gold particles accumulated in tubular structures and multivesicular 
bodies show signs of aggregation. The degree of aggregation is increased in lysosomes, 
and the size of the gold particles becomes difficult to assess. In the sample incubated at 
370C for 10 hours, uranyl acetate and lead citrate staining was not used in the hope of 
distinguishing between 5 and 10 mu gold in the cytoplasmic gold aggregates and also to 
exclude the possibility that the gold aggregates may only be a metal deposit originating 
from specimen treatment with both dyes. However, even after examination without stains 
(uranyl acetate and lead citrate), it is still hard to distinguish between the two sizes. The 
aggregation is due to the destruction of the protein coat that surrounds the gold particles 
when they are attached to the cell surface and to early endosomal compartments. This coat 
is digested in late endosomes and lysosomes, resulting in the observed flocculation of the 
gold colloid particles (Pulczynski, Boesen & Jensen, 1994). This is a further confirmation 
that CD23 lectin and stalk regions are endocytosed into an acidic and proteolytic 
environment. 
Finally, figures 4.18 and 4.19 show that hardly any gold labelling occurs without 
the presence of the equivalent antibodies in samples incubated with anti-mouse IgG 
fragment conjugated to 5nm gold, followed by BU38-biotin (Figure 4.18). Similarly, a 
sample incubated with secondary antibodies only (IgG-5nm gold and anti-biotin-10nm 
gold), shows no gold labelling on the cell (Figure 4.19). 
Colloidal gold aggregation following internalisation and processing 
into late 
endosomes and lysosomes was shown in a recent study 
following internalisation of CD20 
and CD21 in Raji and JOK-1 cells (Pulczynski, 
Boesen & Jensen, 1994). Figure 4.20 
Z7 illustrates gold aggregation and flocculation, following proteolysis of the gold-coating 
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proteins and mild acid conditions in endosomes and lysosomes. The presence of gold 
aggregates following endocytosis of CD23 further proves the exposure of both lectin and 
stalk regions into the acidic and proteolytic environment of the endosomal network. 
Although these results confirm that the intracellular pathway of the lectin domain 
and stalk region is the same for both, the fate of the membrane-anchored stalk region is 
not clear. After exposure to the acidic environment of an endosomal compartment, the 
stalk regions are known to separate from the lectin domain; the lectin domain has been 
shown to accumulate intracellularly following endocytosis of the membrane protein 
(Grenier-Brossette et al., 1992). The membrane-anchored stalk region may either break 
down and dissociate in the lysosome or recycle back to the cell surface. Alternatively, it 
may be proteolysed to a soluble fragment, transported for exocytosis and released to the 
environment in a soluble form. Attempts to show stalk recycling to the cell surface have 
failed due to a number of factors, including the spontaneous shedding of CD23 on the cell 
surface in the course of a few hours, and perhaps loss of EBVCS I antibody attachment to 




Electron micrographs of RPMI 8866 cells kept at 40C during incubations. CD23 stalk 
regions were labelled with mouse EBVCSI antibody, followed by anti-mouse IgG 
conjugated to 5nm gold. The lectin domains were then labelled with biotinylated BU38, 
followed by anti-biotin monoclonal antibody conjugated with 10nm gold. Cell surface 
distribution of 5 and 10 nm gold particles at time 0. N: Nucleus, C: Cytoplasm, PM: 
Plasma Membrane. 
b. Part of a cell section showing 5nm (thin arrows) gold on the surface and in a 
plasmalemmal pit and 10nm gold in a plasmalemmal pit (thick arrow). Most of the 
cytoplasmic gold is associated with the inner membrane of the vesicle. Magnification: 
83,480x, Iýtm=83.48mm. Scale bar: 0.5ýtm. 
b. Part of a section of a cell showing 5 (thin arrows) and 10 nm gold (thick arrow) on 











Electron micrographs of RPMI 8866 cells labelled with EBVCS1, IgG-5nm gold, BU38- 
biotin and anti-biotin-10nm gold. The sample was incubated at 370C for 3.5 hours. Gold 
of 5 and 10 nm is accumulated within cytoplasmic vesicles located in the area close to the 
plasma membrane. N: Nucleus, C: Cytoplasm, PM: Plasma Membrane. 
a. A cell section showing endocytosis of gold in the cytoplasm (thick arrows). Gold 
associated with the plasma membrane is also seen (thin arrow). Magnification: 13,600x, 
I gm= I 3.60mm. Scale bar: I. Ogm. 
b. Detail from the cell section in a. Gold contained in a plasmalemmal vesicle (open 
arrow) fusing within a multivesicular body (thick arrow). Magnification: 58,260x, 
Igm--58.26mm. Scale bar: 0.5gm. 
C. Gold of 5nm (thin arrows) and 10nm (thick arrow) in cytoplasmic plasmalemmal 
pits (open arrow) is still attached to the membrane bound CD23. Magnification: 97,1 00x, 






















Electron micrographs of RPMI 8866 cells labelled with EBVCS1, IgG-5nm gold, BU38- 
biotin and anti-biotin- 10nm gold. The sample was incubated at 370C for 10 hours. The 
cell section was not labelled with either uranyl acetate or lead citrate. Gold is accumulated 
within multivesicular cytoplasmic bodies located in groups around the juxtanuclear area. 
Most of the gold is concentrated in large aggregates. N: Nucleus, C: Cytoplasm, G: Golgi, 
M: Mitochondria, PM: Plasma Membrane. 
a. Part of a cell section showing gold-rich strucutres (thick arrows) located in the 
cytoplasmic area close to the nucleus. Magnification: 27,830x, IRm=27.83mm. Scale bar: 
1.0[tm. 
b. The gold-containing vesicles in a are distinct cytoplasmic structures (thick arrows) 
containing smaller vesicles and membranes. Gold is seen in aggregates (long thick-end 
arrows) within these cytoplasmic structures. Magnification: 83,480x, IRm=83.48mm. 
Scale bar: 0.5gm. 
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Electron micrographs of gold-containing cytoplasmic vesicles in RPMI 8866 cells 
incubated for 10 hours at 370C. Cells were treated as in figure 4.16. The majority of these 
structures are membranous in appearance and contain small vesicles. In most, gold is 
found is aggregates, and lacks the sharp appearance shown in samples incubated for 0 and 
3.5 hours. Gold particles 5nm in diameter prevail; some 10nm gold is also found. The size 
of the gold particles in the aggregates is often hard to assess. C: Cytoplasm. 
a. The cytoplasmic vesicles contain mostly 5nm (long thin arrows) but also 
some 10nm (short thick arrows) gold particles. The gold is not sharp in appearance and is 
found accumulated in aggregates (long thick-end arrows). Magnification: 97,100x, 
I Rm--97.10mm. Scale bar: 0-5ýtm. 
b, c&d. The cytoplasmic vesicles contain mostly 5nm (long thin arrows) but also 
some 10nm (short thick arrows) gold particles. Magnification: 97,100x, l[tm=97.10mm. 








Electron micrograph of a control sample. RPMI 8866 cells were labelled with IgG 
conjugated to 5nm gold only, followed by BU38-biotin and kept in ice during incubations. 
It shows lack of non-specific polyclonal antibody binding to BU38-biotin on the cell 
surface. N: Nucleus, C: Cytoplasm, PM: Plasma Membrane. Scale bar: 0.54m. 
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Electron micrograph of a control sample. RPMI 8866 cells were labelled with IgG 
conjugated to 5nm gold only, followed by anti-biotin-10nm gold and kept in ice during 
incubations. It shows the absence of non-specific polyclonal antibody binding on the cell 
surface. N: Nucleus, C: Cytoplasm, M: Mitochondrion, PM: Plasma Membrane. Scale bar: 
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Figure 4.20 
Electron micrographs of the cytoplasmic vesicles containing endocytosed antibodies for 
CD20 and CD21 in JOK- I cells (Pulczynski, Boesen & Jensen, 1994). 
a-c- Surface labelling and the beginning of endocytosis of CD20 and CD2 1. 
d-f: Endocytosed protein is concentrated in plasmalernmal pits. The gold retains its 
sharp appearance in early endosomes. 
g-i: Gold is accumulated and starts to aggregate in multivesicular bodies. 
j-k: Colloidal gold forms aggregates in lysosomal compartments, where its sharp 
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The above experiments show that the lectin and stalk regions of CD23 are 
endocytosed together and follow the same intracellular path. Confocal images suggest that 
the antibodies for both the lectin and stalk regions are delivered to the same cytoplasmic 
areas. Neither of the two labels seems to be recycled back to the surface membrane. 
Electron micrographs confirm that the lectin domain and the stalk region follow the same 
intracellular pathway, leading to gold aggregation in distinct cytoplasmic vesicles. This 
aggregation suggests that the gold-bound antibodies for the lectin and stalk regions are 
processed and denatured in endosornal and lysosomal compartments. The morphology of 
these vesicles is identical to those observed in other studies (Pulezynski, Boesen & Jensen, 
1994). 
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Chapter 5: Intracellular Co-Localisation of HLA DR and CD23 
5.1 INTRODUCTION 
Previous studies suggest the involvement of CD23 in processing IgE-bound 
antigen for presentation to T cells Pirron et al., 1990; Flores-Romo et al., 1990; Kehry & 
Yamashita, 1989; Heyman et al., 1993). This view is complemented by the finding that 
CD23 and HLA DR are spatially associated on the surface of B lymphocytes (Bonnefoy et 
al., 1988). B cells incubated with antibodies to HLA DR have been shown to grow in 
clusters and CD23 has been shown to gather with HLA DR at the points of contact with 
other cells. The two antigens are also localised together in distinct patches around the 
circumference of B cells (Flores-Romo et al., 1990). 
HLA DR is involved in binding processed antigenic peptides that are delivered 
through endocytosis into an endosomal compartment (Germain, 1986). Peptide binding to 
HLA DR occurs in CPL (compartment for peptide loading) a specialized endosomal body 
(Amirogena et al., 1994; Tulp et al., 1994; West, Lucocq & Watts, 1994). HLA DR then 
transports the peptide to the B cell surface where it presents it to aT cell (Neefjes & 
Ploegh, 1992). 
To study further the association of CD23 and HLA DR, flow cytometry is used 
here to determine whether endocytosis of HLA DR sequesters CD23 intracellularly and to 
quantitate internalisation of both molecules. 
Confocal microscopy is used to study the endocytosis of CD23 lectin and stalk 
regions induced by HLA DR. Visual images allow co-localisation of both molecules on the 
cell surface and intracellularly. 
An immunoelectron microscopy experiment with CR3/43 antibody to HLA DR 
was carried out to investigate the effect upon capping of membrane CD23 and provide 
ultrastructural detail of the internal route and the destination of the labelled molecule. 
206 
5.2 FLOW CYTOMETRY 
5.2.1 HLA DR-Induced Endocytosis. of CD23 
Cells incubated for 0,3 and 6 hours at 370C with fluorescein-labelled IOB8 
antibody to the CD23 lectin domain are shown in figure 5.1. Antibody CR3/43 to HLA 
DR was added to all samples prior to incubations at 370C in figure 5.2. Figures 5.1 a and 
5.2a, show samples kept at 40C during all incubations which exhibit surface fluorescence 
(red histogram) and negative control samples showing background fluorescence (in grey). 
In both figures 5.1 a and 5.2a, the surface-labelled acid stripped sample is used to define 
the threshold for cell surface fluorescence removal (in green). The same sample is shown 
in grey in figures 5.1b and c, 5.2b and c. Green histograms in figure 5.1b and c show 
samples labelled with IOB8 andibody to CD23, incubated at 370C for 3 and 6 hours and 
subjected to acid wash. These histograms match the acid stripped control very closely, 
indicating that no significant internalisation of CD23 was induced within these incubations. 
The fluorescence intensity of the red histograms exhibiting surface (Figure 5.1 a) and total 
surface and internal (Figure 5.1 b& c) fluorescence was altered during the incubations. In 
a sample showing endocytosis, total cell-associated fluorescence intensity would appear 
decreased, as internal fluorescence would be masked by the opaque cell structure. In this 
sample no endocytosis is apparent, however, cell-associated fluorescence would decrease 
both through metabolism and spontaneous CD23 proteolysis on the cell surface. The 
above data suggest that antibody IOB8 does not encourage endocytosis of CD23, a 
finding which agrees with previous flow cytometric experiments (Chapter 3, section 3.2; 
figure 3.1). 
In samples treated with CR3/43 antibody to HLA DR prior to incubations at 370C 
the histograms are certainly altered (Figure 5.2). In samples incubated at 370C for 3 and 6 
hours followed by acid wash, green histograms are distinct from the acid stripped control 
(in grey) and exhibit appreciable internal fluorescence (Figure 5.2b and c). The pattern of 
fluorescence histograms showing surface (Figure 5.2a) and total (Figure 5.2b and c) 
fluorescence (in red) changes dramatically upon incubation at 370C. Cells vary 
considerably in their fluorescence intensity and this distribution of fluorescence intensities 
becomes wider after 3 hours incubation at 370C (Figure 5.2b red histogram). 
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Figure 5.1 
Fluorescence histograms for IOB8 monoclonal antibody efficiency in enhancing 
endocytosis of CD23 in RPMI 8866 cells. 
a. Red histogram shows surface labelling of IOB8 antibody followed by IgG Fab- 
FITC. Green histogram exhibits surface fluorescence removal of a sample labelled on the 
cell surface and acid-washed. Grey histogram is a negative control incubated with IgG 
Fab-FITC only, showing lack of non-specific fluorescence labelling on the cell surface. 
b. Samples incubated at 370C for 3 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 3 hours. Green histogram shows internal fluorescence after 
incubation at 370C and acid stripping. 
C. Samples incubated at 370C for 6 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 6 hours. Green histogram shows internal fluorescence after 
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Fluorescence histograms for IOB8 monoclonal antibody endocytosis of CD23 in RPMJ 
8866 cells. All samples were incubated with CR3/43 antibody to HLA DR prior to all 
incubations at 370C. 
a. Red histogram shows surface labelling of IOB8 antibody followed by IgG Fab- 
FITC. Green histogram exhibits surface fluorescence removal of a sample labelled on the 
cell surface and acid-washed. Grey histogram is a negative control incubated with IgG 
Fab-FITC only, showing lack of non-specific fluorescence labelling on the cell surface. 
b. Samples incubated at 370C for 3 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 3 hours. Green histogram shows internal fluorescence after 
incubation at 370C and acid stripping. 
C. Samples incubated at 370C for 6 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 6 hours. Green histogram shows internal fluorescence after 
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This distribution shows a tendency to resolve into two peaks after 6 hours at 370C (Figure It 
5.2c). These two peaks differ 10-fold in their fluorescence intensity. However, after acid 
stripping this effect disappears and a single curve exhibits the distribution of internal 
florescence (in green, figure 5.2b and c). This heterogeneity in the fluorescent cell 
population could be due to the difference in fluorescence pattern between cells that exhibit 
endocytosis and those that do not. This difference in pattern could be a combination of 
strong surface capping and internal fluorescence for the cell population that shows CD23 
internalisation versus less capping and no internal fluorescence for the other. 
Statistical analysis of the histograms in figures 5.1 and 5.2 show that HLA DR 
antibody has a profound effect on endocytosis of CD23. In samples incubated without 
CR3/43,4.1% of cells show internalised 10138 after 3 hours at 370C. Internal IOB8 
antibody is seen in 2% of all samples after 6 hours at 370C. As both statistical measures 
fall within the 5% error factor allowed in these experiments, it is concluded that IOB8- 
induced intemalisation of CD23 is insignificant. On the other hand, addition of HLA DR 
induces endocytosis of IOB8-labelled surface CD23. After 3 hours incubation, 31% of all 
detected cells exhibit intracellular fluorescence and 35% of cells show internal 
fluorescence after 6 hours at 370C. It is thus seen in this experiment that addition of 
CR3/43 antibody to HLA DR encourages endocytosis of CD23. 
5.2.2 Endocytosis of HLA DR 
Samples labelled for HLA DR-FITC without or with IOB8 antibody to CD23 are 
shown in figures 5.3 and 5.4 respectively. As explained in previous flow cytometric 
experiments performed with antibodies directly conjugated to fluorescein, removal of cell 
surface fluorescence presented a particular limitation (Chapter 4,4.2). The same 
fluorescence removal difficulty is shown in the control sample labelled with CR3/43 which 
was covalently bound to fluorescein and subjected to acid washing (Figures 5.3a, 5.4a, in 
green) (Figures 5.3b &c and 5.4b & c, in grey). As before, the small discrepancy is taken 
into account in the threshold settings. 
Histograms of samples incubated at 370C for 3 and 6 hours and subjected to acid 
wash (in green, Figure 5.3b and 5.3c respectively) are distinct from the acid stripped 
control sample (in grey) indicating the presence of internal HLA DR. The surface and total 
?i -) 
fluorescence intensity shown in the red histograms shows a wide distribution, following a 
pattern similar to that shown for the CD23 label in figure 5.2. The distribution appears 
wider after 3 and 6 hours at 370C (Figure 5.3b & c). However, the intensity does not 
resolve clearly into two peaks as shown in figure 5.2. It is rather obvious from comparing 
histograms of total fluorescence (red curves) between figures 5.1,5.2,5.3 and 5.4 that this 
alteration in fluorescence intensity distribution occurs for both cell-associated CD23 and 
HLA DR and is due to the presence of the CR3/43 antibody. The effect of this antibody 
increases upon incubation at 370C. The reason for this observation is not clear, but it may 
be the result of different degrees of capping in the cell population, resulting in fluorescent 
signals of different intensities. 
The effect of IOB8 antibody to CD23 on the endocytosis of HLA DR is seen in 
figure 5.4. The green histograms in figure 5.4b and 5.4c are, as before, distinct from the 
acid stripped controls showing appreciable internalisation of HLA DR. The pattern of 
fluorescence intensity of histograms showing surface and total fluorescence is similar to 
those in figure 5.3. Histograms representing controls and acid stripped samples in figure 
5.4 differ only slightly from to those in figure 5.3. It is thus seen that IOB8 labelling of 
CD23 on the cell surface of B cells prior to binding of CR3/43 on HLA DR has only a 
minor effect in cell surface fluorescence distribution and internalisation of HLA DR 
membrane antigens. 
These experiments show that upon incubation at 370C, CR3/43 antibody induces 
endocytosis of its ligand, HLA DR. Incubation with IOB8 monoclonal antibody to the 
CD23 lectin domain does not alter the pattern of HLA DR endocytosis. Indeed, statistical 
analysis of samples not treated with IOB8 show that 39% of cells show internal label for 
HLA DR after 3 hours at 370C and 38% possess intracellular fluorescence after 6 hours. 
The binding of IOB8 to CD23 prior to HLA DR labelling does not seem to change 
CR3/43-induced endocytosis. Statistical analysis of samples that feature CD23 engaged 
with IOB 8 show that after 3 and 6 hours at 370C 41 % and 40% of cells show internalised 
HLA DR. 
Antibody IOB8 was previously shown not to enhance endocytosis of CD23 
(Chapter 3, Figure 3.1). The present experiment was performed to establish whether its 
presence on the CD23 lectin regions caused further crosslinking of the CR3/43 antibody, 
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thus enhancing endocytosis of both CD23 and HLA DR. However, according to the above 
results, IOB8 antibody to the CD23 lectin domain does not participate or significantly 
enhance HLA DR endocytosis caused by antibody CR3/43. To that end, it does not 
participate in the initiation of CD23 internalisation caused by the anti-HLA DR antibody. 
Endocytosis of CD23 is therefore enhanced by the sole effect of CR3/43 antibody. It is 
thus proposed that CD23 and HLA DR are associated together inside the cell because of 
their non-covalent link on the cell membrane. Their subsequent co-endocytosis was next 
investigated. 
5.2.3 Co-intemalisation of CD23 and HLA DR 
In these two-colour immunofluorescence measurements CD23 is labelled with 
IOB8 followed by a polyclonal Fab antibody fragment conjugated to R-phycoerythrin, 
while HLA DR is bound to CR3/43 monoclonal antibody covalently coupled to 
fluorescein. The cells are allowed to endocytose HLA DR and CD23 for 0,3 and 6 hours 
at 370C. 
Figure 5.5 shows the histograms of CD23 enclocytosis (R-phycoerythrin label). 
The red histogram in figure 5.5a represents successful cell surface CD23 labelling by 
1OB8. Negative controls and acid washed samples are prepared and displayed as described 
previously. The grey histogram in figure 5.5a is a negative control to which the R-PE- 
conjugated polyclonal was added, followed by fluoresceinated CR3/43 antibody. After 3 
hours at 370C, the acid washed sample (Figure 5.5b, green histogram is distinct from the 
negative control and exhibits low detectable internal fluorescence (Figure 5.5b, in grey). 
The internal label for CD23 emits an even stronger signal after 6 hours at 370C, signifying 
the progress of CD23 intemalisation between 3 and 6 hours (Figure 5.5c, green 
histogram). These results therefore agree with the preceeding single-colour flow 
cytometric measurements. Antibody CR3/43 to HLA DR thus causes intemalisation of 
CD23. 
The histograms for the fluorescein-labelled CR3/43 antibody are shown in figure 
5.6. Histograms of all samples and controls are prepared and displayed as in figure 5.5, 
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Figure 5.3 
Fluorescence histograms for the efficiency of CR3/43 monoclonal antibody in enhancing 
endocytosis of HLA DR in RPMI 8866 cells. 
a. Red histogram shows surface labelling of CR3/43 antibody covalently conjugated 
with FITC. Green histogram exhibits surface fluorescence removal of a sample labelled on 
the cell surface and acid-washed. Grey histogram is a negative control incubated with 
streptavidin-FITC only, showing lack of non-specific fluorescence labelling on the cell 
surface. 
b. Samples incubated at 370C for 3 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 3 hours. Green histogram shows internal fluorescence after 
incubation at 370C and acid stripping. 
C. Samples incubated at 370C for 6 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 6 hours. Green histogram shows internal fluorescence after 
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Fluorescence histograms for CR3/43 monoclonal antibody endocytosis of HLA DR in 
RPMI 8866 cells. All samples were incubated with IOB8 antibody to CD23 prior to a 
incubations. 
a. Red histogram shows surface labelling of CR3/43 antibody, covalently linked to 
FITC. Green histogram exhibits surface fluorescence removal of a sample labelled on the 
cell surface and acid-washed. Grey histogram is a negative control incubated with 
streptavidin-FITC only, showing lack of non-specific fluorescence labell-ing on the cell 
surface. 
b. Samples incubated at 370C for 3 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 3 hours. Green histogram shows internal fluorescence after 
incubation at 370C and acid stripping. 
C. Samples incubated at 370C for 6 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 6 hours. Green histogram shows internal fluorescence after 
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with the exception of the negative control shown in grey in figure 5.6a. The negative 
control was labelled with IOB8 and polyclonal antibody Fab covalently linked to R-PE, 
followed by streptavidin covalently bound to fluorescein. The fluoresceinated streptavidin 
was added in place of CR3/43 antibody to establish the threshold for non-specific antibody 
attachment to the cell membrane. The acid stripped control sample in figure 5.6a does not 
match the negative control shown in grey. The sample is labelled with fluoresceinated 
CR3/43 and presents the same limitation in cell surface fluorescence removal efficiency 
experienced before with the same antibody and with fluorescein-bound BU38 antibody to 
CD23 (Chapters 4 and 5). Due to this technical limitation, the threshold for the cell 
surface fluorescence removal of fluoresceinated HLA DR has therefore been set higher 
than for the IOB8 antibody which is non-covalently conjugated to R-PE. Acid stripped 
samples incubated for 3 and 6 hours displayed in figures 5.6b and 5.6c, show detectable 
internal fluorescence, as their histograms (in green) are distinct from the acid stripped 
control (in grey). These data suggest that CR3/43 antibody induces intemalisation of 
surface HLA DR and confirrn the findings of previous single-colour flow cytometry 
experiments (this chapter). 
Histograms representing surface and total fluorescence in both figure 5.5 and 5.6 
show wide fluorescence distribution in the cell population. These fluorescence intensity 
patterns are similar to those of equivalent histograms in previous observations (Figures 
5.2,5.3 & 5.4). Furthermore, total fluorescence intensity of both HLA DR and CD23 
decreased by up to 65% after 3 and 6 hours at 370C (Figures 5.5 and 5.6, red histograms). 
This fluorescence intensity drop was more prominent in CD23 than in HLA DR. The 
fluorescent label for CD23 decreased to 35% of the initial intensity whereas HLA DR- 
associated fluorescence intensity dropped by 50%. 
There may be a number of reasons for this difference in loss of fluorescence. Some 
loss of intensity has always been observed in samples which have internalised antigen and 
may be due to absorption of the fluorescent signal by the membranous cellular structure. 
Further fluorescence intensity loss would take place upon intracellular degradation of the 
internalised label in an acidic cellular compartment. The above two factors may influence 
total fluorescence loss in both CD23 and HLA DR. 
The difference in loss of fluorescence in CD23 may similarly be due to a number of 
factors. CD23 may lose some fluorescence intensity through proteolysis of the membrane 
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form into soluble fragments. In addition, the secondary antibody Fab fragment binds, to 
IOB8 with lower affinity than fluoresceinated CR3/43 monoclonal antibody attaches to 
HLA DR, and is thus more likely to detach during incubations and washes and be more 
prone to denaturation in an acidic and proteolytic intracellular compartment. A third 
reason may be related to the final destination of each antigen following endocytosis, i. e. 
one may be recycled while the other remains within the cell. This will be discussed below, 
in the light of further data. However, a definitive explanation for both the reduction in 
total fluorescence and the difference in fluorescence loss between CD23 and HLA DR is 
not possible, based on the information available from these experiments. 
Histogram statistics based on the above experiment agree with previous findings 
on endocytosis of both CD23 and BLA DR. 41 % of all detected cells show internal CD23 
after 3 hours incubation and 54% of cells show endocytosed HLA DR. After 6 hours 
incubation at 370C 44% of all cells possess internal CD23 label whereas 53.5% exhibit 
intracellular HLA DR. 
Dot plots of the same samples show the intracellular co-existence of both antigens. 
The dot plots were arranged, as explained previously, in four quadrants and represent cell- 
associated fluorescence intensity of fluorescein plotted against that of R-PE. Figure 5.7a, 
displays fluorescence distribution of a sample labelled for both CD23 and HLA DR and 
kept in ice during all incubations. The cell population displays equal labelling for both 
antigens, as 86% of all cells fall within the upper right quadrant, representing dual 
fluorescence distribution. The threshold gates for each fluorophore were set according to 
the acid stripped control in figure 5.7b. Indeed, gates were set, so that 86% of all cells 
detected fall within the lower left quadrant established to include negative events for both 
fluorescein and R-phycoerythrin. Total fluorescence after incubations at 3 and 6 hours is 
shown in figure 5.7c and 5.7e, respectively. After both incubations, 82-83% of all cells 
register positive for cell-associated fluorescein and R-PE labels. Statistical calculations are 
the average of two experiments. All percentage calculations were substracted from the 
values calculated from the acid-washed control (in Figure 5.7b). 
In figure 5.7d, a sample incubated at 370C for 3 hours and subjected to acid wash 
reveals a change in fluorescence distribution from the acid stripped control in figure 5.7b. 
The fluorescence intensity of the cells is shifted towards the upper right quadrant. 
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Figure 5.5 
Fluorescence histograms for IOB8 endocytosis in RPMI 8866 cells incubated with IOB8 
antibody to CD23 and CR3/43-FITC antibody to HLA DR. IOB8 is labelled with anti- 
mouse IgG covalently bound to R-phycoerythrin. 
a. Red histogram shows surface labelling of IOB8 antibody followed by IgG Fab-R- 
PE. The same sample was also incubated with CR3/43-FITC (histograms for FITC shown 
in Figure 5.6). Green histogram exhibits surface fluorescence removal of a sample labelled 
on the cell surface and acid-washed. Grey histogram is a negative control incubated with 
IgG Fab-FITC only, followed by CR3/43-FITC and shows lack of non-specific R-PE 
fluorescence labelling on the cell surface. 
b. Samples incubated at 370C for 3 hours. Grey histogram is a sample surface- 
labelled and acid washed (same as the green histogram in a). Red histogram shows total 
fluorescence after 3 hours. Green histogram shows internal fluorescence after incubation 
at 370C and acid stripping. 
C. Samples incubated at 370C for 6hours. Grey histogram is a sample surface-labelled 
and acid washed sample (same as the green histogram in a). Red histogram shows total 
fluorescence after 6 hours. Green histogram shows internal fluorescence after incubation 
at 370C and acid stripping. 
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Fluorescence histograms for CR3/43-FITC endocytosis in RPMI 8866 cells incubated with 
IOB8 antibody to CD23 and CR3/43-FITC antibody to BLA DR. Samples were first 
incubated with IOB8, followed by anti-mouse IgG Fab covalently bound to phycoerythrin 
and finally labelled with CR3/43-FITC. 
a. Red histogram shows surface labelling of CR3/43-FITC antibody. The same 
sample was also incubated with IOB8, and anti-mouse IgG Fab bound to R-PE 
(histograms for R-PE shown in Figure 5.5). Green histogram exhibits surface fluorescence 
removal of a sample labelled on the cell surface and acid-washed. Grey histogram is a 
negative control incubated with IOB8, IgG Fab-R-PE, followed by streptavidin-FITC and 
shows lack of non-specific FITC fluorescence labelling on the cell surface. 
b. Samples incubated at 370C for 3 hours. Grey histogram is a sample surface- 
labelled and acid washed (same as the green histogram in a). Red histogram shows total 
fluorescence after 3 hours. Green histogram shows internal fluorescence after incubation 
at 370C and acid stripping. 
C. Samples incubated at 370C for 6 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 6 hours. Green histogram shows internal fluorescence after 
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Dot plots of intensity of fluorescein versus R-phycoerythrin in RPMI 8866 cells incubated 
with IOB8, IgG Fab-R-PE followed by CR3/43-FITC. The dot plots are divided into four 
quadrants, which are defined by the surface labelled and acid washed controls. The lower 
left contains cells which are negative for both R-PE and FITC. The lower right quadrant 
shows events positive for FITC label, whereas the upper left displays cells labelled for R- 
PE only. Finally, the upper right quadrant exhibits cells positive for both fluorochromes. 
a. Distibution of a control sample labelled with both IOB8, IgG Fab-R-PE followed 
by CR3/43-FITC and kept in ice during all incubations. 
b. Distibution of a control sample labelled with both IOB8, IgG Fab-R-PE followed 
by CR3/43-FITC, kept in ice during all incubations and acid washed to remove surface 
fluorescence. 
C. A sample labelled for both fluorophores and incubated at 370C for 3 hours. It 
shows total internal and surface fluorescence. 
d. A sample labelled for both fluorophores, incubated at 370C for 3 hours and acid 
washed to remove surface fluorescence. It shows internal fluorescence only. 
e. A sample labelled for both fluorophores and incubated at 370C for 6 hours. It 
shows total internal and surface fluorescence. 
L-A sample labelled for both fluorophores, incubated at 370C for 6 hours and acid 
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indicating the tendency of all cells to display internal fluorescence for both antigens. 
Statistics calculated from these plots show that 39% of all cells are positive for both 
internal CD23 and HLA DR. In the lower right quadrant, reside 15% of all cells which 
register positive for internal HLA DR only. A negligible number of cells (0.08%) are 
included in the upper left quadrant and register positive for internal CD23 only. 
After 6 hours incubation at 370C (Figure 5.7f), 44% of cells register positive for 
intemalised CD23 and HLA DR, whereas 9% fall within the lower right quadrant 
indicating that they label positive for internal HLA DR. As in the sample incubated at 
370C, after 6 hours, a negligible percentage of cells are displayed in the upper left 
quadrant and are thus positive for internal CD23. 
The majority of cells therefore, intemalise both CD23 and HLA DR. HLA DR and 
CD23 are spatially associated on the cell surface of B lymphocytes. An antibody which 
causes endocytosis of HLA DR would crosslink its ligand on the cell surface. As HLA DR 
is crosslinked and internalised, it may therefore sequester intracellularly its cell membrane 
associate. 
A smaller percentage (15 & 9%) of cells show internal label for HLA DR only. 
The two antigens are indeed spatially associated on the B cell surface, however, each 
antigen is also found on its own on the cell periphery (Bonnefoy et al., 1988). It is thus 
possible that in a fraction of the cell population the R-PE-conjugated CD23-IOB8 
complex may inhibit binding of CR3/43 antibody in those areas where HLA DR and CD23 
exist together. Although the fluorescence labels for each protein would then be localised 
separately on the cell surface, the cells would fluoresce positive for both. Antibody 
CR3/43 would thus intemalise HLA DR membrane clusters free of CD23 and, following 
surface fluorescence quenching, the cells would register positive for internal HLA DR 
only. 
5.2.4 Recycling of HLA DR? 
HLA DR plays a major role in antigen presentation in B lymphocytes. As antibody 
CR3/43 induces endocytosis of HLA DR, it is here examined if a portion of the molecules 
are recycled to the cell surface. Figure 5.8 shows the fluorescence distribution of CR3/43 
antibody on the surface of B cells after two incubation intervals at 370C. In samples left at 
40C during all incubations, cell surface fluorescence tends to resolve into two peaks, 
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differing in their mean fluorescence intensity. The cell surface distribution is changed after 
4 and 8 hours incubation at 370C. The total fluorescence intensity of cells detected above 
the threshold is reduced to 31% the original fluorescence after 4 hours incubation. The 
surface fluorescence intensity however is not further reduced at all (at 31 %) between 4 
and 8 hours incubation. This result constitutes a drastic halt in the loss of HLA DR from 
the cell surface after 4 hours incubation at 370C. It is conceivable that after 4 hours 
incubation, a fraction of the HLA DR molecules disappears due to CR3/43-induced 
endocytosis; the remaining fraction is probably lost during incubations through cell 
metabolism. The massive stabilisation in the number of labelled surface HLA DR 
molecules that occurs between 4 and 8 hours at 370C could not possibly be attributed to a 
halt in the metabolic process. It is however possible that this stabilisation of surface HLA 
DR is due to recycling of the endocytosed HLA DR antigens back to the cell membrane. 
The median fluorescence intensities of the two peaks, comprising the remaining 
surface fluorescence of both 4 hour and 8 hour samples, were examined to assess if either 
of the two cell populations display an increase in fluorescence intensity. Total cell 
population MI exhibits no significant reduction of total fluorescence intensity of the 
original total fluorescence after 4 and 8 hours. Population M2 includes 67% of the total 
detectable cells. Its median fluorescence intensity drops by 8.6% between 4 and 8 hours. 
On the other hand, population M3 which has 32% of detectable cells and registers as the 
one fluoresceing with higher intensity, exhibits an increase in 4.4% in surface fluorescence 
intensity between 4 and 8 hours. As in previous flow cytometry experiments, these 
statistics were calculated from the mean of two experiments, both values of which were 
within I% of each other in this case. 
These results, namely the stabilisation of the fluorescence intensity between -4 and 
8 hours at 370C as well as the small increase in fluorescent intensity of population M3 
during the same timeinterval, imply that HLA DR is recycled back to the surface of B 
lymphocytes. The relatively small recovery of BLA DR surface labelling could be due to 
the dissociation of some CR3/43 from the endocytosed HLA DR, once the complex is 
delivered into an endosomal compartment and exposed to acidic and/or proteolytic 
conditions. The HLA DR may therefore recycle on the cell surface on its own. Without 
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Figure 5.8 
Fluorescence histograms for CR3/43-FITC endocytosis and recycling on the cell surface. 
RPM1 8866 cells were incubated with CR3/43 antibody to HLA DR and incubated at 
370C for 0,4, and 8 hours. After all incubations, the cell surface-associated CR3/43 was 
labelled with anti-mouse IgG Fab-FITC. 
Grey histogram is a negative control to which no CR3/43 was added. It was incubated 
with IgG Fab-FITC to establish the threshold for non-specific surface fluorescence. 
a. Red histogram: a sample labelled with CR3/43 and kept in ice during all 
incubations. 
b. Red histogram: a sample labelled with CR3/43 and incubated at 370C for 4 hours. 
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its label, the protein cannot be recognised by the fluoresceinated secondary antibody Fab 
fragment. It is not possible to relabel the surface HLA DR sites after the incubation with 
CR3/43, since the antibody cannot distinguish between membrane antigen that lost its label 
and antigen that was synthesized and transported to the cell surface during the 
incubations. 
Similar reappearance experiments to examine CR3/43-induced recycling of CD23 
to the cell surface were inconclusive. CD23 was engaged with EBVCS 1, followed by IgG 
Fab fragment bound to biotin. The cells were then treated with CR3/43 antibody to HLA 
DR and incubated at 370C for 4 and 8 hours. Surface CD23 was detected after 
incubations at 370C by labelling with streptavidin-FITC. In the case of CD23 two more 
complications could have contributed to the lack of success. One is the constant loss of 
surface binding sites due to membrane CD23 proteolysis. This is a strong possibility since 
it is suspected that induction of CD23 endocytosis by antibodies may require proteolysis 
of the membrane receptor (for discussion see Chapter 3). It is thus a possibility that 
CR3/43 may have a similar effect to some anti-CD23 monoclonal antibodies in causing 
conformational changes to membrane-bound CD23 which induce its proteolysis and the 
release of soluble CD23 fragments. Another complication is the need to label CD23 with 
EBVCS1 monoclonal antibody and then with a biotinylated mouse polyclonal Fab 
antibody fragment, in order to distinguish between EBVCS I and CR3/43, both of which 
are antibodies produced in mouse. As discussed previously, a polyclonal antibody is likely 
to be more susceptible to dissociation than a monoclonal in the conditions of an 
endosornal. vesicle. Flow cytometry is thus of limited value in quantitating receptor 
recycling. 
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5.3 CONFOCAL MICROSCOPY 
5.3.1 CD23 Endocytosis Through HLA DR 
Confocal. microscopy was employed to confirm that CR. 3/43 antibody to HLA DR 
causes endocytosis of CD23. Samples were labelled with EBVCS I followed by a 
fluoresceinated secondary Fab fragment and incubated with CR, 3/43 prior to incubations 
of 0,2,4 and 6 hours at 370C. Figure 5.9 shows surface fluorescence distribution of 
EBVCS I antibody to CD23 in a sample kept at 40C during all incubations. Fluorescence 
is distributed in patches around the cell periphery and capping has hardly begun to take 
place. Figure 5.10 shows cells incubated at 370C for 2 hours, and strong capping of CD23 
and intracellular accumulation of the fluorescent label has occured. As previously 
demonstrated, non-stimulatory antibodies like EBVCSI are not efficient in inducing 
capping or internalisation of CD23 (Chapter 3). The capping observed here should 
therefore be due to CR3/43 crosslinking of HLA DR. 
After 4 hours at 370C, cells exhibit strong intracellular accumulation of CD23 and 
loss of capping on the cell surface (Figure 5.11). Internal fluorescence is distributed in 
bright bodies tracing a route from the plasma membrane, in the peripheral cytoplasmic 
area, extending further intracellularly and back towards to peripheral cytoplasic area. The 
route shown in figure 5.11 may suggest endocytosis and recycling of CD23 towards the 
cell membrane. However, such a proposal concerning the return of the endocYtosed 
protein to the surface cannot be confirmed from these results. 
After 6 hours at 37oC fluorescence intensity of the cell surface seems relatively 
unaltered, whereas intracellular fluorescence accumulation is harder to find (Figure 5.12). 
In addition, appearance of cytoplasmic fluorescence of decreased intensity is rarely 
observed at this incubation time. This is in contrast to observations made in samples 
treated with antibodies BU38 and MHM6 and incubated for 6 hours at 370C (see 
Chapters 3 and 4). Surface fluorescence is distributed in patches around the circumference 
of the cells. These observations agree with the proposal that CR3/43 antibody may not 
only induce CD23 endocytosis, but may also cause its recycling back to the cell surface. 
A negative control labelled with EBVCS1-FITC complex but not incubated with 
CR3/43 antibody shows few signs of capping and no endocytosis of CD23. One such 
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Figure 5.9 
Confocal optical section displaying CD23 labelling on the cell surface of RPMI 8866 cells. 
Samples were incubated with EBVCS I followed by fluoresceinated goat anti-mouse Ita,, G 
Fab and CR3/43 antibody to HLA DR. They were kept in ice during all incubations. 




Confocal, optical section displaying the effect of CR3/43 antibody in CD23 capping and 
endocytosis. RPMI 8866 cells were incubated with EBVCS1 followed by fluoresceinated 
anti-mouse IgG Fab and CR3/43 antibody to HLA DR. They were incubated at 370C for 




Confocal optical section displaying the effect of CR3/43 antibody in CD23 endocytosis. 
RPMI 8866 cells were incubated with EBVCSI followed by fluoresceinated anti-mouse 
IgG Fab and CR3/43 antibody to HLA DR. They were incubated at 370C for 4 hours. 




Confocal optical section displaying the effect of CR3/43 antibody in CD23 intracellular 
destination. RPMI 8866 cells were incubated with EBVCS I followed by fluoresceinated 
anti-mouse IgG Fab and CR3/43 antibody to HLA DR. They were incubated at 370C for 




A control optical section showing lack of CD23 endocytosis without incubation with 
CR3/43 antibody. RPMI 8866 cells were incubated with EBVCSI followed by 
fluoresceinated anti-mouse IgG Fab. They were incubated at 370C for 4 hours. Optical 




Confocal optical section of a control sample displaying lack of non-specific binding of 
IgG-Fab-FITC on the cell surface of RPMI 8866 cells. Samples were incubated with 
fluoresceinated anti-mouse IgG Fab, followed by CR3/43 antibody to HLA DR. They 





sample is shown in figure 5.13. Although the sample was incubated at 370C for 4 hours, it 
shows no endocytosis and only weak signs of the beginning of capping. These results are 
in line with previous observations that EBVCS I antibody does not enhance endocytosis of 
CD23 (Chapter 3). It is thus concluded that CR3/43 is the cause of CD23 internalisation. 
A second negative control shows the absence of non-specific labelling of IgG Fab- 
FITC on the plasma membrane (Figure 5.14). The cells were not incubated with EBVCS I 
but were treated with IgG Fab conjugated to FITC, followed by CR3/43 antibody to HLA 
DR. They were kept in ice while other samples were incubated at 370C. 
It is thus visually confirmed that CR3/43 antibody to HLA DR causes CD23 
accumulation on one side of the cell membrane, in a capping-like manner. Endocytosis of 
CD23 progresses between 2 and 4 hours at 370C. Confocal images show fluorescent 
labelling distributed in areas close to the membrane and further from the surface. These 
fluorescent signals seem to label a sequence of endocytosis and recycling of the protein 
back to the cell surface (Figure 5.10). Fluorescence is not accumulated intracellularly, as 
seen for antibody-induced endocytosis after 6 hours at 370C. It is mostly found on the cell 
surface in distinct patches which show no signs of capping (Figure 5.11). It thus seems 
that CR3/43 antibody takes CD23 along an intracellular route distinct from that directed 
by stimulatory antibodies. As shown in Chapter 3, antibodies which enhance CD23 
endocytosis seem to cause intracellular accumulation of CD23-associated fluorescence. In 
contrast, CR3/43 causes endocytosis of CD23 but little fluorescence accumulation inside 
the cell after 6 hours at 370C, suggesting that, following endocytosis, the protein may be 
returned to the cell surface. 
5.3.2 Co-localisation of CD23 and HLA DR 
Three-colour confocal images allow co-localisation of CD23 and HLA DR on the 
surface and intracellularly. CD23 was labelled with EBVCS I antibody to the stalk region 
followed by IgG covalently bound to Cy5. Samples were then labelled with 
fluoresceinated CR3/43 antibody to HLA DR. The dye DiBAC4(5) stains the cytoplasm 
and the cell membrane to give an estimate of the intracellular location of both proteins. 
Figure 5.15 shows a sample kept at 40C during all incubations. CD23 and HLA 
DR are located together in distinct patches on the cell periphery. In some cell surface areas 
245 
the label for HLA DR is seen without the presence of CD23. This may be due to the 
higher expression of HLA DR antigens on the cell surface. Furthermore, HLA DR 
antigens exist on their own and are not always associated with CD23 on the cell 
membrane (Bonnefoy et al., 1988). Another possibility is that EBVCS1 antibody to the 
stalk region does not recognise all CD23 epitopes, and does not always show a uniform 
distribution on the cell surface when labelled (author's own observations). It is thus 
possible that it does not bind to some CD23-positive cell membrane areas. 
After 2 hours at 370C both antigens are accumulated in capped areas on the cell 
periphery. Endocytosis of both is seen in cytoplasmic indentations (Figure 5.16). These 
results confirm that the presence of CD23 in capped regions is due to CR3/43 antibody 
crosslinking of HLA DR. As CD23 is associated with HLA DR, it is also anchored into 
the capped region. Both antigens are thus endocytosed together, as a result of their cell 
surface non-covalent spatial association. 
In figure 5.17, showing a sample incubated at 370C for 4 hours, there is 
intracellular distribution of both antigens in distinct cytoplasmic areas. Both antigens seem 
to follow the same cytoplasmic route. Both fluorophores label the same defined 
cytoplasmic bodies from the cell periphery to the cytoplasmic area close to the nucleus and 
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back to the cell periphery. Capping on the cell surface is considerably less pronounced as 
endocytosis of both antigens progresses. The intracellular presence of HLA DR without 
CD23 is also seen on a smaller scale. However, cytoplasmic areas labelling positive for 
intracellular CD23 always contain fluoresceinated CR3/43 antibody to HLA DR. These 
findings agree with previous observations that a few cell surface areas show the presence 
of HLA DR without CD23. Antibody CR3/43 could initiate its intemalisation and it would 
thus be shown intracellularly on its own. On the other hand, EBVCS I does not enhance 
CD23 endocytosis, so CD23 would not be expected to internalise on its own (Chapter 3, 
section 3.2; figure 3.7). CD23 is therefore located intracellularly as a consequence of its 
non-covalent interaction with HLA DR. 
After 6 hours at 370C, intracellular localisation of both labels for CD23 and HLA 
DR is clearly less evident (Figure 5.18). Surface fluorescence is observed in patches 
showing the labels for both antigens. In some cells, a small trace of the Cy5 label for 
246 
Figure 5.15 
A 3-colour confocal optical section displaying CD23 and HLA DR labelling on the cell 
surface of RPMI 8866 cells. Samples were incubated with EBVCSI, IgG-Cy5, followed 
by CR3/43-FITC. They were kept in ice during all incubations. DiBAC4(5) was used to 
label all cytoplasn-tic membranes. Optical section thickness: -I gm. 
a. CR3/43-FITC (green) and EBVCS I -IgG-Cy5 (white). 
b. CR3/43-FITC (green) and DiBAC4(5) (red). 








A 3-colour confocal optical section displaying CD23 and HLA DR capping and 
endocytosis in RPMI 8866 cells. Samples were incubated with EBVCS 1, IgG-Cy5, 
followed by CR3/43-FITC. They were incubated at 370C for 2 hours. DiBAC4(5) was 
used to label all cytoplasmic membranes. Optical section thickness: -I Rm. 
a. CR3/43-FITC (green) and EBVCS I -IgG-Cy5 (white). 
b. CR3/43-FITC (green) and DiBAC4(5) (red). 








A 3-colour confocal optical section displaying CD23 and HLA DR endocytosis in RPMl 
8866 cells. Samples were incubated with EBVCS 1, IgG-Cy5, followed by CR3/43-FITC. 
They were incubated at 370C for 4 hours. DiBAC4(5) was used to label all cytoplasmic 
membranes. Optical section thickness: -1 ýtm. 
a. CR3/43-FITC (green) and EBVCS I -IgG-Cy5 (white). 
b. CR3/43-FITC (green) and DiBAC4(5) (red). 







A 3-colour confocal optical section displaying internal CD23 and HLA DR labels in RPMI 
8866 cells. Samples were incubated with EBVCS1, IgG-Cy5, followed by CR3/43-FITC. 
They were incubated at 370C for 6 hours. DiBAC4(5) was used to label all cytoplasmic 
membranes. Optical section thickness: -I gm. 
a. CR3/43-FITC (green) and EBVCS I -IgG-Cy5 (white). 
b. CR3/43-FITC (green) and DiBAC4(5) (red). 







A 3-colour confocal optical section of a negative control displaying lack of non-specific 
labelling of secondary antibody IgG-Cy5 in RPMI 8866 cells. Samples were incubated 
with IgG-Cy5, followed by fluoresceinated CR3/43-FITC. They were kept at 40C during 
all incubations. Optical section thickness: -Igm. DiBAC4(5) was used to label all 
cytoplasmic membranes. 
a. CR3/43-FITC (green) and EBVCS I -IgG-Cy5 (white). 
b. CR3/43-FITC (green) and DiBAC4(5) (red). 






CD23 is left intracellularly but there seems to be no cytoplasmic accumulation of either 
fluorophore. These findings could be explained in terms of the hypothesis that in an in vivo 
system, CD23 is sequestered inside the cell along with HLA DR and the complex 
delivered to an endosomal compartment where peptide loading would take place. Upon 
peptide loading, the CD23-HLA DR complex is recycled together on the cell surface. The 
trace of fluorescent label for CD23 would occur from partial dissociation of the Cy5- 
linked IgG from CD23-conjugated EBVCS1 in the endosomal compartment where the 
complex is delivered. As discussed above, the fluoresceinated monoclonal antibody 
binding to HLA DR would have been harder to dissociate, and thus only a negligible trace 
of HLA DR label would be left behind. 
In a control experiment shown in figure 5.19, cells were not treated with EBVCS I 
antibody to CD23 but were incubated with IgG-Cy5 followed by CR3/43-FITC antibody 
to HLA DR. They were kept in ice while other samples were incubated at 370C. The 
negative control demonstrates lack of non-specific binding of lgG-Cy5 on the cell surface. 
5.3.3 CD23 and Cell Adhesion 
In the above confocal images it is also observed that cells show a strong tendency 
to adhere to each other and grow in clumps upon addition of CR3/43 (Figure 5.10). CD23 
is concentrated at the sites of contact between these cells. RPMI 8866 cells do indeed 
grow in contact with each other. However, CR3/43 antibody dramatically enhances this 
tendency. This observation is not unique for CR3/43 antibody. A previous study shows 
that antibody BU27 to MHC Class 11 antigens causes cell clustering (Flores-Romo et al., 
1990, figure 1.9). CD23 and MHC Class 11 were localised together at the point of contact 
of the cell aggregates (Figure 1.9). Indeed, CD23 has been previously ascribed a role as an 
adhesion molecule (Kikutani et al., 1989; Shields et al., 1992; Moulder, Barton & 
Weston, 1993). Its co-localisation with HLA DR at the points of contact between cells, 
along with the finding that monoclonal antibodies to CD23 and IgE block alloantigen 
presentation, suggest that its adhesion properties may facilitate antigen presentation 
(Flores-Romo et al., 1990). 
A new dimension for the understanding of the contribution of CD23 in cell 
adhesion emerges from the finding that spontaneous release of the 37 kD soluble fragment 
precedes homotypic cell contact (Moulder, Barton & Weston, 1993). However, the role of 
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the soluble fragment was not confirmed; on the contrary, the authors suggest that the Z: ) 
remaining membrane portion of CD23, rather than the soluble portion, promotes cell 
contact. 
5.3.4 Endocytosis and Proteolysis to Yield Soluble CD23 
More light was shed on the meaning of the association between CD23 and HLA 
DR, by iodination and immunoprecipitation experiments (Murdock et al., manuscript in 
preparation). Cell surface proteins were iodinated, then treated with CR3/43 antibody to 
HLA DR and allowed to incubate for 18 hours at 370C. Following this incubation, 
immunoprecipitation and polyacrylamide gel electrophoresis experiments showed that 
antibody CR3/43 inhibits the production of intracellular 16 kD CD23 fragment. As 
discussed earlier, the 16 kD proteolytic fragment is constitutively accumulated inside the 
cell, and the rate of its formation is enhanced by antibodies to CD23 (Grenier-Brossette et 
al., 1992). The immunoprecipitation and PAGE results show that the inhibition of the 16 
kD fragment formation is accompanied by an increase in extracellular 37 and 33 kD 
soluble CD23 (Figure 5.20a). Following their release, the soluble CD23 forms are 
associated with the cell surface membrane in a non-covalent manner (Figure 5.20b). Since 
CR3/43 is also shown to enhance endocytosis of CD23, it thus proposed that this failure 
to produce the 16 kD fragment and the tendency to release soluble CD23, reflects a switch 
in the intracellular processing of CD23. These alternative intracellular routes may imply 
the existence of two ways in which CD23 can regulate IgE synthesis. Indeed, IgE 
synthesis is known to be up-regulated by the 37 and 33 kD soluble CD23 forms (Lew et 
al., 1986; Chretien et al., 1990) and inhibited by the 16 kD fragment (Sarfati et al., 1992). 
It is therefore possible that CR3/43 antibody to HLA DR may divert the fate of CD23 in 
such a way as to favour production of IgE. Stimulatory antibodies on the other hand may 
give the opposite signal to switch the CD23 intracellular pathway to inhibit IgE synthesis. 
In flow cytometric measurements and confocal images it is shown that CR3/43 
antibody to HLA DR induces capping and internalisation of CD23 within 4 hours at 370C. 
After incubation at 370C for 18 hours, CR3/43 inhibits intracellular accumulation of the 
16 kD fragment and increases the extracellular release of 37 and 33 kD soluble CD23 
fragments which bind non-covalently to the surface of B cells (Murdock et al., in press). 
Both the above findings suggest that after CR3/43 antibody treatment, CD23 
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Figure 5.20 
Immunoprecipitation and PAGE with autoradiography used to show alteration of 
proteolysis of cell-associated CD23 by CD3/43 antibody to HLA DR in RPMI 8866 cells 
(Murdock et al., manuscript in preparation) 
a. Control cells (A), cells treated with CR3/43 for 18 hours (B), control cells after 
acid washing (C) and cells treated with CR3/43 and subjected to acid washing (D). 
b. Control cells (A), control cells treated with chymotrypsin (B), cells treated with 
CR3/43 antibody for 18 hours (C) and cells incubated with CR3/43 for 18 hours at 370C, 
followed by chyrnotrypsin treatment (D). 
In 5.20a, acid washing removes, proteins that are non-covalently associated with the 
extracellular surface. CD23 of 45 kD (short thick arrow) and 16 kD (short thin arrow) are 
precipitated from control cells (A). Treatment with CR3/43 antibody to HLA DR is 
associated with the 37 and 33 kD (long thick-end arrows) CD23 species (B). Acid 
washing of control cells did not remove the 45 kD (short thick arrow) and 16 kD (short 
thin arrow) species (C). However, acid washing of cells treated with CR3/43 antibody 
removed the cell-associated 37 and 33 kD CD23 forms (D), indicating that these species 
are non-covalently associated with the extracellular surface. 
In 5.20b, chymotrypsin treatment is used to cleave all cell surface proteins. CD23 of 45 
kD (short thick arrow) and 16 kD (short thin arrow) are precipitated from control cells 
(A). Chymotrypsin treatment of control cells shows that the 45 kD species is accessible to 
protease and thus a cell surface protein, whereas the 16 kD fragment (short thin arrow) is 
not. In cells treated with CR3/43 antibody to HLA DR, the 45 kD (short thick arrow) and 
the 37 and 33 kD (long-thick-end arrows) CD23 forms in C, disappear after treatment 
with exogenous protease (chymotrypsin) in lane D. These results indicate that the 37 and 
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endocytosed with HLA DR is not cleaved intracellularly to a 16 kD fragment. Both CD23 
and HLA DR may be recycled back to the cell surface together. 
An alternative possibility is that, CD23 may be cleaved to a 37 k-D soluble 
fragment intracellularly and exocytosed into the medium in the same pathway that returns 
HLA DR back to the cell surface. It is thus possible that in this alternative intracellular 
path, CD23 and HLA DR are delivered to a special endosomal compartment which lacks 
the necessary proteases to produce the 16 kD fragment but contains others which promote 
formation of the 37 and 33 kD forms. CD23 recycling may also explain the lack of 
intracellular iodinated CD23 after 18 hours incubation at 370C and the absence of 
progressively decreased cytoplasmic fluorescence for the CD23 label after 6 hours at 
370C (Murdock et al., manuscript in preparation). 
The above results lead to a proposed hypothesis for this alternative fate of CD23. 
In vivo, when enhancement of IgE production is required, IgE-antigen-carrying CD23 
may be co-endocytosed with BLA DR and delivered from a conventional endosomal 
compartment into a specialised compartment for antigen processing (CPL, compartment 
for peptide loading or MIIC, MHC Class 11 compartment). Such a compartment has 
recently been identified to be biochemically distinct from other endosomal and lysosomal 
bodies in its morphology and protease content (Amigorena et al., 1994; Tulp et al., 1994; 
West, Lucocq & Watts, 1994). The existence of such a specialised vesicle may explain the 
switch in proteolysis of CD23 into a 37 kD fragment upon internalisation induced by 
CR3/43 antibody to HLA DR. In contrast, stimulatory antibodies may route CD23 
through the conventional endosomal pathway where the proteases present would favour 
its proteolysis into a 16 kD fragment. Antigen is dissociated in a MIIC and an antigenic 
peptide loaded on HLA DR. However, in vivo, as newly formed HLA DR antigens are 
transferred from the Golgi directly to a MIIC for antigen processing before first appearing 
on the cell surface, the majority of HLA DR binding sites on the cell surface would be 
occupied with various antigenic peptides. Therefore, HLA DR which is endocytosed from 
the cell membrane would already have its binding site occupied with an antigenic peptide. 
Previous studies however, have shown that not only newly synthesized HLA DR proteins 
are available for peptide loading, but also a mechanism for peptide exchange is in 
operation during the intracytoplasmic recycling of these antigen-presenting molecules 
(Harding, Roof & Unanue, 1989; Adorini et al., 1989; Adorini & Nagy, 1990). Peptide 
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unloading and reloading occurs in an endosomal compartment concentrated with new 
antigenic pepticles where the equilibrium is shifted to favour loading of new peptides 
against the outnumbered old (Adorini et al., 1989). 
The HLA DR loaded with a new antigenic peptide along with the 37 kD CD23 
fragment could then be returned to the cell surface. The CD23 fragment may then be 
associated non-covalently with the cell membrane, perhaps to provide stimulatory signals 
for further IgE-antigen processing and presentation. The remaining membrane portion of 
CD23 may stay associated with HLA DR and could play a role in promoting cell adhesion 
to facilitate antigen presentation (Moulder, Barton & Weston, 1993). 
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5.4 ELECTRON MICROSCOPY 
Figure 5.21 shows labelling of membrane CD23 with monoclonal antibody IOB8 
and IgG-5nm gold on RPMI 8866 cells. The sample was then incubated with CR3/43 
antibody to HLA DR and kept in ice during all incubations. As antibody IOB8 is linked to 
5nm gold, the presence of the gold indicates the position of CD23 on the cell membrane. 
Figures 5.21 to 5.24 therefore show the effect of CR3/43 antibody on the movement of 
CD23 across the cell membrane. Indeed, the effect of crosslinking of membrane CD23 is 
apparent, even in a sample kept in ice (Figure 5.21). The gold is observed in clusters 
across the plasma membrane, illustrating capping of CD23 (Figure 5.2 1 a, 5.2 1b&5.2 1 c, 
thin arrows). Although seen in confocal images, this is the first time in the present study 
that capping is clearly visible in electron micrographs. Although the limitations of 
conjugating CD23 with gold-bound antibodies apply, as described in Chapters 3 and 4, it 
is apparent that antibody CR3/43 has a profound effect in inducing crosslinking and 
capping of its ligand. As CD23 is non-covalently linked with BLA DR antigens on the cell 
surface, clusters of gold-conjugated CD23 are frequently encountered. This implies, as 
deduced from the confocal images, that CD23 is anchored in capped areas through its 
association with HLA DR. 
However, in these electron micrographs capping of an entire side of a cell is not 
observed to the extent shown in the confocal images. A major contributing factor is the 
fact that sections for electron microscopical observations are 20-fold smaller in thickness 
than a typical confocal optical section, and therefore contains fewer labelled molecules per 
section. Furthermore, a confocal optical section emits a fluorescent signal which offers less 
detail about the location of the fluorescing molecules in question. On the contrary, gold 
particles can be observed and counted individually on the cell section, revealing the 
location of each labelled molecule. 
Incubation with antibody CR3/43 also causes cell adhesion to a degree higher than 
that so far observed with anti-CD23 antibodies. Clusters of 5nm gold are also 
concentrated in the membrane areas of contact between cells (Figure 5.21c, thick arrow). 
This suggests a possible role of membrane CD23 in cell adhesion. 
The sample in figure 5.21 was kept in ice during all incubations. However, as 
observed in previous electron microscopy experiments, cytoplasmic vesicles located in the 
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area close to the cell periphery appear to contain 5nm gold particles attached to their inner 
membrane (Figure 5.21b, thick arrows). As discussed in previous chapters, the presence of 
gold in plasmalemmal pits may indicate the initiation of antibody-induced endocytosis. 
Alternatively, these vesicles may still be connected with the plasma membrane. The 5nm 
gold-rich pits (Figure 5.21b, thick arrows) are mostly located opposite to membrane areas 
rich in gold clusters. Whether or not they represent cytoplasmic indentations connected to 
capped cell surface regions or independent vesicles detached from the cell membrane, 
these gold-rich areas may indicate the beginning of endocytosis originating from 
membrane areas where surface antigen crosslinking and capping take place. 
In figure 5.22 samples treated with IOB8, anti-mouse IgG-5nm gold, followed by 
CR3/43 antibody to HLA DR, were incubated for 3.5 hours at 370C. Gold of 5nm 
labelling CD23 is found in cytoplasmic pits both in the area close to the cell membrane as 
well as further into the cytoplasm (Figure 5.22a, thick arrows). Budding of a gold- 
containing membrane area and formation of a plasmalernmal pit is observed in Figure 
5.22b (thin arrows). The endocytosed gold in all observed cells is sharp in appearance, 
indicating that it has not been processed in an acidic and/or proteolytic endosomal 
environment. The structure of the gold-containing cytoplasmic bodies ranges from those 
which appear as plasmalemmal pits (Figure 5.22c, open arrow) to other more structured 
bodies, perhaps primary endosomal compartments (Figure 5.22b, thick arrow). In some 
plasmalemmal pits (Figure 5.22c, open arrow) which bear gold associated with their inner 
membrane (Figure 5.22c thin arrows), the gold-containing inner membrane appears to 
detach itself from the remaining structure, and bud from the plasmalemmal pit (Figure 
5.22c, thick arrow). Such budding vesicles may be responsible for delivering CD23 to 
cytoplasmic bodies which belong to the endosornal network (Figure 5.22b, thick arrow). 
In most of these cytoplasmic vesicles, 5nm gold is still attached to the inner membrane of 
the vesicle, indicating that it labels internalised CD23 still anchored by its membrane 
association (Figure 5.22c, thin arrows). 
Figure 5.23 confirms that endocytosis of CD23 is the result of sequestering the 
membrane protein through CR3/43 antibody-induced endocytosis of HLA DR. Binding of 
1OB8-5nm gold complexes is illustrated in cells which were not treated with anti-HLA DR 
antibody and incubated for 3.5 hours at 370C. Cells do not exhibit appreciable clustering 
of 5nm gold on their surface (thin arrows). Gold is observed scattered on the cell 
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membrane in small groups, as previously observed for cells labelled with anti-CD23 
monoclonal antibodies. Endocytosis of CD23 was not seen in this sample. Some gold was 
observed in small cytoplasmic pits very close to the cell membrane (Figure 5.23b, thick 
arow). The cytoplasmic gold may represent a small degree of endocytosis or the gold-rich 
vesicle may be a short extension of the plasma membrane. The lack of extensive 
endocytosis of CD23 is in line with previous experiments showing that antibody IOB8 
does not enhance the rate of CD23 internalisation (Chapter 3, figure 3.1). 
After 10 hours at 370C, gold particles are delivered into structured vesicles 
located in the cytoplasmic area close to the nucleus (Figure 5.24a, thin arrows). The 
sections were labelled with uranyl acetate for 10 minutes but no lead citrate was used to 
label membranes since aggregated gold particles are not sharp in appearance and therefore 
harder to distinguish once in the membranous structure of endosomal vesicles. Indeed, 
gold particles are detached from the inner membrane of vesicles and form aggregates 
(Figure 5.24b, long thick-end arrows), indicating that the CD23, associated with HLA 
DR, has encountered acidic and proteolytic conditions in its intracellular journey. Gold- 
containing cytoplasmic bodies appear to be similar to those observed in previous 
experiments, with multilarnmenal and multivesicular structures (Figure 5.24b, short thin 
arrows), indicating that they constitute components of the endosomal network. 
It is therefore clear that HLA DR antibody CR3/43 causes endocytosis of CD23 
and delivery to a compartment of the endosomal pathway. It is to be expected that 5nm 
gold-conjugated IgG separates from IOB8 and CD23 once the membrane-associated 
complex reaches acidic and proteolytic conditions. The fate of internalised CD23 cannot 
therefore be followed beyond the late endosornes, once the gold label has become 
detached. 
To further observe the structure of the cytoplasmic vesicles involved in processing 
of the label for CD23, cell sections were labelled with uranyl acetate for 10 minutes, 
followed by treatment with lead citrate for 5 minutes and observed under the electron 
microscope (Figure 5.25). As previously discussed, in sections labelled with lead citrate 
the aggregated gold is even less sharp in appearance than in unlabelled ones (Chapter 4, 
section 4.4). Treatment with lead citrate is however, used here to obtain more information 
on the appearance of the cytoplasmic bodies involved in endocytosis of 
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Figure 5.21 
Electron micrographs of RPMI 8866 cells kept at 40C during incubations. CD23 was 
labelled with IOB8 antibody, followed by IgG Fab conjugated to 5nm gold. HLA DR was 
incubated with CR3/43 antibody. Cell surface distribution of 5 nm gold particles at time 0. 
C: Cytoplasm, N: Nucleus, PM: Plasma Membrane. 
a. A section of a whole cell showing gold distribution on the cell surface (thin 
arrows). Magnification: 14,840x, Igm=14.84mm. Scale bar: LOgm. 
b. Portion of the cell section in a showing 5nm gold clustering on the cell membrane 
(thin arrows) and in plasmalemmal pits (thick arrows) adjacent to the gold-rich membrane 
areas. Magnification: 27,830x, Igm--27.83mm. Scale bar: I. Ogm. 
C. Portion of two cells, featuring gold clusters on the surface (thin arrows) and in the 
points of cell-cell contact (thick arrow). Magnification: 37,100x, 1Rm=37.10mm. Scale 
bar: L%tm. 
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Electron micrographs of RPMI 8966 cells labelled with IOB8, IgG Fab-5nm gold and 
CR3/43. The sample was incubated at 370C for 3.5 hours. Gold of 5 nm is accumulated 
within cytoplasmic vesicles located in the area close to the plasma membrane. C: 
Cytoplasm, N: Nucleus, PM: Plasma Membrane. 
a. Part of a cell section showing gold associated with cytoplasmic vesicles (thick 
arrows). Magnification: 56,520x, Igm=56-52mm. Scale bar: 0.5gm. 
b. Detail from the cell section in a showing 5nm gold contained in a multivesicular 
body (thick arrow). Gold is also contained in an invagination from the cell membrane 
towards the cytoplasm (thin arrows). Magnification: 76,520x, IýLrn--76.52mm. Scale bar: 
0.5gm. 
C. Portion of a cell, featuring a gold-rich vesicle (thick arrow) budding from a 
plasmalernmal pit (open arrow). Gold is associated with the inner membrane of the 











Electron micrograph of a control sample of RPM1 8866 cells labelled with IOB8, IgG Fab 
conjugated to 5nm. gold only, without incubation with CR3/43. It was then incubated at 
370C for 3.5 hours. It shows gold binding on the cell surface. C: Cytoplasm, N: Nucleus, 
PM: Plasma Membrane. 
a. Part of a cell section showing gold scattered on the cell surface (thin arrows). 
Magnification: 58,260x, Igm=58.26mm. Scale bar: 0.5ýtm. 
b. Portion of a cell section showing the presence of cell surface gold (thin arrows) but 
no gold clustering on the cell membrane and no endocytosis. A small plasmalemmal pit is 
shown in the cytoplasmic area immediately opposite to the plasma membrane (thick 
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Electron micrographs of RPMI 8866 cells labelled with IOB8, IgG Fab-5nm gold and 
CR3/43. The sample was incubated at 370C for 10 hours. The cell section was not 
labelled with either uranyl Acetate or lead citrate. Gold is accumulated within 
multivesicular cytoplasmic bodies located in groups. Most of the gold is concentrated in 
large aggregates (long thick-end arrows). C: Cytoplasm, N: Nucleus, PM: Plasma 
Membrane. 
a. Part of a cell section showing gold, mostly in aggregates, associated within a 
group of cytoplasmic vesicles (thin arrows). Magnification: 37,680x, Iýtm=37.68rnm. 
Scale bar: 0.5ýLrn. 
b. A closer look at these vesicles from a shows 5nm gold aggregates (long thick-end 
arrows) contained in multivesicular bodies of various structures (short thin arrows). 
















Electron micrographs of RPMI 8866 cells showing cytoplasmic organelles bearing gold 
aggregates. Sections were labelled with uranyl acetate and lead citrate to highlight the 
unique structural features of these vesicles. C: Cytoplasm. 
a. The coiled-rope motif of the vesicle is seen clearly (long thick arrow). Gold is seen 
in aggregates (short thin arrow). Individual gold particles are also shown within the rope- 
like motif (short thin arrow). A neighbouring vesicle (open arrow) does not have the same 
features but also contains gold (short thin arrow). Magnification: 78,270x, 
1ýtm-_78.27mm- Scale bar: 0.5[Lm. 
b. Three gold-containing vesicles feature similar coiled-rope motifs (long thick 
arrows). Gold is shown by short thin arrows. The adjacent endosomal body (open arrow) 





Electron micrographs of ultrathin cryosections of Raji cells showing the morphology of 
the compartment for peptide loading (CPQ or MIIC (Sanderson et al., 1994). 
a. MIIC compartment (star) is located in the cell cytoplasm and is rich in HLA DM cc 
chain protein (large gold) and class 11 molecules (small gold). The cell membrane is 
labelled with only class 11 molecules (small gold). 
b. Two MIIC (stars) compartments labelled for HLA DM P chain (large gold) and 
class 11 (small gold). 
C. Two MIIC (stars) compartments labelled with HLA DM a chain (large gold) are 
also labelled with the lysosomal protein LAMP- I (small gold). 








Electron micrograph of a control sample showing RPMI 8866 cells labelled with IgG 
conjugated to 5nm gold only, followed by CR3/43 and kept in ice during incubations. It 
shows the absence of non-specific polyclonal. antibody binding to CR3/43 on the cell 
surface. C: Cytoplasm, N: Nucleus, PM: Plasma Membrane. 
a. Part of a section showing no gold labelling on the cell membrane or intracellularly. 
Magnification: 33,000x, Igm--33.00mm. Scale bar: LOgm. 
b. Part of a section showing no gold labelling in the points of contact between cells 
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CD23. As discussed previously, it has been suggested that incubation with CR3/43 
antibody results in alteration of the intracellular path of CD23 (Murdock et al., manuscript 
in preparation; Figure 5.20). It would thus be interesting to observe the vesicles involved 
in the processing of its label. Figure 5.25 shows aggregated gold particles (thin arrows) 
found in multilamennal and multivesicular bodies (open arrows), identified as components 
of the endosomal network. However, gold (thin arrows) is also observed contained in a 
novel vesicle (long thick arrows) with structure distinct from the others observed so far in 
antibody-induced endocytosis experiments (Chapters 3 and 4). It features a multilayered 
membrane, resembling a coiled rope (Figure 5.25a & 5.25b, long thick arrows), and often 
a plain core inner structure best seen in figure 5.26c (Sanderson et al., 1994, indicated by 
a star). As previously suspected, the effect of anti-HLA DR antibody may be to cause a 
switch in the processing pathway of endocytosed CD23. This newly observed vesicle may 
be a component involved in such a switch. The gold accumulated inside these unique 
cytoplasmic bodies is aggregated and lacks the sharpness of membrane-bound gold in 
appearance (Figure 5.25a & 5.25b, vesicles indicated by long thick arrow, gold by small 
thin arrow). This lack of sharpness has, as previously shown, been observed for gold 
contained in vesicles belonging to the endosomal network and is the result of the loss of 
the protein coat surrounding each gold particle. This has been observed to occur in the 
acidic and proteolytic environments of endosomes and lysosomes (Pulczynski et al., 1994; 
Figure 4.20). The above observation, as well as the diffuse appearance of the gold 
contained in different compartments of the endosomal network imply that, under particular 
circumstances, these coiled multilayered structures belong to or intercept the endosomal 
degradative pathway of endocytosed proteins. 
I Indeed, recent studies have identified similar structures as compartments rich in 
MHC class-11 antigens, where antigenic peptide loading onto class 11 binding site takes 
place (Amigorena et al., 1994; Sanderson et al., 1994). These vesicles (MIIC 
compartments) have been identified as parts of the class 11 transport network and feature 
some characteristics of lysosomal compartments including expression of lysosomal 
enzymes. A study of Raji cells also reports HLA DM antigen expression in MHC 
compartments and lack of HLA DR which was mostly found on the cell surface (Figure 
5.26). Figure 5.26 outlines the typical features of an MIIIC vesicle. The coiled rope-like 
structural characteristic of the vesicle resembles the gold aggregate-containing body 
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observed in the present experiment in figure 5.24. Sanderson et al., (1994) employed post- 
embeddment labelling on ultrathin cryosections with 10 and 15 nm gold-conjugated 
antibodies to identify HLA DM antigen and LAMP-1 lysosornal marker in RaJi cells 
(Figure 5.26). Since post-embeddment labelling was employed, no gold aggregation was 
therefore observed. 
The above observations strongly imply that the intracellular route of CD23, which 
is induced by CR3/43 antibody to HLA DR, may intercept cytoplasmic compartments 
involved in antigenic peptide loading to HLA DR. In fact, the recent observation that HLA 
DR antigens are mostly found on the cell surface of Raji cells and the MIIC vesicles are 
rich in HLA DM, may suggest endocytosis and recycling to the cell surface of HLA DR 
antigens rather than a one-way route, starting with delivery of newly synthesized HLA DR 
to MIIC compartments, loading with antigen and transporting to the surface for antigen 
presentation (Schmid and Jackson, 1994). 
The observation that gold label for CD23 is accumulated in compartments 
suspected to be MI1Cs does not constitute proof that CD23 itself is delivered to these 
compartments. Indeed, gold in these vesicles is found in aggregated form (Figure 5.26, 
small thin arrows), suggesting that it is separated from 10138 and thus from CD23. It is 
possible that CD23 separates from its gold-bound label before its delivery to MHCs and 
the protein processed further for degradation in lysosomes or proteolysed into a soluble 
form and returned to the surface for release in the medium. Alternatively, CD23 and HLA 
DR may be delivered to MIICs together, where antigenic peptide loading onto HLA DR 
would occur. Peptide-carrying HLA DR and CD23, possibly cleaved into a soluble form, 
would then be transported to the cell surface. The latter possibility is supported by 
confocal microscopy images that show endocytosis and delivery of CD23 and HLA DR in 
the same cytoplasmic areas, implying that both antigens may stay together (see section 
5.3). Furthermore, minimum accumulation of the fluorescent labels for CD23 or HLA DR 
was shown after 6 hours at 370C, suggesting that both proteins may be transported back 
to the cell membrane (see section 5.3, figure 5.18). Indeed, recycling of CD23 and release 
of a 37 kD soluble CD23 fragment which binds non-covalently to the cell membrane were 
claimed by a recent immunoprecipitation study (Murdock et al., manuscript in 
preparation). 
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After peptide loading, the gold label would be delivered into endosomes and 
lysosomes - as would any remaining antigenic peptides - for further processing and 
degradation. In the present electron microscopy experiment, the 5nm gold label might be 
expected to be thus encountered across the entire endosomal network, as indeed it is. 
However, localisation of the gold label for CD23 in suspected M11IC compartments may 
implicate CD23 in antigen processing, and suggests that a switch in its intracellular 
pathway may indeed take place upon treatment with CR3/43 antibody. 
Finally, the possibility of any accidental cross-binding of CR3/43 antibody with 
IgG-5nm gold is excluded in a negative control experiment (Figure 5.27). Control samples 
were not treated with IOB8 antibody but were incubated with anti-mouse IgG-5nm gold, 
followed by anti-HLA DR antibody CR3/43 from mouse. Gold labelling is absent from the 
cell surface and from the cell cytoplasm (Figure 5.27a), as well as from the points of cell- 
cell contact (Figure 5.27b, arrow). This indicates that cell surface and endocytosed gold- 
conjugated antibody follows the intracellularjoumey of CD23 only. 
Future Studies 
In the above electron microscopy experiment the intracellular journey of CD23 
was followed up to the point of intercepting acidic and proteolytic conditions. In order to 
identify its destination, cryosectioning of RPMI 8866 cells may be attempted, followed by 
post-embeddment labelling with antibodies and appropriate IgG conjugted to gold. As 
discussed in previous chapters, post-embeddment labelling has been attempted without 
success. However, as performed in Raji cells by Sanderson et al., (1994) cryosectioning 
was successful in preserving antigenicity of HLA DR, HLA DM and LAMP-1. Although 
there'is no way of assessing whether CD23 could be labelled after embeddment in 
cryosections or that cryosectioning may be succcessful in preserving antigenicity in RPMI 
8866 cells, employing such a technique may be a worthwhile approach. However, no 
monoclonal antibody for CD23 should be used prior to embeddment since acidic and 
proteolytic conditions would also result in its detachment from the CD23 lectin domain; 
thus the intracellular path of CD23 can again only be partially followed. A further 
limitation in employing cryosectioning with no labelling on CD23 would be that, provided 
successful post-embeddment labelling of the protein is achieved, it must be proven that the 
cytoplasmic label represents protein originating from the cell surface and not newly 




Crosslinking by CR3/43 antibody on the surface of RPMI 8866 cells causes 
capping and endocytosis of HLA DR antigen. CD23 is also sequestered inside the cell 
through its non-covalent association with HLA DR. 
Confocal images suggest that both antigens are found in the same surface capped 
regions, endocytosed together and delivered into the same cytoplasmic areas. Minimum 
accumulation of their labels was observed in the cell cytoplasm, suggesting that both 
antigens may be recycled rather than degraded following endocytosis. The above findings 
are in line with recent immunoprecipitation. experiments suggesting recycling of CD23 and 
its release as a 37 kD soluble fragment which binds non-covalently to the cell surface 
(Murdock et al., manuscript in preparation). Flow cytometry data also imply that HLA 
DR may also be recycled back to the cell surface following treatment with CR3/43 
antibody and endocytosis. 
Electron microscopy images display endocytosis of CD23 and delivery of the gold 
label into vesicles belonging to the endosomal network. Aggregated 5nm gold label is also 
found within cytoplasmic compartments resembling recently identified endosomal 
structures (MIICs) specialising in loading of antigenic peptides onto Class 11 molecules. 
The above data further implicate CD23 in the processing of antigenic peptides and thus in 
antigen presentation. 
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Chapter 6: Endocytosis of IgE and CD23 
6.1 INTRODUCTION 
Experimental evidence suggests that there may be two alternative pathways which 
determine the intracellular fate of CD23. One has been shown to cause CD23 proteolysis 
to produce an intracellular 16 kD fragment which includes the IgE binding site (Grenier- 
Brossette et al., 1992). The other causes its fragmentation to 37 and 33 kD soluble fonns 
which include the lectin domain; these fragments bind non-covalently to the B cell surface 
(Murdock et al., manuscript in preparation, Figure 5.20). 
In a recent study it is shown that the presence of the stalk-free 25 kD lectin 
fragment in the cell medium causes loss of cell to cell contact, whereas reduction of the 
membrane protein into a 37 kD soluble CD23 restores cell adhesion (Moulder, Barton & 
Weston, 1993). Since cell adhesion is an important component of antigen presentation, 
IgE and CD23 endocytosis is here examined in conjunction with the presence of a 
recombinant 37kD sCD23 fragment in the cell medium. 
Flow cytometry is employed to determine the degree of CD23 and IgE 
endocytosis, and the role of the soluble 37 kD fragment in enhancing their intemalisation. 
Confocal microscopy is used to co-localise mCD23, sCD23 and IgE on the cell 
surface and their internalisation. Confocal experiments also investigate the location and 
acidic nature of the CD23 and IgE-containing intracellular compartments. 
Electron microscopy is employed to visualise tha cellular compartments containing 
intemalised IgE and CD23. 
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6.2 FLOW CYTOMETRY 
6.2.1 Endocytosis of Ig 
Cells were incubated for 0,2.5 and 5 hours at 370C with IgE, followed by anti-IgE 
monoclonal antibody (F- chain specific, Vector Labs) covalently bound to FITC. Figure 
6.1a displays the cell surface fluorescence distribution of a sample kept at 40C during all 
incubations. The negative control shown in grey (Figure 6.1a) was not labelled with IgE 
but was incubated with the fluoresceinated anti-IgE antibody and kept in ice. In figure 
6.1 a, the surface-labelled and acid-washed control was used to define the threshold for cell 
surface fluorescence removal (in green). The same sample is shown in green in figure 6.1 b 
and 6.1 c. As discussed previously, a problem with cell surface fluorescence removal was 
encountered in these experiments for the FITC-bound monoclonal antibody to IgE. This 
small discrepancy is compensated by an increase in the threshold settings. The green 
histograms in figure 6.1b and 6.1c represent samples incubated with IgE for 2.5 and 5 
hours at 370C respectively, and acid stripped to remove surface fluorescence and to allow 
detection of any internal IgE. Both histograms are hardly distinguishable from the negative 
acid stripped controls (in grey, figure 6.1b & c), indicating the absence of internal IgE 
after 2.5 and 5 hours incubation at 370C. It is therefore concluded that the conditions 
established in this experiment do not promote endocytosis of IgE. It thus appears that 
endocytosis of IgE is not simply triggered by binding of IgE to its low affinity receptor on 
the surface of RPMI 8866 cells. The presence of another component is apparently 
necessary to initiate internalisation of CD23-IgE complexes. 
The failure of IgE alone to induce endocytosis of CD23 is probably due to its 
inability to crosslink its membrane receptor. In the above experiment, engagement of IgE 
with a monoclonal antibody (F- chain specific, Vector Labs) did not cause its 
internalisation. It is therefore possible that the monoclonal antibody failed to crosslink IgE 
on the cell surface. Indeed, the possibility that only one epitope is available for antigen 
binding on each IgE molecule (depending on the precise location of that epitope; Sutton & 
Gould, 1993) may explain the inability of this particular anti-IgE antibody to crossfink 
membrane-associated IgE in this experiment. 
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Figure 6.1 
Fluorescence histograms for IgE endocytosis. 
a. Red histogram shows surface labelling of IgE followed by anti-IgE monoclonal 
antibody directly bound to FITC. Green histogram exhibits surface fluorescence removing 
of a sample labelled on the cell surface and acid-washed. Grey histogram is a negative 
control incubated with anti-IgE-FITC only, showing non-specific fluorescence labelling on 
the cell surface. 
b. Samples incubated at 370C for 2.5 hours. Grey histogram is a surface-labelled and 
acid washed sample (same as the green histogram in a). Red histogram shows total 
fluorescence after 2.5 hours. Green histogram shows internal fluorescence after incubation 
at 370C and acid stripping. 
C. Samples incubated at 370C for 5 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 5 hours. Green histogram shows internal fluorescence after 
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Fluorescence histograms of IgE endocytosis. All samples were incubated with 
recombinant 37 kD CD23 fragment prior to all incubations. 
a. Red histogram shows surface labelling of IgE followed by anti-IgE monoclonal 
antibody directly bound to FITC. Green histogram exhibits surface fluorescence removing 
of a sample labelled on the cell surface and acid-washed. Grey histogram is a negative 
control incubated with anti-IgE-FITC only followed by sCD23, showing non-specific 
fluorescence labelling on the cell surface. 
b. Samples incubated at 370C for 2.5 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 2.5 hours. Green histogram shows internal fluorescence after 
incubation at 370C and acid stripping. 
C. Samples incubated at 370C for 5 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 5 hours. Green histogram shows internal fluorescence after 
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Figure 6.2 displays flow cytometric measurements of samples treated as in figure 
6.1. However, after incubation with 1gE and an anti-IgE-FITC antibody, these samples 
were treated with recombinant 37kD sCD23 fragment. The cells were then incubated at 0, 
2.5 and 5 hours at 370C. As in figure 6.1, green histograms in figure 6.2b and 6.2c 
represent the presence of intracellular fluorescence after 2.5 and 5 hours respectively, at 
370C. Unlike the histograms in figure 6.1, green histograms in figure 6.2b and 6.2c show 
appreciable internal fluorescence, quite distinct from the acid washed controls represented 
by the grey histograms. Although internal fluorescence is normally hard to detect, the 
intensity of the green histograms is the highest observed in all experiments performed so I 
far. It is thus concluded that addition of the 37 kD soluble CD23 fragment has a dramatic 
effect upon internalisation of IgE. 
Statistical calculations derived from the above histograms quantify the effect of 
sCD23 upon endocytosis of IgE. After 2.5 hours at 370C, 46% of all cells detected show 
internal IgE label in samples to which sCD23 was added. During the same incubation, only 
5% of all cells show internal IgE in samples not treated with sCD23. After 5 hours at 
370C, in samples incubated with sCD23,65% of all cells emit a signal for internal IgE 
whereas in sCD23-deprived samples only 7% of all cells show any detectable internal 
fluorescence (average of two experiments). 
It is therefore concluded that addition of the recombinant sCD23 actively 
encourages internalisation of surface-bound IgE. The above findings may indicate that IgE 
binding to its cell surface receptor is not the only component required for its endocytosis 
and intracellular pathway. In vivo the presence of antigen may be necessary to crosslink 
and intemalise CD23-IgE complexes. The present experiments also show that soluble 
CD23 may also influence the process of endocytosis of IgE and CD23. As suspected by a 
number of researchers, the different soluble fragments of CD23 influence the direction of 
immune responses in various ways, shifting the equilibrium to regulate IgE levels in the 
system (Delespesse et al., 199 1). 
6.2.2 Endocytosis of IgE and membrane CD23 
It has so far been established that the recombinant sCD23 induces internalisation of 
surface-bound IgE in RPMI 8866 cells. Since the only receptor for IgE on the 
B cell 
surface is CD23, the endocytosis of both proteins is here examined. 
CD23 was labelled 
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with EBVCS I antibody to the stalk region followed by IgG-Fab fragment directly 
conjugated to R-PE. IgE was then allowed to bind to its low affinity receptor and labelled 
by a monoclonal antibody (e chain specific, Vector Labs) samples were incubated with the 
recombinant sCD23 fragment before being incubated for 0,2,4 &6 hours at 370C and 
some samples subjected to an acid wash to remove surface-associated fluorescence. Figure 
6.3 shows fluorescence histograms for sCD23-induced endocytosis of membrane CD23 
(R-PE label). The red histogram in figure 6.3 a displays cell surface labelling by EB VCS 1. 
The grey histogram in figure 6.3a is a negative control in which cells were incubated with 
the R-PE-conjugated polyclonal antibody Fab fragment, followed by IgE and anti-IgE 
monoclonal antibody bound to FITC. All other samples and acid stripped controls were 
prepared and are displayed as described previously. After 2 hours at 370C the acid- 
washed sample shown in green is distinct from the acid-stripped control in grey and 
exhibits detectable internal fluorescence (Figure 6.3b). The internal label emits a stronger 
signal after 4 hours at 370C (Figure 6.3c) and the signal is increased further after 6 hours 
(Figure 6.3d). This increase in the signal intensity signifies a progress in the internalisation 
of CD23. From the histograms in figure 6.3, it is therefore concluded that sCD23 induces 
endocytosis of the membrane-bound IgE complex with its low affinity receptor. 
The histograms for the FITC-labelled IgE are displayed in figure 6.4. Histograms 
of all samples are the same as those in histograms of figure 6.3, except for the negative 
control shown in grey in 6.3a. The negative control was labelled with EBVCS 1, followed 
by the polyclonal Fab conjugated to R-PE. The sample was not incubated with IgE, but 
only with the FITC-bound anti-IgE monoclonal antibody, in order to establish the 
threshold for non-specific fluorescent labelling of the antibody on the cell surface. As 
shown in figure 6.1, the acid stripped control (green histogram) does not perfectly match 
the negative control shown in grey (Figure 6.4a), displaying the same limitation in the 
efficiency of cell surface fluorescence removal experienced before for all antibodies 
covalently linked to FITC (Chapters 4 and 5; Figures 6.1 & 6.2). As previously, this 
technical limitation is corrected by setting higher threshold gates. Acid-stripped samples in 
figure 6.4b, 6.4c and 6.4d clearly exhibit histograms with appreciable fluorescence 
intensity. Fluorescence of internal IgE is easily detectable (green histograms) and, in 
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Figure 6.3 
Fluorescence histograms for EBVCS I endocytosis in samples incubated with EBVCS I 
antibody to CD23, IgE, and recombinant 37 kD sCD23. EBVCS I is labelled with anti- 
mouse IgG Fab covalently bound to R-phycoerythrin. 
a. Red histogram shows surface labelling of EBVCS I antibody followed by IgG Fab- 
R-PE. The same sample was also incubated with IgE, followed by anti-IgE-FITC and 
sCD23 (histograms for FITC shown in Figure 6.4). Green histogram exhibits surface 
fluorescence em,,, ing of a sample labelled on the cell surface and acid-washed. Grey 
histogram is a negative control incubated with IgG Fab-R-PE only, followed by IgE and 
anti-IgE-FITC and shows non-specific R-PE fluorescence labelling on the cell surface. 
b. Samples incubated at 370C for 2 hours. Grey histogram is a sample surface- 
labelled and acid washed (same as the green histogram in a). Red histogram shows total 
fluorescence after 2 hours. Green histogram shows internal fluorescence after incubation 
at 370C and acid stripping. 
C. Samples incubated at 370C for 4 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 4 hours. Green histogram shows internal fluorescence after 
incubation at 370C and acid stripping. 
d. Samples incubated at 370C for 6 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 6 hours. Green histogram shows internal fluorescence after 
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Fluorescence histograms for IgE endocytosis in samples incubated with EBVCS I antibody 
to CD23, IgE, and sCD23. Samples were first incubated with EBVCS 1, followed by anti- 
mouse IgG Fab covalently bound to R-phycoerythrin and finally labelled with IcYE. anti- 
IgE-FITC. All samples were incubated with 37 kD sCD23 prior to all incubations. 
a. Red histogram shows surface labelling of IgE. The same sample was also 
incubated with EBVCS1, and anti-mouse IgG Fab bound to R-PE (histograms for R-PE 
shown in Figure 6.3). Green histogram exhibits surface fluorescence removing of a sample 
labelled on the cell surface and acid-washed. Grey histogram is a negative control 
incubated with EBVCS 19 IgG Fab-R-PE, followed by anti-IgE-FITC and shows non- 
specific FITC fluorescence labelling on the cell surface. 
b. Samples incubated at 370C for 2 hours. Grey histogram is a sample surface- 
labelled and acid washed (same as the green histogram in a). Red histogram shows total 
fluorescence after 2 hours. Green histogram shows internal fluorescence after incubation 
at 370C and acid stripping. 
C. Samples incubated at 370C for 4 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 4 hours. Green histogram shows internal fluorescence after 
incubation at 370C and acid stripping. 
d. Samples incubated at 370C for 6 hours. Grey histogram is a sample surface- 
labelled and acid washed sample (same as the green histogram in a). Red histogram shows 
total fluorescence after 6 hours. Green histogram shows internal fluorescence after 
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Dot plots of intensity of fluorescein versus R-phycoerythrin in samples incubated with 
EBVCS 1, IgG Fab-R-PE followed by IgE and anti-IgE-FITC. The dot plots are divided 
into four quadrants, which are defined by the surface labelled and acid washed controls, 
The lower left contains cells which are negative for both R-PE and FITC. The lower right 
quadrant shows events positive for FITC label, whereas the upper left displays cells 
labelled for R-PE only. Finally, the upper right quadrant exhibits cells positive for both 
fluorochromes. 
a. Distribution of a control sample labelled with both EBVCS 1, IgG Fab-R-PE 
followed by IgE and anti-IgE-FITC and kept in ice during all incubations. 
b. Distribution of a control sample labelled with both EBVCS 1, IgG Fab-R-PE 
followed by IgE and anti-IgE-FITC, kept in ice during all incubations and acid washed to 
remove surface fluorescence. 
C. A sample labelled for both fluorophores and incubated at 370C for 2 hours. It 
shows total internal and surface fluorescence. 
d. A sample labelled for both fluorophores, incubated at 370C for 2 hours and acid 
washed to remove surface fluorescence. It shows internal fluorescence only. 
e. A sample labelled for both fluorophores and incubated at 370C for 4 hours. It 
shows total internal and surface fluorescence. 
f. A sample labelled for both fluorophores, incubated at 370C for 4 hours and acid 
washed to remove surface fluorescence. It shows internal fluorescence only. 
9. A sample labelled for both fluorophores and incubated at 370C for 6 hours. It 
shows total internal and surface fluorescence. 
h. A sample labelled for both fluorophores, incubated at 370C for 6 hours and acid 
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these samples, it seems to follow closely the sample displaying total surface and internal 
fluorescence (red histograms). This indicates that the majority of detectable fluorescence is 
found intracellularly. 
Acid stripped samples which show internal fluorescence in figures 6.3 and 6.4 
show a tendency to resolve into two peaks. These peaks may represent two cell 
populations that exhibit internal fluorescence of different intensity. The reason for this 
phenomenon is not easy to extract from the data in this experiment. One explanation may 
be that, since internal fluorescence intensity is harder to evaluate, it is possible that in some 
cells more cytoplasmic material and membranes absorb a fraction of the fluorescent signal. 
Furthermore, it is possible that some cells but not others are more efficient in processing 
CD23 and IgE. However, the differences in the pattern of intemalisation and the 
intracellular fluorescence shown for CD23 and IgE suggest that separate intracellular 
routes exist for each antigen. 
. Statistics based on the above experiments quantitate the extent of sCD23-induced 
endocytosis of membrane CD23 and IgE. After 2 hours incubation at 370C, 50% of all 
cells detected show internal IgE while 54% of cells show intemalised membrane CD23. 
Internal IgE is detected in 68% of all cells whereas 63% of all cells show endocytosed 
membrane CD23 after 4 hours at 370C. Between 4 and 6 hours at 370C internal IgE is 
displayed by 70% of all cells and 67% show endocytosed membrane CD23. Internalisation 
of both membrane CD23 and IgE seems to progress between 0,2 and 4 hours, but reaches 
a plateau between 4 and 6 hours at 370C. 
Dot plots of the same samples display the uptake of both membrane CD23 and IgE 
by RPMI 8866 cells. The dot plots are arranged as shown in previous experiments and 
display cell-associated fluorescence intensity of FITC-conjugated IgE plotted against R- 
PE-bound CD23. Figure 6.5a displays the fluorescence distribution of a sample labelled 
for both membrane CD23 and IgE and kept on ice during all incubations. The majority of 
the cells detected display cell surface fluorescence for both IgE and CD23 (85%). A small 
percentage of events appear in the upper left quadrant indicating that 10% of cells did not 
label for IgE. An acid-stripped control sample in panel B shows the efficiency of 
fluorescence removal for both antigens and allows for the setting of the threshold gates, 
such that 95% of all events fall within the the lower left quadrant, which hosts cells 
emitting negative signal for both fluorophores. Statistical calculations are the average of 
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two experiments. All percentage calculations were substracted from the values calculated 
from the acid-washed control (in Figure 6.5b). Total surface and internal fluorescence in 
figure 6.5c, 6.5e and 6.5g follows the same pattern as the surface labelled control in 6.5a. 
The fluorescence intensity of these samples is reduced but the majority of all cells register 
positive for both IgE and membrane CD23. Indeed, 80% of all cells are positive for both 
fluorophores intracellulary and on the surface after 2,4 and 6 hours at 370C. 
The cell population in samples incubated at 370C for 2 hours and acid stripped, 
shows a clear tendency to move towards the upper right quadrant, which hosts cells 
displaying internal fluorescence for both CD23 and IgE (Figure 6.5d). Indeed, this 
quadrant contains 44% of all cells, whereas 10% of cells register positive for internal 
CD23 only and 6% register positive for endocytosed IgE only. After 4 hours at 370C, 
58% of all cells seem to possess internal label for both fluorophores (Figure 6.5f). In this 
sample, 10% of cells show internal fluorescent label for IgE only whereas 5% of events 
seem positive for internal CD23 only. Internalisation seems to have progressed further 
after 6 hours at 370C when 62% of all cells register in the upper right quadrant (Figure 
6.5h), indicating that both fluorophores exist internally. Internalised CD23-positive signals 
constitute 5% of the cell population and cells positive for only IgE constitute 8% of all 
registered events. 
The above data show that endocytosis of CD23 and IgE is parallel, and both 
antigens are taken up by the cells at the same time. In the acid stripped samples, a small 
portion of the cell population does, however, register positive for one of the fluorophores. 
However, the cell cluster seems to follow the same tendency towards the upper right 
quadrant, indicating that the vast majority of cells possses both internal labels 
simultaneously. One reason for a small percentage of cells falling within the single 
fluorophore quadrants is a result of the setting of the threshold gates. These gates, 
however, are arbitrary boundaries and the cells falling within the single-fluorophore 
quadrants are in close proximity to the cells in the upper right quadrant which count 
positive for both fluorophores. It is therefore reasonable to claim that these cells also 
possess internal signal for the other fluorophore and constitute a single population. 
The above experiments demonstrate the parallel endocytosis of 
both IgE and 
membrane CD23 in samples treated with the recombinant sCD23 
fragment. The effect of 
the 37 kD fragment on the endocytosis of both IgE and membrane CD23 
is probably a 
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result of its association with a cell surface protein. There are four possible proteins to 
which the 37 kD fragment could bind. 
One possibility is binding to cell surface CD21, the Epstein-Barr virus and 
complement component receptor (also known as CR2). This would be a reasonable 
assumption since CD21 has been linked to cell activation and is a known ligand for CD23 
(Mossalayi et al., 1992; Aubry et al., 1992; Bonnefoy et al., 1993). In order to evaluate 
whether binding of sCD23 to cell surface CD21 is an option in this experimental system, a 
monoclonal antibody to CD21 was utilised to assess the extent of expression of surface 
CD21 on RPMI 8866 cells used in these experiments. Figure 6.6 displays flow cytometric 
measurements of samples labelled with HB5 mouse monoclonal antibody to CD21 
followed by fluoresceinated polyclonal IgG Fab. Surface labelling of CD21 on RPMI 8866 
cells was tested by using HB5 anti-CD21 monoclonal antibody in two concentrations. The 
grey histogram shows a negative control sample to which no monoclonal antibody to 
CD21 was added but was incubated with the FITC-conjugated polyclonal antibody. In 
figure 6.6a, the red histogram exhibiting surface fluorescence of the CD21 positive label is 
hardly distinguishable from the negative control shown in grey. In figure 6.6b, the red 
histogram exhibits CD21-associated surface fluorescence of cells in which the monoclonal 
antibody concentration was increased five-fold. As in figure 6.6a, the red histogram barely 
diverges from the negative control. The evidence in the above experiment thus suggests 
that CD21 is not expressed on the surface of RPMI 8866 cells. Similar experiments 
investigating the cell surface expression of CD21 on RPMI 8866 cells were performed 
recently (Murdock et al., manuscript in preparation). Similarly to the findings shown in 
figure 6.6, no cell surface expression of CD21 was detected by the authors. Binding of 
sCD23 fragment to cell membrane-expressed CD21 is therefore not possible. 
Another potential ligand for soluble CD23 is membrane IgE. Figure 6.7 shows 
flow cytometric measurements for the cell surface expression of IgE. The red histogram 
represents a sample incubated with anti-IgE monoclonal antibody covalently linked to 
biotin, followed by fluoresceinated streptavidin. The grey histogram is a negative control 
incubated with streptavidin bound to fluorescein only to exhibit non-specific cell surface 
fluorescence. In figure 6.7, the red histogram is also hardly distinguishable from the 
negative control, also suggesting that IgE is not expressed on the surface of RPMI 8866 
cells. It is therefore apparent that the effect of the 37 kD soluble CD23 on the endocytosis 
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of membrane CD23 and IgE could not be a result of its binding to membrane-expressed 
IgE. 
Thirdly, the binding of the soluble CD23 to the membrane CD23-IgE complex 
remains a possibility. In these experiments, soluble CD23 can bind to IgE through its lectin 
domain. Alternatively, it can associate non-covalently with membrane CD23 on the cell 
surface. However, since in these flow cytometric experiments the recombinant sCD23 was 
added after binding of IgE to membrane CD23 on the cell surface, it is not possible to 
distinguish between these alternatives. A fourth possibility is of course that sCD23 binds 
to an as yet unidentified surface receptor on these cells. 
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Figure 6.6 
Fluorescence histograms for the surface expression of CD21 in RPMI 8866 cells. Cells 
were labelled with HB5 mouse monoclonal antibody to CD21, followed by anti-mouse 
IgG Fab covalently bound to FITC. The grey histogram is a negative control which was 
incubated with IgG Fab-FITC antibody only and displays non-specific surface binding. 
a. Red histogram: cell surface expression of CD21. Anti-CD21: I ýtg/n-d 
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Fluorescence histograms for the surface expression of IgE in RPMI 8866 cells. Cells were 
labelled with a biotinylated monoclonal antibody to IgE, followed by streptavidin-FITC. 
The grey histogram is a negative control which was incubated with streptavidin-FITC 
antibody only and displays non-specific surface binding. 
a. Red histogram: cell surface expression of IgE. Anti-IgE: I ýtg/ml 
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6.3 CONFOCAL MICROSCOPY 
6.3.1 Endocytosis of IgE and membrane CD23 
Three colour-confocal images have been used to explore the surface co- 
localisation and internalisation of IgE and its cell surface receptor, CD23. Cells were 
labelled with EBVCS 15 IgG-Cy5, IgE, followed by anti-IgE monoclonal antibody (F- chain 
specific, Vector Labs) bound to FITC. They were finally incubated with recombinant 
37kD sCD23 and incubated at 370C at different time intervals. A sample showing surface 
fluorescence for both CD23 and IgE is displayed in figure 6.8. Fluorescent signals for 
receptor and ligand are localised together in the cell periphery. Extensive capping is seen 
in membrane areas mostly by CD23. IgE is found in patches contained in capped regions. 
The labels for CD23 and IgE are sometimes found on their own on the cell surface. As 
discussed in previous Chapters (3,4 & 5), it is expected that not all cell membrane areas 
will be labelled uniformly by two proteins, even if they target the same surface receptor. 
A sample incubated at 370C for 2 hours is shown in figure 6.9. Almost all cells 
observed exhibit strong intracellular fluorescence. Fluorescence has mostly disappeared 
from the cell surface and is concentrated in bright patches in the cytoplasm, as seen in 
figure 6.9b and 6.9c. Both membrane CD23 and IgE are intracellularly localised. 
However, while some cytoplasmic areas appear positive for both CD23 and IgE, each 
antigen also appears in cytoplasmic areas separately from the other. 
After 4 hours at 370C (Figure 6.10) the endocytosed proteins show a similar 
tendency to separate from each other as in samples incubated for 2 hours. CD23 and IgE 
are both internalised but their intracellular locations are quite distinct. As previously seen, 
some cytoplasmic areas seem to contain labels for both antigens but each protein also 
appears on its own. Another interesting observation is that the labels for CD23 and IgE 
have moved further apart from one another. Indeed, the Cy5-conjugated CD23 shows a 
tendency to move away from IgE, and seems to accumulate in the area closer to the cell 
surface. The above observations imply that the intracellular destination of CD23 may 
be 
different from that of IgE. IgE appears to progress towards the juxtanuclear area whereas 




A 3-colour confocal optical section displaying CD23 and IgE labelling on the cell surface 
of RPMI 8866 cells. Samples were incubated with EBVCS1, IgG-Cy5, followed by IgE 
and anti-IgE-FITC. Recombinant sCD23 was added and samples were kept in ice during 
all incubations. DiBAC4(5) was used to label all cytoplasmic membranes. Optical section 
thickness: -I ýLm. 
a. IgE-anti-IgE-FITC (green) and EBVCS I -IgG-Cy5 (white). 
b. IgE-anti-IgE-FITC (green) and DiBAC4(5) (red). 











A 3-colour confocal optical section displaying CD23 and IgE endocytosis in RPMI 8866 
cells. Samples were incubated with EBVCS 1, IgG-Cy5, followed by IgE and anti-IgE- 
FITC. Soluble CD23 was added prior to incubations at 370C for 2 hours. DiBAC4(5) was 
used to label all cytoplasmic membranes. Optical section thickness: -I gm. 
a. IgE-anti-IgE-FITC (green) and EB VCS I -IgG-Cy5 (white). 
b. IgE-anti-IgE-FITC (green) and DiBAC4(5) (red). 
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Figure 6.10 
A 3-colour confocal optical section displaying CD23 and IgE endocytosis in RPMI 8866 
cells. Samples were incubated with EBVCSI, IgG-Cy5, followed by IgE and anti-IUUE- 
FITC. Soluble CD23 was added prior to incubations at 370C for 4 hours. DiBAC4(5) was 
used to label all cytoplasmic membranes. Optical section thickness: -I 4m. 
a. IgE-anti-IgE-FITC (green) and EBVCS I -IgG-Cy5 (white). 
b. IgE-anti-IgE-FITC (green) and DiBAC4(5) (red). 
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Figure 6.11 
A 3-colour confocal optical section displaying internal CD23 and IgE in RPMI 8866 cells. 
Samples were incubated with EBVCS1, IgG-Cy5, followed by IgE and anti-IgE-FITC. 
Soluble CD23 was added prior to incubations at 370C for 6 hours. DiBAC4(5) was used 
to label all cytoplasmic membranes. Optical section thickness: -I ýtm. 
a. IgE-anti-IgE-FITC (green) and EBVCS I -IgG-Cy5 (white). 
b. IgE-anti-IgE-FITC (green) and DiBAC4(5) (red). 
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Figure 6.12 
A 3-colour confocal optical section of a control sample displaying CD23 and 14--E a Iling aI be 
on the cell surface of RPMI 8866 cells. Samples were incubated with EBVCS 1, ICTG-Cý, 5' 
followed by IgE and anti-IgE-FITC. Recombinant sCD23 was not added but cells, were 
incubated for 2 hours at 37oC. DiBAC4(5) was used to label all cytoplasmic membranes. 
Optical section thickness: -I gm. 
a. IgE-anti-IgE-FITC (green) and EBVCS I -IgG-Cy5 (white). 
b. IgE-anti-IgE-FITC (green) and DiBAC4(5) (red). 





IgE & CD23 -2 Hours - No, ýCD23 
317 
Figure 6.13 
A 3-colour confocal optical section of a negative control displaying lack of non-specific 
labelling of secondary antibody IgG-Cy5 in RPMI 8866 cells. Samples were incubated 
with IgG-Cy5, followed by IgE, anti-IgE-FITC and sCD23. They were kept at 40C during 
all incubations. Optical section thickness: -Igm. DiBAC4(5) was used to label all 
cytoplasmic membranes. 
a. IgE- anti-IgE-FITC (green) and EB VCS I -IgG-Cy 5 (white). 
b. IgE-anti-IgE-FITC (green) and DiBAC4(5) (red). 
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Figure 6.14 
A 3-colour confocal optical section of a negative control displaying absence of non- 
specific labelling of anti-IgE-FITC antibody in RPMI 8866 cells. Samples were incubated 
with EBVCS1, IgG-Cy5, followed by anti-IgE-FITC and sCD23. They were kept at 40C 
during all incubations. Optical section thickness: -Igm. DiBAC4(5) was used to label all 
cytoplasrnic membranes. 
a. IgE-anti-IgE-FITC (green) and EB VCS I -IgG-Cy5 (white). 
b. IgE-anti-IgE-FITC (green) and DiBAC4(5) (red). 
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degraded within an endosornal compartment as observed previously (Chapters 3&4, 
Grenier-Brossette et al., 1992), it may be recycled. 
Samples incubated for 6 hours at 370C exhibit internal label for both CD23 and 
IgE. Figure 6.11 shows an optical section of a cell featuring both labels for IgE and CD23 
in the cytoplasm. Although both labels appear to be localised together, the Cy5- 
conjugated CD23 seems of relatively strong intensity, and does not appear degraded. 
Indeed, vesicles containing Cy5 label for CD23 appear to separate from cytoplasmic 
enclosures and show some tendency to move towards the cell membrane. The FITC label 
for IgE appears less intense in cytoplasmic areas and some of this label seems to 
accompany CD23 on its journey back towards the cell membrane, away from the 
cytoplasmic fluorescent areas that contain the labels for both CD23 and IgE. Some of the 
label for IgE is still localised in the juxtanuclear cytoplasmic area and its fluorescence 
intensity appears decreased (Figure 6.11). 
From the above observations, it may be significant that samples incubated for 6 
hours display a tendency for both their labels to reach the cell surface. The fluorescent 
label for much of the CD23 and some IgE appear again at the cell membrane. Indeed, in 
samples incubated for 2 and 4 hours at 370C, almost no fluorescent label for either CD23 
or IgE was observed to remain at the cell surface (Figures 6.9 and 6.10). Figure 6.11 may 
thus at first imply that CD23 and possibly IgE tend to recycle back to the cell surface. 
However, it is difficult to assess with confidence whether this is the case from the above 
confocal images. Furthermore, the fluorescent label is attached to the monoclonal 
antibodies rather than directly to CD23 or IgE. Either of the two proteins may therefore 
have dissociated from its fluorophore-bound antibody at some point during their 
intracellular processing. The fate of each protein may thus not always be followed by the 
fluorescent signal. 
The fluorescence of the FITC label for IgE appears significantly reduced after 6 
hours at 370C, whereas the fluorescence intensity of the Cy5 label for CD23 appears 
essentially unchanged. Furthermore, the labels appear to separate from each other once 
inside the cytoplasm. These findings may imply that IgE and CD23 are originally delivered 
into the same compartments, but that the FITC-bound anti-IgE antibody dissociates 
from 
IgE and is further delivered into a separate cytoplasmic where it is subjected to 
denaturing 
conditions. Alternatively, CD23 and IgE are targetted into the same cytoplasmic 
bodies 
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and further processed into separate cytoplasmic compartments, with IgE reaching acidic 
conditions much earlier than CD23. Inside endosomal vesicles, and within acidic and 
proteolytic conditions, the fluorescence of FITC is expected to decrease much more 
quickly than that of Cy5. It is also possible that if IgE reached a lysosomal environment 
faster than CD23, and if the fate of the two proteins was within the endosomal network, it 
would be expected that after these proteins reached proteolytic and acidic environment, 
they would separate from their fluorescent labels. After IgE or CD23 reach late 
endosomes the fate of the protein is no longer followed. 
A control experiment is seen in figure 6.12. The cells were labelled for CD23 and 
IgE as all other samples (see above, this section) except that no recombinant 37kD sCD23 
was added. They were incubated at 370C for 2 hours and show surface but no internal 
fluorescence for CD23 and IgE. 
Another control experiment is shown in figure 6.13, which was treated as above 
but incubation with EBVCS I was omitted. The cells were kept in ice during all 
incubations. A confocal optical section show labelling of IgE on the cell surface but lack 
of Cy5-conjugated EBVCS 1. A third control was treated as all samples but was not 
labelled with IgE (Figure 6.14). Labelling with Cy5-conjugated CD23 is seen, but labelling 
by the FITC-bound monoclonal antibody to IgE is not observed. 
Discussion 
The above confocal images suggest that CD23 and IgE are originally localised 
together on the cell membrane and are endocytosed via the same cellular pathway. 
However, once internalised within the cytoplasm, the two proteins seem to separate and 
are contained in adjacent cytoplasmic areas. Both proteins seem to stay in close proximity 
to one another and indeed, their labels frequently overlap to a small extent. This suggests 
that CD23 and IgE could be delivered to different specialised vesicles which may be part 
of the same network. After 6 hours at 370C, most fluorescent label for IgE remains in the 
cytoplasm, whereas a tendency of CD23 towards recycling to the cell surface is observed. 
All attempts in this study to show membrane CD23 recycling using flow cytometry 
have been inconclusive. As discussed in the previous section, this failure may be due to 
spontaneous shedding of the protein on the cell surface. Although IgE and IgE complexes 
are known to prevent proteolysis of CD23 on the cell surface (Lee, Rao 
& Conrad, 1987; 
Sherr et al., 1989), it is possible that the addition of sCD23 fragments may alter this 
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stabilisation mechanism. Furthermore, it is likely that CD23 may be recycled in a soluble 
rather than in a membrane-bound form, released into the medium and associated non- 
covalently with the cell membrane. In this experiment, recombinant sCD23 would also be 
available in the medium for non-covalent association with RPMI 8866 cells. This would 
make quantification of the possible recycling of CD23 more difficult since the recycled 
soluble CD23 fragment would have to compete for non-covalent cell surface association 
with the already present recombinant sCD23. This may account for the lack of extensive 
Cy5 labelling for recycled CD23 in cells incubated at 370C for 6 hours. 
The possibility that the intracellular destination of CD23 may differ from that in 
previous experiments, could have interesting implications in its role in antigen processing 
and presentation. As discussed in Chapter 5, it appears that a monoclonal antibody to 
HLA DR causes endocytosis of both HLA DR and CD23 and perhaps their recycling back 
to the cell surface and release of soluble 33 and 37 kD CD23 fragments into the medium. 
As HLA DR is involved in antigen presentation, recycling of CD23 may be a true effect in 
an in vivo cell system where antigen-bound IgE binds to CD23 and is endocytosed. As 
shown in flow cytometry experiments (Section 6.2), the presence of sCD23 is crucial in 
the induction of endocytosis of IgE-membrane CD23 complexes. It was also shown that a 
37kD CD23 fragment, which originated from proteolysed membrane CD23, bound non- 
covalently to the cell surface of RPMI 8866 cells (Murdock et al., manuscript in 
preparation). These larger soluble CD23 fragments, which comprise the whole of the 
lectin domain and part of the stalk region, may bind to antigenic complexes associated 
with membrane CD23 and trigger their endocytosis. It is then tempting to speculate that 
the release of such fragments may be the key to antigen presentation and IgE synthesis. It 
is also possible that soluble CD23 fragments of certain size may be produced in favour of 
others in an in vivo cell system. The release of such fragments may be an integral part of a 
regulatory mechanism responsible for antigen presentation. 
Previous studies show that various factors can favour the release of some soluble 
CD23 fragments to the medium over others (Moulder, Barton & Weston, 1993). If such a 
regulatory process exists, it would be interesting to investigate the effect of the I&D or 
25kD soluble CD23 fragments, which lack the sequences from the stalk region, in 
triggering endocytosis of CD23-IgE complexes. If indeed they enhance endocytosis of 
such complexes, it would be crucial to establish whether they alter the intracellular 
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pathway of CD23 and possibly IgE. Some antibodies to CD23 cause its endocytosis into 
an acidic compartment and its degradation to a l6kD fragment, whereas recent evidence 
suggests that CR3/43 antibody to HLA DR alters the intracellular fate of CD23 to 
produce 33 and 37 kD soluble fragments (Grenier-Brossette et al, 1992; Murdock et al., 
manuscript in preparation). It would therefore be interesting to investigate if the presence 
of recombinant 16 or 25kD soluble CD23 match the effects of some monoclonal 
antibodies in inducing endocytosis and degradation of CD23 to a l6kD, fragment. 
The above confocal experiment implies that IgE-CD23 complexes are intemalised 
together and may be delivered into endosomal compartments where proteolytic conditions 
permit their dissociation. Antigen processing and peptide loading onto HLA DR may take 
place in specialised vesicles. CD23 may then separate from IgE and remaining antigenic 
peptides which are processed further into a lysosomal body for degradation; CD23, 
possibly together with peptide-carrying HLA DR, may then be recycled back to the cell 
surface. 
6.3.2 Endocytosis of soluble and membrane CD23 
The surface and intracellular co-localisation of membrane CD23 and the soluble 37 
kD CD23 recombinant fragment is investigated in this experiment. The membrane CD23 
was first labelled with EBVCS I antibody, followed by IgG bound to Cy5 and subsequent 
incubation with IgE. To distinguish between membrane and soluble CD23, biotinylated 
soluble 37 kD species was used and, as in the previous experiments, added after IgE 
binding to membrane CD23. The sCD23 fragment was labelled with FITC-conjugated 
streptavidin. 
Figure 6.15 displays the cell surface location of both soluble and membrane species 
in samples kept in ice during all incubations. Both membrane and soluble CD23 are 
localised together in distinct patches in the cell periphery. The first stages of capping are 
visible, as fluorescent patches showing both forms of CD23 start to merge on the cell 
surface. It is thus seen that soluble CD23 is accumulated in areas containing membrane 
CD23. This observation confirms previous data suggesting that sCD23 may cause 
internalisation of IgE-CD23 complexes by directly binding to them (see section 6.2). 
Incubation of samples at 370C for 2 hours results in capping and intemalisation of 
both membrane and soluble CD23 (Figure 6.16). The fluorescent labels of both CD23 
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species are displayed together intracellularly as well as in capped surface areas at the 
points of contact between cells. The location of both membrane and soluble CD23 in the 
points of cell to cell contact areas further implies a possible role of both membrane and 
soluble CD23 in homotypic cell adhesion. Unlike intemalisation of CD23 and T,,, -E. 
endocytosis of the two CD23 species results in accumulation of both in the same 
cytoplasmic areas. The two labels seem co-localised inside the cytoplasm. As shown in 
figure 6.9, at this incubation interval, endocytosed CD23 and IgE are localised separately 
in the cytoplasm. The soluble 37kD fragment thus seems to follow the intracellular route 
of the membrane CD23. This observation implies that the soluble species binds directly to 
the membrane CD23 rather than IgE on the cell surface CD23-IgE complexes, and thus 
accompanies membrane CD23 in its intracellularjourney. 
Samples incubated at 370C for 4 hours show the internal location of both CD23 
species in the cytoplasmic area next to the nucleus as well as close to the cell membrane 
(Figure 6.17). As seen in samples incubated for 2 hours, both sCD23 and mCD23 are 
located together in the same cytoplasmic areas. However, their intracellular location after 
4 hours implies a greater tendency to stay in the cytoplasmic area closer to the cell 
membrane. 
After 6 hours at 370C (Figure 6.18) the previously observed cytoplasmic 
localisation for both soluble and membrane CD23 species is difficult to find in marked 
contrast to the results described in Chapters 3 and 4. As shown in figure 6.18, most 
fluorescence is seen associated with the cell membrane. Both CD23 species are localised 
together on the cell membrane or in cytoplasmic areas directly adjacent to or associated 
with the cell surface. The membrane and soluble CD23 species resemble a capping-like 
feature, something that would suggest starting of endocytosis rather than recycling. 
However, a small trace of label for sCD23 which is seen further into the cytoplasmic area 
close to the nucleus, marks the intracellular journey of both membrane and soluble forms. 
To further support the recycling argument, very little surface fluorescence (but much 
cytoplasmic fluorescence) for either species was observed in samples incubated for 4 hours 
at 370C (Figure 6.17). The subsequent abundance of surface and lack of internal 
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Figure 6.15 
A 3-colour confocal optical section displaying mCD23 and sCD23 labelling on the cell 
surface of RPMI 8866 cells. Samples were incubated with EBVCS1, IgG-Cy5, followed 
by IgE, biotinylated soluble CD23 and Streptavidin-FITC. Samples were kept in ice durinzon, 
all incubations. Dfl3AC4(5) was used to label A cytoplasmic membranes. Optical section 
thickness: -I ýtrn- 
a. sCD23-Biot-Strept-FITC (green) and EBVCS I -IgG-Cy5 (white). 
b. sCD23-Biot-Strept-FITC (green) and DiBAC4(5) (red). 
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Figure 6.16 
A 3-colour confocal optical section displaying mCD23 and sCD23 endocytosis in RPMl 
8866 cells. Samples were incubated with EBVCS 1, IgG-Cy5, followed by IgE, 
biotinylated soluble CD23 and Streptavidin-FITC. Samples were incubated at 370C for -1 
hours. DiBAC4(5) was used to label all cytoplasmic membranes. Optical section thickness: 
-Iýtm. 
a. sCD23-Biot-Strept-FITC (green) and EBVCS I -19G-Cy5 (white). 
b. sCD23-Biot-Strept-FITC (green) and DiBAC4(5) (red). 
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Figure 6.17 
A 3-colour confocal optical section displaying mCD23 and sCD23 endocytosis in RPMI 
8866 cells. Samples were incubated with EBVCSI, IgG-Cy5, followed by hyE, C 
biotinylated soluble CD23 and Streptavidin-FITC. Samples were incubated at 370C for 4 
hours. DiBAC4(5) was used to label all cytoplasmic membranes. Optical section thickness: 
-Iýtrn. 
a. sCD23-Biot-Strept-FITC (green) and EBVCS I -19G-Cy5 (white). 
b. sCD23-Biot-Strept-FITC (green) and DiBAC4(5) (red). 
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Figure 6.18 
A 3-colour confocal optical section displaying internal mCD23 and sCD23 in RPMI 8866 
cells. Samples were incubated with EBVCS 1, IgG-Cy5, followed by IgE, biotinylated 
soluble CD23 and Streptavidin-FITC. Samples were incubated at 370C for 6 hours. 
DiBAC4(5) was used to label all cytoplasmic membranes. Optical section thickness: 
-IRM. 
a. sCD23-Biot-Strept-FITC (green) and EBVCS I -19G-Cy5 (white). 
b. sCD23-Biot-Strept-FITC (green) and DiBAC4(5) (red). 
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Figure 6.19 
A 3-colour confocal optical section of a negative control for mCD23 and sCD23 in RPMl 
8866 cells. It shows lack of non-specific labelling of streptavidin-FITC. Samples were 
incubated with EBVCS 1, IgG-Cy5, followed by IgE, streptavidin-FITC. Samples were 
kept in ice during all incubations. DiBAC4(5) was used to label all cytoplasmic 
membranes. Optical section thickness: -I gm. 
a. sCD23-Biot-Strept-FITC (green) and EBVCS I -19G-Cy5 (white). 
b. sCD23-Biot-Strept-FITC (green) and DiBAC4(5) (red). 
C. EBVCS I -IgG-Cy5 (white) and DiBAC4(5) (red). 
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Figure 6.20 
A 3-colour confocal optical section of a negative control for mCD23 and sCD23 in RPMI 
8866 cells. It shows absence of non-specific labelling of IgG-Cy5. Samples were incubated 
with IgG-Cy5, followed by IgE, recombinant sCD23 and streptavidin-FITC. Samples were 
kept in ice during all incubations. DiBAC4(5) was used to label all cytoplasmic 
membranes. Optical section thickness: -I gm. 
a. sCD23-Biot-Strept-FITC (green) and EBVCS I -IgG-Cy5 (white). 
b. sCD23-Biot-Strept-FITC (green) and DiBAC4(5) (red). 
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fluorescence after 6 hours at 370C cannot therefore be dismissed as a sign of induction of 
internalisation rather than recycling. Nevertheless, no further evidence is available from 
flow cytometry experiments to support the recycling hypothesis. 
Figure 6.19 shows a negative control labelled with EBVCS1, IgG-Cy5, IgE and 
streptavidin-FITC. The cells were not treated with biotinylated recombinant sCD23 and 
were kept at 40C during all incubations. Figure 6.19 shows fluorescence for Cy5 defining 
mCD23 labelling but no FITC labelling. Figure 6.20 displays a second negative control 
which was not treated with EBVCS I but was incubated with IgG-Cy5, IgE, sCD23, 
streptavidin-FITC and kept at 40C during incubations. No Cy5 labeling for mCD23 is 
observed whereas FITC displays binding of sCD23 on the cell surface. 
Discussion 
The above confocal images suggest that soluble and membrane CD23 follow the 
same intracellular route from the cell membrane into the cytoplasmic area close to the 
nucleus. They seem to recycle to the cell membrane, occasionally leaving behind a small 
trace of their fluorescent label. The observation that sCD23 accompanies mCD23 
intracellularly, whereas CD23 and IgE appear to separate following their co-endocytosis, 
implies that the effect of sCD23 in inducing endocytosis of CD23-IgE complexes may be 
the result of the association of sCD23 with membrane CD23 and not with IgE. Indeed, 
this is supported by Murdock et al. (manuscript in preparation) who show that the 37kD 
soluble CD23 fragment, which originates from cleavage of the membrane-bound form, is 
non-covalently associated with the cell membrane (Figure 5.20). Indeed, polymeric 
complexes of CD23 larger than trimers were shown to exist both on the cell membrane 
and in solution (Beavil et al., 1995). Binding of the recombinant sCD23 to membrane- 
bound CD23, and not to IgE, may therefore trigger endocytosis of IgE-CD23 complexes. 
6.3.3 IgE and Clathrin 
In this experiment, the possible surface and internal co-localisation of IgE and 
clathrin is investigated. Samples labelled with IgE, anti-IgE-FITC (from goat) and sCD23 
were kept in ice during incubations. After permeabilisation, they were incubated with a 
monoclonal antibody to clathrin (from mouse), followed by anti-mouse IgG-Cy5. The cells 
show surface fluorescence of membrane-associated IgE (Figure 6.21b). Clathrin 
(shown in 
white) is associated with the cells (Figure 6.21c) but is rarely co-localised with 
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Figure 6.21 
Confocal optical sections showing co-localisation of IgE and clathrin. RPMI 8866 cells 
were labelled with IgE, anti-IgE-FITC antibody, followed by sCD23. After incubations, 
cells were permeabilised and labelled with anti-clathrin antibody followed by anti-mouse 
IgG Fab covalently bound to Cy5. The sample was kept at 40 showing surface labelling of 
IgE and intracellular clathrin staining. Optical section thickness: -Iýtm. DiBAC4(5) was 
used to label all cytoplasmic membranes. 
a. IgE-anti-IgE-FITC (green) and anti-clathrin-IgG-Cy5 (white). 
b. IgE-anti-IgE-FITC (green) and DiBAC4(5) (red). 














Confocal optical sections showing co-localisation of IgE and clathrin. RPMI 8866 cells 
were labelled with IgE, anti-IgE-FITC antibody, followed by sCD23. After incubations, 
cells were permeabilised and labelled with anti-clathrin antibody followed by anti-mouse 
IgG Fab covalently bound to Cy5. The sample was incubated at 370C for I hour showing 
the intracellular co-localisation of IgE and clathrin. Optical section thickness: -I ýtm. 
DiBAC4(5) was used to label all cytoplasmic membranes. 
a. IgE-anti-IgE-FITC (green) and anti-clathrin-IgG-Cy5 (white). 
b. IgE-anti-IgE-FITC (green) and DiBAC4(5) (red). 
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Figure 6.23 
Confocal optical sections showing co-localisation of IgE and clathrin. Cells were labelled 
with IgE, anti-IgE-FITC antibody, followed by sCD23. After incubations, RPMI 8866 
cells were permeabilised and labelled with anti-clathrin antibody followed by anti-mouse 
IgG Fab covalently bound to Cy5. The sample was incubated at 370C for 2 hours showing 
the intracellular localisation of IgE and clathrin. Optical section thickness: gm. 
DiBAC4(5) was used to label all cytoplasmic membranes. 
a. IgE-anti-IgE-FITC (green) and anti-clathrin-IgG-Cy5 (white). 
b. IgE-anti-IgE-FITC (green) and DiBAC4(5) (red). 
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Figure 6.24 
Confocal optical sections of a control for IgE and clathrin. It shows lack of non-specific 
binding of the anti-mouse IgG-Cy5. RPMI 8866 cells were labelled with IgE, anti-IgE- 
FITC antibody, followed by sCD23. After incubations, cells were permeabilised and 
labelled with anti-mouse IgG Fab covalently bound to Cy5. The sample was incubated at 
370C for I hour. Cells show fluorescent label for IgE (in green). Optical section thickness: 
~I ýtm. DiBAC4(5) was used to label all cytoplasmic membranes. 
a. IgE-anti-IgE-FITC (green) and anti-clathrin-IgG-Cy5 (white). 
b. IgE-anti-IgE-FITC (green) and DiBAC4(5) (red). 
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Figure 6.25 
Confocal. optical sections of a control for IgE and clathrin. It shows absence of non- 
specific binding of the anti-IgE-FITC antibody. RPM1 8866 cells were not treated with 
IgE but were labelled with anti-IgE-FITC antibody, followed by sCD23. After 
incubations, cells were permeabilised and labelled with anti-clathrin monoclonal antibody. 
followed by anti-mouse IgG Fab covalently bound to Cy5. The sample was incubated at 
370C for I hour. Cells show fluorescent Cy5 label for clathrin (in white). Optical section 
thickness: -I ýtm. DiBAC4(5) was used to label all cytoplasmic membranes. 
a. IgE-anti-IgE-FITC (green) and anti-clathrin-IgG-Cy5 (white). 
b. IgE-anti-IgE-FITC (green) and DiBAC4(5) (red). 
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IgE (in green). Only a small amount of clathrin is observed in areas where IgE seems to 
merge in patches (Figure 6.21a, cell on right). Clathrin, however, is more concentrated in 
areas where capping of IgE is starting to form (Figure 6,21a, cell on left). Fluorescent 
label for clathrin is also located independently of IgE (Figure 6.21, cell in centre). This 
implies that although the two proteins are localised independently in cells, their paths may 
intercept once crosslinking and capping of IgE CD23 signal the start of endocytosis. 
Incubation at 370C for I hour results in endocytosis of IgE (Figure 6.22). IgE is 
almost exclusively found in the cytoplasmic area adjacent to the cell membrane (Figure 
6.22b). In these cells all cytoplasmic areas containing IgE are also positive for clathrin 
(Figure 6.22a); these IgE-positive cytoplasmic areas are concentrated with Cy5- 
conjugated clathrin. This observation differs dramatically from the previous sample which 
was kept in ice, where clathrin was rarely shown co-localised with IgE-positive patches on 
the cell membrane (Figure 6.21). As suggested by the co-localisation of the two proteins 
in capped membrane areas (Figure 6.21), clathrin and IgE are not observed together until 
crosslinking and capping of the receptor-ligand complexes takes place. Furthermore, the 
paths of IgE and clathrin meet in cytoplasmic areas where IgE concentrates after I hour at 
370C (Figure 6.22). 
Figure 6.23 shows endocytosis of IgE after 2 hours at 370C. Internalised IgE 
appears to have progressed further into the cytoplasm (Figure 6.23b). Clathrin, however, 
does not follow IgE further into the cytoplasm. It seems to remain in the cytoplasmic area 
close to the cell membrane and is co-localised with cytoplasmic IgE which has not 
progressed further internally. On the contrary, IgE-positive areas located closer to the 
juxtanuclear cytoplasm are free of clathrin (Figure 6.23). 
In a control experiment, cells were treated as all samples but no antibody to 
clathrin was added after permeabilisation (Figure 6.24). The cells were incubated at 370C 
for I hour. No labelling for IgG-Cy5 -conjugated clathrin is shown. The green 
fluorescent 
label indicates the presence of cell-associated IgE. In a second control sample, (Figure 
6.25) cells were not treated with IgE but were incubated with anti-IgE monoclonal 
antibody bound to FITC and recombinant sCD23. They were then permeabilised and 
labelled with anti-clathrin antibody and IgG-Cy5. The cells were incubated at 
370C for I 
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hour and show lack of non-specific FITC-conjugated anti-IgE antibody binding on the cell 
surface. 
The above confocal images suggest that after 2 hours at 370C the intracellular 
paths for clathrin and IgE appear to diverge. It thus seems that the co-localisation of the 
two proteins is short-lived and is initiated by capping of membrane- assoc i ated IgE. 
Clathrin is therefore involved in the invagination and pinching off of membrane areas 
containing capped IgE inside the cell. Once IgE is delivered to its cytoplasmic recipient 
bodies, its association with clathrin ceases. 
These results suggest that IgE is internalised via clathrin-containing vesicles and, 
like other ligands of C-type animal lectins, may therefore undergo receptor-mediated 
endocytosis. Following endocytosis IgE may be delivered into cytoplasmic compartments 
that belong to the endosomal network. 
6.3.4 fizE, CD23 and Acidic Vesicles 
The processing of IgE and CD23 in acidic vesicles is investigated with the use of 
2-colour confocal images. The presence of TRITC -conj u gated DAMP in acidic organelles 
(shown in bright red areas, over a pale red background produced by the TRITC-bound 
antibody) is shown in parallel with the intracellular presence of IgE or CD23 (in green). 
The DAMP reagent, which labels acidic vesicles, occupies distinct areas of the cytoplasm, 
indicating the intracellular presence of the endosomal compartments. 
Upon incubation at 370C for 4.5 hours, the internal label for IgE is localised 
intracellularly in the cytoplasm. In the majority of cells, its intracellular location falls in the 
area labelled by DAMP (Figure 6.26, showing in yellow). This observation strongly 
suggests that IgE is processed intracellularly through the endosornal pathway. However, 
some IgE-rich cytoplarnsic areas do not fall within the DAMP-labelled network (Figure 
6.26a, in green). Since not all the organelles of the endosomal pathway are acidic, it is 
possible that a portion of IgE still resides in early endosomes and has not yet reached tile 
acidic late endosomes and lysosomes. 
The intracellular localisation of CD23 after 4.5 hours at 370C is seen in 
cytoplasmic areas close to acidic organelles (Figure 6.27). Although the FITC label for 
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Figure 6.26 
Confocal optical sections showing co-localisation of IgE in acidic vesicles. Cells were 
labelled with IgE, anti-IgE-FITC antibody, followed by sCD23. After incubations, cells 
were incubated with DAMP, permeabilised and labelled with 2,4-anti-DNP antibody 
covalently bound to TRITC. The sample was incubated at 370C for 4.5 hours showing the 
intracellular co-localisation of IgE and DAMP. Optical section thickness: -I ýLrn. 
a. Intracellular localisation of IgE (green) and acidic vesicles (red). Not all IgE is 
localised in acidic organelles. 
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Figure 6.27 
Confocal optical sections showing co-localisation of CD23 in acidic vesicles. Cells were 
labelled with EBVCSI, IgGFab-FITC, IgE, followed by sCD23. After incubations, cells 
were incubated with DAMP, permeabilised and labelled with 2,4-anti-DNP antibody 
covalently bound to TRITC. The sample was incubated at 370C for 4.5 hours showing the 
intracellular co-localisation of CD23 and DAMP. Optical section thickness: -I ýIrn. 
a. Intracellular localisation of CD23 (green) and acidic vesicles (red). A small portion 
of CD23 is localised in acidic organelles. 
b. Intracellular localisation of CD23 (green) and acidic vesicles (red). CD23 is not 
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Figure 6.28 
Confocal optical sections showing a negative control for IgE, CD23 and acidic vesicles. It 
shows faint non-specific labelling of anti -2,4-dinitrophenol IgG-TRITC in RPM1 8866 
cells which defines the cell structure. After incubations, cells were not incubated with 
DAMP. They were permeabilised and labelled with 2,4-anti-DNP-TRITC. The sample was 
incubated at 370C for 4.5 hours. Optical section thickness: -I ýIm. 
a. Intracellular localisation of IgE (green) and acidic vesicles (red). Cells were 
labelled with IgE, anti-IgE-FITC and sCD23. 
b. Intracellular localisation of CD23 (green) and acidic vesicles (red). Cells were 
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Figure 6.29 
Confocal optical sections showing a negative control for IgE, CD23 and acidic vesicles. It 
shows lack of non-specific labelling of anti-IgE-FITC (a), or IgGFab-FITC (b) in RPMI 
8866 cells. Cells were labelled with IgGFab-FITC, IgE, followed by sCD23. After 
incubations, cells were incubated with DAMP, permeabilised and labelled with 2,4-anti- 
DNP-TRITC. The sample was incubated at 370C for 4.5 hours. Optical section thickness: 
-I Rm. 
a. Intracellular localisation of IgE (green) and acidic vesicles (red). 
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CD23 sometimes intercepts these acidic areas (Figure 6.27a, CD23-FITC appears in 
yellow), the majority of CD23 is not co-localised with DAMP-TRITC (Figure 6.27a & 
6.27b, CD23-FITC appears in green). 
Two sets of negative controls have been established in (Figures 6.28 & 6.29). 
Figure 6.28a shows a sample labelled for IgE-FITC and incubated at 370C for 4.5 hours, 
as in figure 6.26. Figure 6.28b is a sample labelled for EBVCSI-FITC as in figure 6.27. 
To these samples no DAMP reagent was added to label acidic vesicles. In both figures 
6.26a and 6.26b, the cells were treated with anti-2,4-dinitrophenol IgG-TRITC after 
permeabilisation to show the a small non-specific binding of the antibody in the cell, a 
uniform pale red fluorescence shown throughout the cell. Indeed, no strong labelling of 
cytoplasmic areas is observed, indicating lack of label for acidic vesicles. Another set of 
negative controls are shown in figure 6.27. In one, the cells were not treated with IgE but 
were incubated with anti-IgE-FITC and sCD23 (Figure 6.29a). In figure 6.29b, cells were 
not treated with EBVCS I antibody to the CD23 stalk region, but incubated with IgGFab- 
FITC, IgE and sCD23. Both samples were incubated at 370C for 4.5 hours and labelled 
with DAMP, permebilised and treated with anti-2,4-dinitrophenol IgG-TRITC. They show 
lack of labelling of IgE (Figure 6.29a) or CD23 (Figure 6.29b), whereas the acidic vesicles 
are clearly shown in both (Figures 6.29a and 6.29b, shown in bright red). 
Discussion 
The above confocal images suggest that the intracellular pathway of IgE intercepts 
acidic conditions, whereas internalised CD23 is less likely to be exposed to acidic 
compartments. These findings are in line with previous observations that the labels for 
CD23 and IgE may be delivered to different cytoplasmic areas. It is now apparent that 
these cytop1smic areas containing endocytosed IgE label are more likely to possess acidic 
properties than CD23-positive areas. Furthermore, since CD23 is located in such close 
proximity to acidic organelles it is possible that the cytoplasmic compartments containing 
CD23 and the acidic areas are all interacting components and may belong to the same 
cytoplasmic network. 
The targeting of the FITC label for IgE in acidic compartments and the delivery of 
CD23 in adjacent non-acidic cytoplasmic areas may imply that the fate of IgE is through 
the degradative pathway in lysosomal compartments, whereas CD23 is destined to be 
recycled back to the cell membrane. This hypothesis is in line with the scheme of antigen 
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presentation, in which CD23 and IgE may be delivered together in specialised 
compartments where antigen processing and presentation occurs. Upon peptide loading 
onto HLA DR, IgE may be processed further for degradation into acidic vesicles, whereas 
CD23 and HLA DR may recycle back to the cell membrane, for antigen presentation. The 
degradation of IgE could also be part of an intracellular mechanism which may regulate 
the levels of extracellular IgE available for binding to foreign antigen. Studies recently 
revealed the existence of the peptide-loading compartments (CPL or MIIQ as the major 
site for peptide loading to HLA DR for antigen presentation (Amigorena et al., 1994; Tulp 
et al., 1994; West, Lucocq & Watts, 1994). These studies show that peptide exchange 
does requires a special combination of proteases, but it is not clear if an acidic 
environment is necessary (Harding, Roof & Unanue, 1989; Adorini et al., 1989; Adorini & 
Nagy, 1990). It is not yet established whether MIIC compartments possess an acidic 
environment. IgE may first encounter peptide loading compartments which may or may 
not display acidic properties (Figure 6.26a). Following antigen processing and peptide 
loading, IgE may be transferred into lysosomal organelles for degradation (Figures 6.26b 
& 6.26c). 
Accompanying CD23 on its recycling journey could be an alternative fate for the 
endocytosed IgE. Delivery of IgE into a cytoplasmic compartment may subject it to 
appropriate conditions which would result in partial dissociation from its fluorescent 
antibody. Some of the FITC-conjugated anti-IgE antibody would be further processed into 
a lysosomal compartment and would thus localise separately from CD23. This argument is 
supported by the observation that some FITC label accompanies CD23 back towards the 
cell membrane as well as by the fact that FITC label of reduced intensity is seen in the 
cytoplasm. 
The intracellular route of IgE and CD23 would therefore be followed more 
accurately with introduction of a fluoresceinated or biotinylated CD23 or IgE species. 
Indirect labelling with antibodies has a disadvantage over biotin-streptavidin conjugates 
and covalent FITC labels. Direct labelling would be resistant to proteolysis and 
dissociation and would thus allow more accurate account of the process of endocytosis. 
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6.4 ELECTRON MICROSCOPY 
In this immunoelectron microscopy experiment, the cell membrane localisation and 
intracellular route of IgE and CD23 are followed by using gold antibodies of two sizes. 
Figure 6.30 illustrates the cell surface association of EBVCS I antibody to the stalk 
region of CD23. It is indicated by the binding of an IgG antibody covalently conjugated to 
5nm gold. The association of IgE with membrane CD23 is observed by a biotinylated 
monoclonal antibody to IgE, followed by streptavidin bound to 10nm gold. Recombinant 
sCD23 was added after all antibody binding. This sample was kept at 40C during all 
incubations. As seen with a double immunoelectron labelling experiment in Chapter 4, the 
10nm conjugate is not as abundant as the 5nm one. Although equal concentrations of all 
antibodies were used in this experiment, it appears that the 10nm gold conjugate has a 
disadvantage over the antibody bound to 5nm gold. 
As previously observed in a confocal microscopy experiment (Chapter 4), it is not 
always possible to successfully label two domains of the same cell membrane protein, since 
the presence of one label prevents binding of the other in the same cell surface area. This 
limitation is exaggerated in immunoelectron microscopy since gold conjugates are bigger 
than fluoresceinated antibodies. However, in the electron microscopy experiment in 
Chapter 4, l0nm gold-bound anti-biotin antibody was added after incubation with IgG- 
5nm. In the present experiment, both IgG-5nm and streptavidin-10nm gold were added to 
the cells simultaneously. This was done in the hope of avoiding hindering 10nm gold 
binding by the 5nm gold conjugate association with CD23. The two conjugates would 
therefore compete with each other for the available binding sites on the cell surface. 
Despite this modification, the binding of l0nm gold on the cell surface of RPMI 
8866 cells (Figure 6.30d, thick arrow) is still less than that of the 5nm gold conjugates 
(Figure 6.30d thin arrow). This persisting limitation implies a possible advantage of the 
5nm gold conjugate. Indeed, an antibody or conjugate bound to a 5nm gold particle would 
be lighter than one bound to l0nm gold, and therefore more mobile in solution. Upon its 
binding to the cell surface, multiple washings would result in less dissociation of a 5nm 
gold conjugate than one bound to l0nm gold. Compared to the previous experiment, 
however, more l0nm gold particles are seen associated with the cell surface. 
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Figure 6.30d shows that gold of both sizes is associated with the cell membrane in 
patches. Indeed, the effect of crosslinking of CD23 and IgE complexes is illustrated in the 
movement of their gold conjugates on the cell membrane. The clusters of gold on the cell 
surface (Figure 6.20a & 6.20b, thin arrows) are even more abundant than those observed 
in CR3/43-induced capping of membrane CD23 (Chapter 5). Immunoelectron 
microscopical images thus show cell surface capping of CD23 and IgE together in the 
same areas. It is not clear whether capping is a result of IgE binding on the cell surface. It 
is possible that the recombinant sCD23 added to all samples after all antibodies and gold 
conjugates may have an effect in crosslinking CD23-IgE complexes and initiating capping. 
Indeed, flow cytometry experiments and confocal images showed that sCD23 causes 
capping and endocytosis of both membrane CD23 and IgE (Sections 6.2 & 6.3). This 
effect of sCD23 was shown without the presence of EBVCS I antibody to the stalk region 
of CD23 (Figures 6.1 & 6.2) as well as without the monoclonal antibody to IgE (Figures 
6.16 & 6.17). However, the presence of an antibody to CD23 or IgE may provide an 
artificial bridge and therefore contribute to the phenomenon of capping. 
In Chapter 5, crosslinking of membrane CD23 by CR3/43 antibody to HLA DR 
was shown to cause capping as well as cell adhesion. Cell adhesion was observed in the 
present experiments with sCD23, but was not more prominent than in samples treated 
with antibodies to CD23 (Chapters 3& 4). This suggests that the presence of 37kD 
sCD23 in the extracellular matrix does not enhance cell adhesion. The profound effect of 
CR3/43 antibody in promoting cell to cell contact is therefore unlikely to be the result of 
soluble CD23 formation. 
Although the cells were kept on ice at all times, gold is concentrated in clusters on 
the plasma membrane where invaginations to form budding vesicles are formed (Figure 
6.30d, open arrow). Furthermore, cytoplasmic vesicles are located in the area close to the 
cell periphery (Figure 6.30c). The gold is mostly associated with the inner membrane of 
these plasmalemmal pits, indicating that it is still bound to the protein which it has labelled 
(5nm gold shown by thin arrow, 10nm gold shown by thick arrow). These vesicles are in 
close proximity to the cell membrane, and particularly close to areas showing gold 
clusters. It is therefore possible that they represent extensions of the capped areas towards 
the cytoplasm and may indicate the beginning of endocytosis of CD23-IgE complexes. 
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In figure 6.31 a sample labelled with EBVCS I antibody to the stalk region of 
CD23 and 5nm gold, and with IgE, biotinylated anti-IgE antibody and streptavidin-10nm 
gold, was incubated for 4 hours at 370C. Capping is even more extensive, in places 
occupying almost half the cell membrane shown on a section (Figure 6.31b, long thin 
arrows). In these samples, large, dark, diffuse structures are associated with the capped 
regions on the cell surface (Figure 6.31b, long thick-end arrows). These structures are 
electron dense and appear selectively associated with the gold-rich regions (Figure 6.3 1 b). 
They are found nowhere else on the cell membrane. The electron dense material also 
appears in cytoplasmic vesicles containing endocytosed gold (Figure 6.3 1 a, see long thick- 
end arrow). The origin of this dense material and the reason for its association with 
membrane areas containing gold clusters cannot be determined with certainty. 
It may be that the material represents aggregates of unbound recombinant sCD23. 
These aggregates may bind specifically to membrane CD23 or IgE, or non-specifically to 
antibodies or the gold particles. Exposure to a higher temperature may have caused the 
formation of large aggregates of sCD23. The recombinant protein is isolated from E. coli 
and exists in dimeric form when tested at room temperature (R. Re1jic, personal 
communication). In the present study, sCD23 is kept at -200C for storage and brought to 
40C immediately before use. The temperature rise from 4 to 370C and prolonged 
exposure to 370C may therefore have caused protein aggregation. This may explain the 
lack of dense material associated with cells kept in ice, and yet their presence in samples 
incubated at 370C. 
Figure 6.31 also shows endocytosis of 5 and 10nm gold into cytoplasmic vesicles 
after 4 hours at 370C. Gold of both sizes is contained together in cytoplasmic bodies. 
Gold of 5nm prevails in these vesicles although 10nm gold is also found. Some of the 
gold-containing vesicles are located in the cytoplasmic area closer to the cell membrane 
(Figuye 6.31b, long thick arrow) and others are found adjacent to the nucleus (Figure 
6.31a, long thick arrow). Some of these vesicles (Figure 6.31a, long thick arrow) are 
much larger than, and bear no resemblance to, those observed to contain endocytosed 
gold label for CD23 in previous electron microscopy experiments (Chapters 3,4 & 5). 
Neither do they appear similar to the plasmalernmal pits featuring a thick membrane, or the 
typical multivesicular appearance of endosomal compartments seen in Chapters 3 and 4. It 
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is very hard to distinguish any clear structural features of these structures. The only 
distinct characteristic of the large cytoplasmic structures is the bead-like appearance of 
their outer membrane (Figure 6.31a and 6.31c, long thick arrow). Some of these 
structures are at times found in close proximity to cytoplasmic vesicles featuring the 
coiled-rope structure of peptide-loading compartments (MIICs, indicated with open 
arrow), but no gold has been seen within MIICs in this experiment (Figure 6.3 1 c). 
Occasionaly, two or three 10nm gold particles are contained in cytoplasmic 
vesicles separately from 5nm gold (not shown). As the labelling by 10nm-bound 
streptavidin is not extensive in this experiment, little can be concluded from this 
obserýation except that perhaps this may agree with the confocal images which suggest 
that endocytosed CD23 and IgE may have separate fates. However, in this electron 
microscopy experiment, binding of 10nm gold which indicates the presence of IgE, was 
limited. Therefore, the intracellular fate of IgE cannot be followed as well as that of 
CD23, rendering this experiment less comparable to the equivalent confocal data. 
. Endocytosed gold of both sizes is sharp in appearance, and some of the gold 
particles are still associated with the inner membrane of the cytoplasmic vesicles (Figure 
6.31a, short thick arrows). This indicates that the gold is still attached to IgE and CD23, 
and that the proteins may still be in the beginning of their processing, and have not yet 
reached acidic conditions. 
Cells incubated at 370C for 10 hours show extensive endocytosis of CD23 and IgE 
(Figure 6.32). Gold of 5 and l0nm is found contained in cytoplasmic vesicles (Figure 
6.32c and 6.32d, 5nm gold shown in long thin arrows, l0nm gold shown in short thick 
arrows). Even after 10 hours incubation at 370C, the gold is still sharp in appearance. It is 
still associated with the inner membrane of some cytoplasmic vesicles (Figure 6.32c, short 
thin arrow) although it appears to be transferred into others (Figure 6.32c, long thick-end 
arrow). These gold-rich bodies do not possess the familiar structure of endosomes and 
lysosomes seen in all previous experiments. They are also found throughout the cytoplasm 
(Figure 6.30b, where short thick arrows are shown). Some of the gold-containing vesicles 
have no recognisable structural features. Occasionally, their structure may be masked by 
their high gold content. Gold-containing vesicles (Figure 6.32a, short thick arrow) are also 
seen emerging from larger, more structured bodies that appear rich in sub-vesicular 
structures (Figure 6.32a, long thick arrow) and show a movement towards the plasma 
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membrane. The identity and role of these bodies is not clear. Unlike all previous 
experiments, cytoplasmic gold is not aggregated within these structures. It is sharp in 
appearance, just as seen in the sample that was kept in ice. This further indicates that gold 
and possibly CD23 and IgE have not been exposed to strong acidic and proteolytic 
conditions which would cause the loss of the protein coat surrounding each particle and 
result in aggregation of gold within endosomal compartments. It is possible that certain 
lysosomal enzymes are required for protein degradation and gold flocculation, and the 
gold in this experiment is simply not exposed to such conditions. As seen in previous 
samples, mostly 5 and some l0nm gold is seen in these cytoplarnsic bodies. 
The fact that endocytosed 5nm gold retains its sharp appearance after 10 hours 
incubation at 370C agrees with previous confocal images suggesting that most CD23 is 
not localised within acidic vesicles after 4.5 hours at 370C (Figure 6.27). Again this is 
consistent with the theory that CD23 is not degraded but indeed recycled back to the cell 
surface. Less can be concluded about the fate of IgE, as cytoplasmic l0nm gold is also 
sharp. Confocal experiments have localised most IgE within acidic areas (Figure 6.26). 
However, it is possible that an acidic environment is not sufficient to induce degradation 
of the protein coat surrounding the gold particles. It may be that only long exposure to a 
combination of low pH and specific proteases is required to cause the effect on gold 
aggregation seen in previous experiments. 
A control experiment is shown in figure 6.33. RPMI 8866 cells were not incubated 
with EBVCS I but were treated with IgE, biotinylated anti-IgE antibody, excess of anti- 
mouse IgG bound to 5nm gold, followed by sCD23. The sample was kept in ice during all 
incubations. It shows the lack of non-specific binding of the 5nm gold conjugate on the 
cell surface. 
Two more controls were established to examine the extent of non-specific binding 
of streptavidin-bound l0nm gold on the surface of RPMI 8866 cells (Figures 6.34,6.35). 
The cells were treated with EBVCS 1. The sample shown in figure 6.34 was not incubated 
with IgE, but was treated with biotinylated anti-IgE antibody, excess of streptavidin-10nm 
gold, followed by sCD23. Gold is not seen on the plasma membrane 
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Figure 6.30 
Electron micrographs of RPMI 8866 cells kept at 40C during incubations. CD23 was 
labelled with EBVCS I antibody, followed by IgG Fab conjugated to 5nm gold. Cells were 
labelled with IgE, biotinylated anti-IgE monoclonal antibody (from goat), streptavidin- 
10nm gold and sCD23. Cell surface distribution of 5 m-n and 10 nrn gold particles at time 
0. Thin arrows indicate gold clusters on the cell membrane and in plasmalemmal pits. 
Thick arrows indicate location of 10nm gold. N: Nucleus, C: Cytoplasm, PM: Plasma 
Membrane, M: Mitochondrion. 
a. Section of a whole cell showing gold bound on the cell surface. Magnification: 
13,190x, Igm=13.2mm. Scale bar: LORm. 
b. Part of the cell section in a showing localisation of gold on the cell surface and in 
plasmalemmal pits found in the cytoplasm directly opposite to the cell membrane capped 
areas (thin arrows). Magnification: 32,030x, I gm=32. Omm. Scale bar: I. Ogm. 
C. Detail of two plasmalemmal pits showing 5nm (thin arrow) and 10nm gold (thick 
arrows) associated with their inner membrane. Magnification: 75,360x, IRm=75.4mm. 
Scale bar: 0.2grn. 
d. Detail of a capped membrane region showing most 5nm gold particles (thin arrow) 
and one 10nm gold particle (thick arrow). The capped plasma membrane area forms an 
invagination towards the cytoplasm (open arrow). Magnification: 75,360x, lgm=75.4mm. 
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Electron micrographs of RPMI 8866 cells labelled with EBVCS1, IgG Fab-5nm gold and 
IgE, anti-IgE-biotin, streptavidin-10nm gold and sCD23. The sample was incubated at 
370C for 4 hours. Gold of 5nm and 10nm is accumulated within cytoplasmic vesicles. N: 
Nucleus, C: Cytoplasm, PM: Plasma Membrane. 
a. Part of the cell section showing cell membrane- associated gold (thin arrow) 
endocytosed gold associated with the inner membrane of cytoplasmic vesicles (thick short 
arrows). Gold is also seen accumulated within a large cytoplasmic structure located next 
to the nucleus (long thick arrow). Diffuse electron dense structures are associated with 
surface gold and endocytosed gold in cytoplasmic vesicles (long thick-end arrows). 
Magnification: 75,600x, Igm=75.6mm. Scale bar: O. Sgm. 
b. Part of a cell section showing strong capping of gold particles on the cell 
membrane (thin arrows) and the beginning of endocytosis in a pit emerging from the cell 
membrane (thick arrow). Gold is contained in cytoplasmic vesicles (long thick arrow). 
Diffuse, electron-dense structures are associated with capped gold on the plasma 
membrane (long, thick-end arrows). Magnification: 75,600x, Igm=75.6mm. Scale bar: 
0.5grn. 
C. Detail of a cell section showing endocytosed gold in a cytoplasmic vesicle (long, 
thick arrow) located next to other cytoplasmic structures, one of which features the 
coiled-rope structure known to identify peptide-loading compartments or MHCs (open 
arrow). Magnification: 56,520x, I grn=56.5mm. Scale bar: 0.5gm. 
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Figure 6.32 
Electron micrographs of RPMI 8866 cells labelled with EBVCS 1, IgG Fab-5nm gold and 
IgE, anti-IgE-biotin, streptavidin-10nm gold and sCD23. The sample was incubated at 
370C for 10 hours. Gold of 5nm is accumulated within cytoplasmic vesicles located 
throughout the cytoplasm. Gold of 10 nm is accumulated within cytoplasmic structures 
and appears to emerge from large multivesicular cytoplasmic bodies. N: Nucleus, 
C: Cytoplasm, PM: Plasma Membrane. 
a. Part of a cell section not labelled with either lead citrate or uranyl acetate. It shows 
a gold-rich vesicle (small thick arrow) emerging from a large structured cytoplasmic body 
containing smaller sub-vesicles (long thick arrow). Magnification: 75,360x, I gm=75.4nim. 
Scale bar: 0.5ýtm. 
b. Part of a cell section showing endocytosed gold (small thick arrows) associated 
with cytoplasmic vesicles, and gold associated with the cell membrane (long thin arrows). 
Magnification: 22,600x, lgm=22.60mm. Scale bar: I. Ogm. 
C. Detail of a cell section showing gold associated with the inner membrane of a 
cytoplasmic vesicle (small thin arrow). The gold appears to be transferred into another 
vesicle (long thick-end arrow). Gold of 5nm (long thin arrow) and l0nm (short thick 
arrow) is seen. Magnification: 56,970x, Igm--56.97mm. Scale bar: 0.5gm. 
d. Detail of a cell section where gold of 5nm (long thin arrow) and 10nm (short thick 
arrow) is contained in a cytoplasmic vesicle in close proximity with multilamennal 
structures (open arrow). Magnification: 97,850x, IRm--97.85mm. Scale bar: 0.25ýLrn. 
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Electron micrographs of a control sample labelled with IgE, anti-IgE-biotin, IgG-5nm and 
streptavidin-10nm and kept in ice during incubations. It shows lack of non-specific IgG- 
5nm antibody binding to IgE on the cell surface of RPMI 8866 cells. N: Nucleus, C: 
Cytoplasm, M: Mitochondrion, PM: Plasma Membrane. 
a&b. Absence of 5 and 10nm gold from the plasma membrane and cytoplasm. 
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Electron micrograph of a control sample labelled with EBVCS1, anti-IgE-biotin, IgG-5nm 
gold, anti-biotin-10nm gold and kept in ice during incubations. It shows lack of non- 
specific streptavidin binding to EBVCS I on the surface of RPMI 8866 cells. N: Nucleus, 
C: Cytoplasm, PM: Plasma Membrane. 
a. Absence of 5 and l0nm gold from the plasma membrane and cytoplasm. 
Magnification: 58,260x, I ýLrn=58.26mm- Scale bar: 0.5gm. 
b. Absence of gold from the cell membrane and cytoplasmic vesicles (thin arrows). 
Magnification: 58,260x, 1ýtm--58.26mm. Scale bar: 0.5ýLm. 
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Electron micrograph of a control sample labelled with EBVCS 1, IgE, IgG-5nm gold, anti- 
biotin-10nm gold and kept in ice during incubations. It shows absence of non-specific 
streptavidin binding to EBVCS1 on the surface of RPMI 8866 cells. N: Nucleus, 
C: Cytoplasm, PM: Plasma Membrane. 
a. Absence of 5 and l0nm gold from the plasma membrane and cytoplasm. 
Magnification: 77,680x, I ýtm--77.68mm. Scale bar: 0.5ýtm. 
b. Absence of gold from the cell membrane and cytoplasmic vesicles (thin arrows). 
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or associated with any cytoplasmic vesicles (Figure 6.34b, long thin arrows). The , ample 
shown in figure 6.35 was treated with IgE but not with biotinylated anti-IgE antibody. The 
cells were then incubated with excess of streptavidin-10nm gold and sCD23. Both control 
samples were kept on ice during all incubations. 
Discussion 
The above electron microscopy experiment suggests that CD23 may not enter the 
endosornal network upon endocytosis. This does indeed constitute a definite switch from 
the pattern of its endocytosis and processing observed so far. In all previous experiments 
(Chapters 3,4 & 5), endocytosed CD23 encounters acidic and proteolytic conditions, 
resulting in degradation of its gold conjugate. Its association with IgE and perhaps most 
importantly sCD23 results in prominent capping to an extent not encountered in previous 
experiments, and endocytosis of CD23 is observed, but no aggregation of its gold label is 
seen, after a 10 hour incubation at 370C. This is only a preliminary study of the process of 
endocytosis of IgE-CD23 complexes, and further experiments are required to define the 
role of each component. 
Flow cytometry studies have indicated the significance of the 37kD soluble CD23 
fragment in inducing endocytosis of CD23-IgE complexes. However, the contribution of 
the cell surface association of 19E in the endocytosis of mCD23 is not clear at this point. 
An internalisation study should be performed in which IgE is excluded from the intitial 
membrane complexes. Furthermore, flow cytometry experiments have failed to provide 
definite evidence for recycling of either CD23 or IgE. Immunoprecipitation studies may 
provide some insight into the intracellular pathway and processing of CD23 and IgE, the 
pattern of their cytoplasmic degradation and perhaps a possible re-association of either 
molecule with the cell membrane following their recycling. Their endocytosis, which is 
triggered by a 37kD sCD23 fragment, may differ from their possible fate once treated with 
a 25 or IRD CD23 fragment and this may have significant implications in the regulation 
of IgE levels. A further study of the effect of smaller CD23 fragments may therefore shed 
more light in this area. 
Confocal images presented in this Chapter suggest that recombinant sCD23 
follows the intracellular route of CD23, whereas IgE appears to separate from its receptor 
following endocytosis. A recent study also suggests that soluble 37kD CD23 fragments 
may associate with a novel receptor on the surface of RPMI 8866 cells (Murdock et al.. 
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manuscript in preparation). Data shown in this chapter suggest that the 37kD cell surface 
receptor may be mCD23 itself. Further studies of the cell surface complex formed upon 
addition of the soluble 37kD fragment may offer some information on this controversy. It 
would also be interesting to establish if a possible association of mCD23 or CD23-1gE 
complex can exist with smaller CD23 soluble fragments. 
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6.5 CONCLUSION 
Binding of IgE to membrane CD23 on the cell surface does not alone enhance 
endocytosis of its membrane receptor. Addition of a recombinant 37kD soluble CD23 
fragment causes capping and extensive intemalisation of both mCD23 and IgE. 
Upon endocytosis of the complex, CD23 separates from IgE and shows a tendency 
to return to the cell surface. The recombinant sCD23 internalises with, and follows the fate 
of, mCD23. The evidence suggests that endocytosis of IgE occurs through clathrin- 
containing vesicles prior to delivery into acidic cytoplasmic compartments, while most 
internalised CD23 is not localised within acidic areas. Endocytosed CD23 is targetted into 
novel cytoplasmic compartments whose structures are unlike conventional endosomes and 
lysosomes observed in previous chapters. Unlike previous experiments investigating 
antibody-induced endocytosis of CD23, here, internalised gold label for CD23 is not found 
in aggregates within these novel compartments. This suggests that CD23 is not exposed to 
the acidic and proteolytic environment necessary to cause gold flocculation. 
It is thus concluded that the intracellular journey of CD23 to the endosomal 
network caused by antibodies to the lectin domain, is altered by the introduction of IgE 
and a recombinant 37kD soluble CD23 fragment. 
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Chapter 7: Conclusion 
This study used RPMI 8866 cells, an EBV transformed cell line, as an in vitro cell 
model to investigate the process of endocytosis of CD23. Various factors were examined 
for their possible effect in inducing endocytosis of CD23 or altering its intracellular 
processing. 
Some Antibodies to CD23 Trigger its Endocytosis 
Antibody-induced endocytosis was a question recently addressed in an 
immunoprecipitation study (Grenier-Brossette et al., 1992; Figure 1.7). According to the 
authors, antibodies to CD23 enhance the rate of its endocytosis and processing into a 
IRD fragment comprising the lectin domain. In response to the above study, the 
efficiency of a group of antibodies in enhancing internalisation of CD23 was explored in 
Chapter 3. Antibodies BU38 and MHM6 to the lectin domain show the highest efficiency 
in inducing endocytosis of CD23. These two antibodies belong to a specific group 
recognising the lectin domain. All four antibodies belonging to this group provide a 
stimulatory signal for phorbol ester-primed B cells. BU38 and MHM6 cause capping and 
endocytosis of CD23 and its processing into a cytoplasmic network of multivesicular and 
multilamennal compartments, probably belonging to the endosomal network. Another 
group of antibodies to the lectin domain, and EBVCS I antibody to the stalk region, did 
not appreciably enhance endocytosis of CD23. 
Simultaneous labelling of CD23 stalk region with EBVCS I and the lectin domain 
with BU38 allowed the endocytosis of both parts of the membrane protein to be followed. 
Data presented in Chapter 4 show that antibody BU38 crosslinking causes capping and 
endocytosis of lectin and stalk. Both are endocytosed together and delivered into the 
same cytoplasmic areas. Electron micrographs suggest that lectin and stalk are delivered 
into endosomal compartments. 
CD23 and HLA DR are Endocytosed Together 
CD23 and HLA DR are non-covalently associated on the cell surface (Bonnefoy et 
al., 1998). Upon addition of CR3/43 monoclonal antibody to HLA DR and incubation at 
370C, capping and endocytosis of both CD23 and HLA DR take place. The two proteins 
appear to follow the same intracellular path. Some evidence suggests that HLA DR may 
be recycled back to the cell surface (Chapter 5). A recent immunoprecipitation study 
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(results presented in Figure 5.20) further indicates that treatment with CR3/43 causes 
recycling of endocytosed CD23 and its release into the medium as a 37kD soluble 
fragment (Murdock et al., manuscript in preparation). The released soluble fragment may 
re-associate with the cell membrane in a non-covalent manner (Figure 5.20). Electron 
micrographs suggest that some of the gold label for the lectin domain of CD23 is delivered 
into distinct cytoplasmic structures resembling the recently identified endosornal 
compartments specialised for antigenic peptide loading onto MHC Class Il prior to 
antigen presentation. The intracellular processing pathway for CD23, leading to a 37kD 
soluble fragment, its recycling and release to the cell medium, strongly implies the 
existence of more than one intracellular pathway for the low affinity receptor for IgE. 
Furthermore, the presence of gold label for CD23 in M11C cytoplasmic compartments 
implicates CD23 in antigen processing and presentation. 
A 37kD Soluble CD23 Fragment Induces Endocytosis of membrane CD23 and 
IgE 
Evidence presented in this study shows that binding of IgE on the surface of RPM1 
8866 cells does not alone provide a trigger for the endocytosis of CD23-IgE complexes. 
However, addition of a recombinant 37kD sCD23 fragment induces capping and 
endocytosis of CD23-19E complexes. CD23 and IgE are endocytosed together but their 
intracýllular destinations appear to be different. Once inside the cell, the fluorescent label 
for IgE progresses further into the cytoplasm, whereas CD23 shows a tendency to remain 
closer to the cell membrane and may possibly be recycled. The recombinant sCD23 
follows the same intracellular path as mCD23. 
Endocytosis of IgE appears to occur in clathrin-labelled vesicles and to be 
delivered into cytoplasmic areas labelled with a marker indicating low pH. Most internal 
CD23 is not often found within acidic vesicles but cytoplasmic CD23 and acidic areas are 
in close proximity. Electron micrographs showing sCD23-induced endocytosis of CD23- 
IgE complexes suggest that CD23 is not delivered into the endosomal network. The gold 
label for CD23 appears in novel cytoplasmic structures which do not possess the 
morplIology of previously observed endosomal components. These structures lack the 
acidic and proteolytic conditions attributed to members of the late endosomal network. 
These observations point towards the existence of a novel intracellular route for CD23- 
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This alternative fate may involve endocytosis of CD23, bypassing of endosomal 
compartments and recycling to the cell surface. 
Evidence for Recycling of CD23? 
Evidence shown in the present study sheds some light on the process of 
endocytosis of CD23. There is no doubt that some conditions, i. e. binding of certain 
antibodies, influence the triggering of endocytosis of CD23. A number of factors, 
including spontaneous shedding of membrane CD23, also lead to lack of conclusive 
evidence to support or disprove its possible recycling back to the cell surface following 
internalisation. However, a series of observations made under certain experimental 
conditions imply the presence of a recycling mechanism rather than an intracellular 
degradative fate. 
Firstly, engagement of HLA DR with CR3/43 antibody triggers endocytosis of 
both HLA DR and CD23. Unlike observations from similar experiments exploring MHM6 
or BU38 antibody-induced internalisation of CD23, after 6 hours at 370C, little or no 
internal CD23 or HLA DR was observed in cells treated with CR3/43. This suggests that 
in the latter experiments CD23 did not follow a degradative pathway which would result 
in intracellular accumulation of its fluorescent label after 6 hours at 370C. In the same 
experiments, electron micrographs indicate the presence of some gold label for CD23 in 
cytoplasmic compartments specialising in antigenic peptide loading (MlICs) onto HLA 
DR. After peptide loading within MIICs (Amigorena et al., 1994; Tulp et al., 1994; West, 
Lucocq & Watts, 1994) it has been shown that HLA DR is transported to the cell surface 
to present antigen to autologous T cells (Neefjes & Ploegh, 1992) . The non-covalent 
spatial association of CD23 with HLA DR (Bonnefoy et al., 1988) suggests that CD23 
may be sequestered back to the cell surface, perhaps to participate in antigen presentation. 
lodination and immunoprecipitation experiments showed that intracellular degradation of 
CD23 to a 16kD fragment is altered after treatment with CR3/43 antibody to HLA DR 
and incubation at 370C. Endocytosed CD23 was instead reduced to a 37kD soluble 
fragment which recycles and associates non-covalently with the cell membrane (Murdock 
et al., manuscript in preparation, Figure 5.20). 
The involvement of the 37kD soluble CD23 fragment in a possible recycling fate of 
membrane CD23 is further suggested in the present study. Treatment with a recombinant 
37kD sCD23 fragment induces endocytosis of CD23-IgE complexes. Although internal 
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CD23 was abundant after 2 and 4 hours at 370C, it was commonly associated with the cell 
membrane after 6 hours. Furthermore, electron micrographs showed that the gold label for 
endocytosed CD23 under these conditions, was not subjected to the acidic and/or 
proteolytic environment previously observed in this study to cause digestion of the protein 
coat of gold particles and gold aggregation in cytoplasmic multilamennal and 
multivesicular bodies. Confocal microscopy and electron microscopy thus further imply 
the existence of a non-degradative fate for CD23. 
The above observations were made in the course of investigating the components 
involved in the process of endocytosis of CD23. Taken together, they suggest that under 
certain conditions internalised CD23 may not be targetted for cytoplasmic degradation. 
Although there is no single definitive experiment, indirect evidence points towards the 
possibility of CD23 recycling. 
Soluble Fragments and IgE May Determine the Mechanism of CD23 
Internalisation 
The findings of the present study point towards at least two major factors which 
may determine the mechanism of endocytosis and processing of CD23. One is the 
production and release of soluble fragments of CD23 and the other is the presence or 
absence of IgE binding to mCD23- 
From the present study it appears that a 37kD soluble CD23 fragment may be a 
key factor in initiating the process of endocytosis. Cleavage of CD23 into soluble 
fragments is a well known property of the membrane form. Indeed, soluble CD23 
fragments of various sizes have been known to differ in their ability to regulate IgE 
synthesis (Delespesse et al., 199 1). The presence of soluble CD23 is also linked to growth 
and differentiation of B cell precursors. It has been proposed that soluble fragments 
comprising the lectin domain and part of the stalk region are able to stimulate 
IgE 
synthesis (Sarfati et al., 1984b; Chretien et al., 1990). The 25kD fragment which 
does not 
contain sequences from the stalk region has no effect on IgE regulation, whereas the 
l6kD 
species which lacks the DRG sequence suppresses ongoing and 
EL-4-induced IgE 
syntheses (Sarfati et al., 1992; Delespesse et al., 199 1). Thus a regulatory mechanism may 
exist 
ývhich acts to favour release of certain soluble CD23 fragments over others, which 
in 
turn affects the endocytosis of CD23 on B lymphocytes. 
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The present study demonstrates that a 37kD soluble fragment induces endocytosis 
of CD23-IgE complexes. It has also been shown that some conditions such as the 
presence or absence of foetal calf serum, proteases and protease inhibitors in the medium 
can switch the release of soluble CD23 from a 25kD fragment into a 37kD soluble species 
(Moulder, Barton & Weston, 1993). Recent evidence further suggests that CR3/43 
antibody to HLA DR causes a change in the intracellular degradation of CD23 from a 
I&D fragment into a 37kD soluble from which is recycled and released to the medium 
(Murdock et al., manuscript in preparation, see Figure 5.20). Previous studies also reveal 
that CD23 can be proteolysed on the cell surface to release an unstable 37kD fragment 
which is further cleaved to form a stable 25kD species (Letellier, Sarfati & Delespesse, 
1989). Intracellular processing and recycling of CD23 may be a further regulatory step 
ensuring proteolysis of CD23 to a 37kD soluble fragment in a stable, perhaps dimeric or 
trimeric form that is more resistant to further degradation than the species released directly 
from membrane CD23. Further experimentation is necessary to establish whether 
fragments of smaller sizes (<37kD) can influence intemalisation of CD23-IgE complexes, 
or of unbound mCD23. It is possible that only fragments containing sequences from the 
stalk region are capable of promoting endocytosis of CD23- 
I The presence or absence of IgE binding to mCD23 may be another factor 
determining the direction of intracellular processing of CD23. Indeed, this could be true in 
vivo, where processing of CD23 may be a direct reflection of the IgE levels in the system. 
Depending on the availability of IgE for binding, the intracellular route of CD23 may vary. 
Binding of IgE, although not effective alone in enhancing endocytosis of CD23, may, 
along with sCD23 of various sizes, determine the intracellular processing, proteolysis and 
final destination of its receptor. As discussed above, immunoprecipitation experiments 
show that at least two routes exist for the intracellular processing of endocytosed CD23; 
one causes the proteolysis of CD23 into a 37kD fragment (Murdock et al., manuscript in 
preparation) and the other its endosomal degradation into a l6kD form (Grenier-Brossette 
et al., '1992). As discussed in Chapter 3, stimulatory antibodies may not only recognise an 
area of the lectin domain belonging to the IgE binding site, but may also cause 
destabilisation and proteolysis of membrane CD23. Destabilisation of mCD23 would 
facilitate production of soluble fragments and enhance endocytosis; their binding to the 
lectin domain may further determine the intracellular direction for the internalised protein. 
I 
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The binding of IgE is known to stabilise membrane CD23 and preN, ent its 
proteolysis (Lee, Rao & Conrad, 1997). It has also been shown in an in vivo cell system, 
that binding of IgE-antigen complexes inhibits ongoing IgE synthesis (Sherr et al., 1989). 
The present study shows that IgE binding is unable to provide a signal for endocytosis and 
that the presence of soluble fragments may be necessary to regulate endocytosis of CD23- 
IgE complexes. In the absence of free IgE available for binding to CD23, processing of 
CD23 may occur via an endosomal and lysosomal. route. In the presence of high levels of 
IgE however, CD23 may serve to remove IgE from the system, and may perhaps recycle 
to the cell surface to bind and process more IgE molecules. Further experiments would be 
needed to establish whether 37kD soluble CD23 fragments have an effect on the 
intracellular processing of mCD23 in the absence of IgE. 
To this end, sCD23, IgE and mCD23 may be components of a regulatory cycle 
which uses endocytosis, intracellular processing and proteolysis as the mechanism for 
controlling antigen presentation and the levels of IgE in the system. This mechanism may 
also involve other membrane proteins such as HLA DR. Co-endocytosis of CD23 and 
HLA DR in RPM1 8866 cells suggests the involvement of both in antigen processing and 
presentation. Further experiments are needed to establish the conditions necessary for 
endocytosis of IgE-antigen complexes and antigen processing in MIIC compartments. The 
cell line used in the present study does not express CD21. However, CD21 can bind 
soluble CD23 and may therefore be another key player in the signalling pathway leading to 
cell activation and regulation of IgE production. 
Concluding Remarks 
It is of no surprise that more than one pathway may exist for the process of 
endocytosis of CD23. Indeed, CD23 is a versatile protein linked to a number of 
immunological processes from induction of growth and differentiation of B cells, to 
regulation of IgE synthesis and antigen presentation. Further study of these endocytotic 
pathways of the low affinity receptor of IgE may increase our understanding of its 
biological role in the immune system. 
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